data_1x9v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x9v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.616 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 20.2 m95 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.542 0.687 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.431 ' HA ' ' CD ' ' A' ' 58' ' ' GLU . 3.2 m -49.65 -22.4 1.32 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.319 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -89.95 -15.77 57.26 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.528 ' CG1' HD23 ' B' ' 68' ' ' LEU . 21.9 t -99.3 -54.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.451 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HA ' HD13 ' A' ' 61' ' ' ILE . 12.5 pt-20 -50.59 -45.89 57.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.616 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.514 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -71.62 -19.5 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.997 . . . . 0.0 109.05 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 11.6 mt -88.06 -22.38 24.21 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' B' ' 64' ' ' LEU . 25.3 mt -71.92 -37.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 63' ' ' ILE . 11.3 ptp180 -87.96 -42.73 12.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 6.6 mm -53.83 -36.78 31.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.516 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 21.3 mt -76.61 -41.09 47.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.239 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 1.8 pt20 -68.93 -40.22 79.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.471 ' O ' HD12 ' A' ' 70' ' ' ILE . 8.0 tt0 -57.98 -53.67 55.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.438 -0.789 . . . . 0.0 109.301 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 14.5 mt -52.16 -61.87 2.0 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.814 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 HD21 ' CZ3' ' B' ' 54' ' ' TRP . 1.8 mm? -44.86 -48.68 11.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.079 -1.013 . . . . 0.0 109.874 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.563 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -47.29 -32.27 4.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.41 -0.806 . . . . 0.0 109.752 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 1.2 mp -82.95 -51.85 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.605 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 10.5 t60 -46.67 -45.79 19.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -74.27 -38.25 63.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.469 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.508 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.605 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 20.4 m95 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.643 0.735 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.425 ' HA ' ' CD ' ' B' ' 58' ' ' GLU . 3.2 m -49.73 -22.31 1.35 Allowed 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.317 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -89.99 -15.7 57.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.525 ' CG1' HD23 ' A' ' 68' ' ' LEU . 21.8 t -99.34 -54.93 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -1.077 . . . . 0.0 109.448 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' B' ' 61' ' ' ILE . 12.5 pt-20 -50.7 -45.8 58.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.93 . . . . 0.0 109.611 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.515 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -71.67 -19.55 62.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.036 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 11.6 mt -88.09 -22.25 24.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.552 HG12 ' CB ' ' A' ' 64' ' ' LEU . 25.6 mt -71.95 -37.38 60.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.511 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 11.3 ptp180 -88.0 -42.69 12.27 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.391 0.615 . . . . 0.0 110.364 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' B' ' 59' ' ' ALA . 6.6 mm -53.82 -36.82 31.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 21.3 mt -76.57 -40.98 48.07 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 109.234 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 1.8 pt20 -69.16 -40.17 78.34 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.463 ' O ' HD12 ' B' ' 70' ' ' ILE . 7.9 tt0 -57.98 -53.67 55.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 14.5 mt -52.18 -61.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.557 ' CD2' ' CZ3' ' A' ' 54' ' ' TRP . 1.8 mm? -44.81 -48.74 10.99 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.234 -0.916 . . . . 0.0 109.839 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.579 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -47.22 -32.23 4.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.814 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.2 mp -83.04 -51.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 10.6 t60 -46.65 -45.79 19.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -0.864 . . . . 0.0 110.744 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.4 OUTLIER -74.33 -38.18 63.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.064 -1.022 . . . . 0.0 110.614 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.467 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.107 -0.996 . . . . 0.0 110.495 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.677 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 26.3 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.548 0.689 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -51.11 -22.3 2.41 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.441 -0.903 . . . . 0.0 108.749 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -86.19 -20.06 55.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TRP . 79.1 t -94.49 -51.57 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.522 -0.987 . . . . 0.0 108.996 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.462 ' HA ' HD11 ' A' ' 61' ' ' ILE . 2.7 mm-40 -46.61 -56.8 5.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.262 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 62' ' ' ARG . . . -62.89 -16.52 59.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.359 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 13.2 mt -91.26 -21.66 20.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CD1' ' CD1' ' B' ' 68' ' ' LEU . 83.5 mt -76.58 -34.42 24.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.51 ' HG3' HD11 ' A' ' 63' ' ' ILE . 16.8 ptp180 -88.44 -41.8 12.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.804 -0.56 . . . . 0.0 110.468 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.51 HD11 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -44.23 -41.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.426 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.545 ' CB ' HG12 ' B' ' 61' ' ' ILE . 37.9 mt -69.66 -49.79 50.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -63.38 -33.84 76.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.13 . . . . 0.0 108.093 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.04 -53.92 51.26 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -53.46 -50.77 64.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 108.971 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' CD1' ' CD1' ' B' ' 61' ' ' ILE . 3.1 mt -48.94 -53.46 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.84 . . . . 0.0 109.314 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.3 m-85 -43.78 -39.98 4.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.748 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.51 ' HA ' ' CG ' ' A' ' 73' ' ' ARG . 1.9 mp -71.65 -38.88 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CG ' ' CZ2' ' B' ' 54' ' ' TRP . 1.5 t60 -53.71 -47.03 70.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.594 -0.692 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -76.32 -15.6 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 0.0 111.051 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.51 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 120.998 -1.063 . . . . 0.0 110.597 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.672 ' CZ2' ' CG ' ' A' ' 71' ' ' HIS . 25.6 m95 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -51.1 -22.29 2.38 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.783 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -86.2 -20.07 55.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' B' ' 54' ' ' TRP . 79.1 t -94.53 -51.56 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.52 -0.988 . . . . 0.0 108.937 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.448 ' HA ' HD11 ' B' ' 61' ' ' ILE . 2.7 mm-40 -46.71 -56.71 5.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.491 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -62.89 -16.48 59.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 13.2 mt -91.28 -21.69 20.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 64' ' ' LEU . 82.7 mt -76.67 -34.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.514 ' HG3' HD11 ' B' ' 63' ' ' ILE . 16.8 ptp180 -88.51 -41.69 12.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.806 -0.559 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.514 HD11 ' HG3' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -44.29 -42.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.322 -179.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 64' ' ' LEU . 38.4 mt -69.58 -49.83 50.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.61 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -63.36 -33.84 76.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.998 -1.064 . . . . 0.0 108.163 178.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -61.02 -53.98 50.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.467 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -53.44 -50.74 64.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 108.987 178.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.542 ' CD1' ' CD1' ' A' ' 61' ' ' ILE . 3.0 mt -48.97 -53.4 20.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.323 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.3 m-85 -43.9 -39.93 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.518 ' HA ' ' CG ' ' B' ' 73' ' ' ARG . 1.8 mp -71.7 -38.82 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.677 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.5 t60 -53.75 -46.96 71.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.546 -0.721 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.8 OUTLIER -76.44 -15.45 59.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 111.078 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.518 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.084 . . . . 0.0 110.56 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.668 ' CZ2' ' CG ' ' B' ' 71' ' ' HIS . 20.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.431 0.634 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -52.19 -21.06 3.0 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.001 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -95.04 -17.51 37.31 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' ILE . 25.0 t -97.52 -53.18 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.995 . . . . 0.0 109.426 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 62' ' ' ARG . 4.8 tp10 -49.97 -54.15 21.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.307 -0.87 . . . . 0.0 109.409 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -65.02 -19.41 65.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.439 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 11.4 mt -89.06 -23.39 22.56 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.565 ' CD1' ' CD1' ' B' ' 68' ' ' LEU . 31.7 mt -71.59 -34.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 12.5 ptp180 -90.96 -41.7 10.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.563 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 9.1 mm -58.4 -33.24 47.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.027 -1.046 . . . . 0.0 110.042 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 26.3 mt -77.71 -37.1 50.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 66' ' ' GLN . 1.1 pt20 -78.67 -41.12 32.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -57.97 -47.94 81.44 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.434 -0.791 . . . . 0.0 108.996 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 9.4 tp -61.7 -46.19 90.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' CD1' ' CD1' ' B' ' 61' ' ' ILE . 1.1 mt -50.43 -54.99 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.8 m-85 -43.08 -40.35 3.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.416 -0.803 . . . . 0.0 110.067 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 1.3 mp -72.94 -47.44 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.659 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 2.5 t60 -46.05 -46.11 16.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -78.39 -14.64 59.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.856 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.532 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.981 -1.075 . . . . 0.0 110.557 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.659 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 19.9 m95 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.7 m -52.14 -21.01 2.89 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.008 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' B' ' 60' ' ' LEU . . . -95.11 -17.49 37.21 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 61' ' ' ILE . 25.1 t -97.44 -53.21 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.38 -1.07 . . . . 0.0 109.417 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.523 ' OE2' ' CZ ' ' B' ' 62' ' ' ARG . 4.8 tp10 -49.99 -54.23 21.41 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -64.98 -19.38 65.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 11.4 mt -88.99 -23.46 22.62 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.558 ' CD1' ' CD1' ' A' ' 68' ' ' LEU . 32.1 mt -71.58 -34.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.523 ' CZ ' ' OE2' ' B' ' 58' ' ' GLU . 12.5 ptp180 -90.98 -41.63 11.0 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.597 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.521 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 9.1 mm -58.45 -33.18 47.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.074 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 26.9 mt -77.7 -37.1 50.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.561 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.49 ' CG ' ' N ' ' B' ' 66' ' ' GLN . 1.1 pt20 -78.59 -41.23 32.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.49 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -57.86 -48.0 81.07 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.437 -0.79 . . . . 0.0 108.988 178.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 9.4 tp -61.64 -46.23 90.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.565 ' CD1' ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -50.5 -54.92 18.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.8 m-85 -43.11 -40.33 3.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.3 mp -72.92 -47.43 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.668 ' CG ' ' CZ2' ' A' ' 54' ' ' TRP . 2.5 t60 -46.03 -46.16 16.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.529 -0.732 . . . . 0.0 110.767 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.3 OUTLIER -78.36 -14.71 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 110.925 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.524 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.09 . . . . 0.0 110.529 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.686 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.19 0.519 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.8 m -51.91 -22.1 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.065 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 60' ' ' LEU . . . -58.26 -17.0 29.63 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.6 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 17.4 t -94.73 -55.79 5.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.421 -1.046 . . . . 0.0 109.026 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.536 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -45.52 -54.67 7.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . . . -66.44 -13.07 60.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.522 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.4 mt -96.26 -20.52 18.48 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.507 ' CD1' HG11 ' A' ' 57' ' ' VAL . 45.9 mt -81.56 -32.64 11.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 16.7 ptp180 -85.63 -43.98 12.99 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.47 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -51.07 -39.13 19.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.824 -1.151 . . . . 0.0 108.103 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.505 ' CD2' HG13 ' B' ' 61' ' ' ILE . 0.1 OUTLIER -64.45 -54.67 29.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -60.28 -40.23 89.69 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -56.81 -45.62 82.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.227 -0.92 . . . . 0.0 108.763 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HA ' HD11 ' A' ' 70' ' ' ILE . 1.4 tt -70.69 -42.01 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 109.756 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.522 ' CB ' HD12 ' B' ' 61' ' ' ILE . 0.2 OUTLIER -55.08 -33.16 62.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 108.717 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -60.36 -60.59 3.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.599 ' HA ' ' CG ' ' A' ' 73' ' ' ARG . 2.1 mp -52.39 -32.68 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.998 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.682 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 7.9 t60 -58.84 -32.79 69.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.375 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -91.07 -42.54 10.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.856 -1.153 . . . . 0.0 111.303 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.633 ' N ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 O-C-N 120.475 -1.391 . . . . 0.0 110.39 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.682 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.165 0.507 . . . . 0.0 109.684 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 86.0 m -52.03 -22.01 3.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -58.24 -17.03 29.62 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 17.3 t -94.75 -55.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.489 -1.006 . . . . 0.0 109.004 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.548 ' HG3' ' CZ2' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -45.6 -54.61 7.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.499 ' HA ' ' NE ' ' B' ' 62' ' ' ARG . . . -66.43 -13.12 60.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 12.4 mt -96.35 -20.49 18.44 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.522 HD12 ' CB ' ' A' ' 68' ' ' LEU . 46.0 mt -81.64 -32.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 16.6 ptp180 -85.49 -44.01 13.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.526 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.509 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -51.14 -39.07 19.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.121 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.5 ' CD2' HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -64.45 -54.72 28.23 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -60.27 -40.25 89.71 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.534 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 0.0 OUTLIER -56.76 -45.7 81.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 108.756 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.59 -42.06 71.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.79 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -55.09 -33.2 62.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 108.655 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.603 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 0.3 OUTLIER -60.29 -60.61 3.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 108.413 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.608 ' HA ' ' CG ' ' B' ' 73' ' ' ARG . 2.1 mp -52.35 -32.82 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.686 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 7.9 t60 -58.73 -32.87 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.361 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -91.0 -42.64 10.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 111.248 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.634 ' N ' ' CD1' ' B' ' 72' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.943 0 O-C-N 120.486 -1.384 . . . . 0.0 110.361 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' B' ' 68' ' ' LEU . 14.4 m95 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.651 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -42.73 -25.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.783 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 60' ' ' LEU . . . -102.02 37.47 3.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' TRP . 93.4 t -157.98 -53.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.946 -0.737 . . . . 0.0 109.557 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -62.44 -46.51 88.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.0 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HA ' ' CD ' ' A' ' 62' ' ' ARG . . . -89.43 -5.14 57.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' CD1' HD12 ' B' ' 64' ' ' LEU . 0.2 OUTLIER -100.53 -21.29 15.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' B' ' 64' ' ' LEU . 44.0 mt -83.83 -37.33 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' CD ' ' HA ' ' A' ' 59' ' ' ALA . 12.4 ptm180 -78.97 -42.36 26.98 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -44.67 -42.29 2.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.184 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.611 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 25.4 mt -71.38 -44.65 64.57 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -56.66 -44.74 81.67 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.456 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -61.44 -47.39 85.97 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -60.83 -42.89 98.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.477 -0.765 . . . . 0.0 109.154 178.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.0 -43.62 81.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 108.78 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 1.8 m-85 -62.75 -17.27 60.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.807 . . . . 0.0 109.012 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 4.1 mt -95.88 -51.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.529 ' CD2' ' CD2' ' B' ' 54' ' ' TRP . 1.5 t60 -46.98 -45.17 20.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -60.74 -35.51 76.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' B' ' 57' ' ' VAL . 14.6 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.436 0.636 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -42.71 -25.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.78 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' B' ' 57' ' ' VAL . . . -101.99 37.44 3.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' B' ' 54' ' ' TRP . 92.9 t -158.0 -53.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.845 -0.797 . . . . 0.0 109.539 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.952 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -89.49 -5.1 57.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.85 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.533 ' CD1' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.6 -21.26 15.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 64' ' ' LEU . 44.0 mt -83.75 -37.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.879 0.847 . . . . 0.0 108.799 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.4 ptm180 -79.09 -42.39 26.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.85 -0.531 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.533 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.8 OUTLIER -44.48 -42.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.091 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.611 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 24.8 mt -71.2 -44.71 64.88 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.07 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.476 ' HA ' HD22 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -56.6 -44.86 81.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -61.49 -47.23 86.59 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -61.0 -42.77 99.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.474 -0.766 . . . . 0.0 109.166 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -56.99 -43.58 81.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 108.788 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 1.8 m-85 -62.83 -17.32 61.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.885 . . . . 0.0 109.008 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.482 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 4.0 mt -95.85 -51.84 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.537 ' CD2' ' CD2' ' A' ' 54' ' ' TRP . 1.5 t60 -46.93 -45.24 20.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.85 . . . . 0.0 110.133 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -60.72 -35.41 76.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 110.067 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.95 . . . . 0.0 110.08 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.68 ' CD1' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.114 0.483 . . . . 0.0 109.767 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -44.59 -26.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -53.92 -23.39 22.92 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.585 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 34.9 t -97.57 -33.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.583 -0.951 . . . . 0.0 109.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.474 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 3.3 tp10 -61.75 -51.34 68.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.291 -0.88 . . . . 0.0 109.458 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.48 ' O ' HD11 ' A' ' 63' ' ' ILE . . . -63.51 -23.44 67.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.461 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.505 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 37.8 mt -86.52 -21.41 26.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' B' ' 64' ' ' LEU . 1.3 mm -76.09 -38.41 34.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.787 0.803 . . . . 0.0 108.991 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 15.2 ptm180 -84.04 -42.52 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -46.5 -42.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.828 -1.149 . . . . 0.0 108.743 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.608 ' HB3' HG12 ' B' ' 61' ' ' ILE . 49.4 mt -74.22 -41.87 60.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.08 -43.29 82.01 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 10.8 tt0 -62.43 -50.8 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 4.9 tt -59.09 -45.69 90.2 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.207 -0.933 . . . . 0.0 108.714 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.642 ' CD2' ' CH2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -47.82 -56.9 6.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.484 -0.76 . . . . 0.0 109.643 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 4.9 m-85 -45.28 -33.53 2.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 67' ' ' LEU . 30.9 mm -79.9 -22.71 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.949 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.675 ' CE1' ' CD1' ' B' ' 54' ' ' TRP . 27.7 t60 -67.37 -34.78 78.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -0.852 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 1.6 p90 -88.89 -30.38 18.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.222 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.675 ' CD1' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.134 0.492 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -44.58 -26.67 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -53.92 -23.37 22.82 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 35.1 t -97.5 -33.64 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.578 -0.954 . . . . 0.0 109.676 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.479 ' HB2' ' CZ2' ' B' ' 54' ' ' TRP . 3.4 tp10 -61.78 -51.35 68.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.486 ' O ' HD11 ' B' ' 63' ' ' ILE . . . -63.43 -23.47 67.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.441 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 38.3 mt -86.55 -21.4 26.91 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.608 HG12 ' HB3' ' A' ' 64' ' ' LEU . 1.3 mm -76.11 -38.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.771 0.796 . . . . 0.0 108.944 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 15.2 ptm180 -84.15 -42.51 15.94 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.512 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.7 OUTLIER -46.48 -42.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.844 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.606 ' HB3' HG12 ' A' ' 61' ' ' ILE . 49.1 mt -74.27 -41.8 60.65 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.296 -0.878 . . . . 0.0 108.735 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.513 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.01 -43.27 81.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.513 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 10.7 tt0 -62.57 -50.69 70.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 4.9 tt -59.12 -45.68 90.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.753 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -47.87 -56.88 6.5 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.368 -0.832 . . . . 0.0 109.631 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 4.9 m-85 -45.13 -33.64 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.325 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 67' ' ' LEU . 31.5 mm -79.88 -22.74 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -0.764 . . . . 0.0 109.932 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.68 ' CE1' ' CD1' ' A' ' 54' ' ' TRP . 27.7 t60 -67.29 -34.82 78.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.258 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 1.6 p90 -88.81 -30.39 19.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 110.252 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.417 ' O ' ' HD2' ' B' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.068 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 18.1 m95 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.453 0.644 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.24 -23.69 1.46 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -82.99 -30.64 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 16.7 t -82.47 -38.72 15.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.658 -0.907 . . . . 0.0 108.568 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -59.12 -54.36 47.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' A' ' 63' ' ' ILE . . . -64.47 -17.43 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 108.746 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 56' ' ' GLY . 12.1 mt -88.29 -22.92 23.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' B' ' 64' ' ' LEU . 1.0 OUTLIER -72.09 -38.93 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' HG3' HD11 ' A' ' 63' ' ' ILE . 9.7 ptm180 -86.08 -41.75 14.51 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.802 -0.561 . . . . 0.0 110.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 59' ' ' ALA . 1.1 mp -43.91 -42.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.321 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 11.1 mt -70.68 -44.65 66.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -68.04 -30.51 69.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.134 -0.979 . . . . 0.0 108.805 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.541 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 32.5 tt0 -68.64 -53.97 19.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.436 -0.79 . . . . 0.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.7 -32.44 73.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.662 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 4.4 mt -63.61 -45.2 91.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.627 ' CZ ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -68.22 -25.28 65.12 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.278 -0.889 . . . . 0.0 109.195 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.627 ' CD1' ' CZ ' ' A' ' 69' ' ' PHE . 13.8 mm -85.32 -18.84 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.158 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -68.91 -51.57 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.563 -0.711 . . . . 0.0 110.154 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.551 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 2.1 p90 -71.02 -14.85 62.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.576 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 17.9 m95 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.394 0.616 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.19 -23.71 1.42 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.657 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -82.93 -30.72 31.01 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 54' ' ' TRP . 16.9 t -82.39 -38.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.579 -0.954 . . . . 0.0 108.619 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.472 ' O ' ' HB ' ' B' ' 61' ' ' ILE . 0.2 OUTLIER -59.19 -54.29 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' B' ' 63' ' ' ILE . . . -64.51 -17.4 63.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 108.762 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 56' ' ' GLY . 12.2 mt -88.23 -22.8 23.78 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -72.28 -38.92 63.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.5 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 9.7 ptm180 -86.2 -41.61 14.52 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.368 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' B' ' 59' ' ' ALA . 1.1 mp -43.84 -42.18 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.355 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 11.4 mt -70.52 -44.78 66.85 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -68.06 -30.58 69.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 108.76 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.545 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 32.3 tt0 -68.61 -54.01 19.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.332 -0.855 . . . . 0.0 109.264 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.66 -32.46 73.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.647 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' B' ' 64' ' ' LEU . 4.4 mt -63.67 -45.24 91.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.981 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.634 ' CZ ' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -68.08 -25.45 65.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.22 -0.925 . . . . 0.0 109.212 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' B' ' 69' ' ' PHE . 13.9 mm -85.21 -18.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 109.217 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.608 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.0 OUTLIER -68.82 -51.66 38.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.539 -0.725 . . . . 0.0 110.168 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.549 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 2.1 p90 -71.03 -14.75 62.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.648 ' CD2' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.251 0.548 . . . . 0.0 109.826 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 22.0 m -53.94 -19.1 4.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 109.729 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -68.69 -7.51 54.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 16.1 t -111.87 3.85 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -1.129 . . . . 0.0 110.269 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 55' ' ' THR . 11.0 pt-20 -121.86 -37.56 2.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.276 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -87.88 -20.34 26.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.982 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.54 ' CB ' HD12 ' B' ' 64' ' ' LEU . 23.1 mt -85.67 -25.34 26.61 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' B' ' 68' ' ' LEU . 3.9 mt -67.0 -45.11 87.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 7.6 ptm180 -78.97 -42.98 25.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.395 0.617 . . . . 0.0 109.857 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 2.6 mm -47.36 -41.01 6.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.937 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.537 ' CB ' HG12 ' B' ' 61' ' ' ILE . 95.5 mt -72.14 -45.49 60.33 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.41 -41.54 80.55 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.544 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 0.8 OUTLIER -56.34 -54.56 44.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -54.98 -51.09 67.29 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.123 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 ' CD1' ' CD1' ' B' ' 61' ' ' ILE . 0.6 OUTLIER -43.24 -53.12 5.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.36 -0.838 . . . . 0.0 110.426 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.35 -25.55 49.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 109.043 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.598 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.5 mt -91.47 -19.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.203 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.622 ' CE1' ' CD2' ' B' ' 54' ' ' TRP . 65.9 t60 -67.99 -30.93 70.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.649 -0.657 . . . . 0.0 110.52 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -86.62 -31.44 21.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.441 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.622 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.203 0.525 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' B' ' 58' ' ' GLU . 22.1 m -53.85 -19.22 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' B' ' 60' ' ' LEU . . . -68.56 -7.49 53.77 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.58 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 16.2 t -111.91 3.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' B' ' 55' ' ' THR . 11.0 pt-20 -121.84 -37.58 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.331 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.512 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -87.9 -20.25 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.975 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.526 ' CB ' HD12 ' A' ' 64' ' ' LEU . 23.2 mt -85.77 -25.26 26.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 68' ' ' LEU . 3.9 mt -67.13 -45.06 87.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.541 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 7.6 ptm180 -78.86 -43.06 25.87 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.433 0.635 . . . . 0.0 109.835 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.541 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 2.5 mm -47.5 -40.95 7.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.896 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.552 ' CB ' HG12 ' A' ' 61' ' ' ILE . 95.2 mt -72.05 -45.59 60.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.4 -0.812 . . . . 0.0 109.067 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.35 -41.62 80.42 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.539 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 0.8 OUTLIER -56.12 -54.74 41.46 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -54.87 -51.2 66.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -43.29 -53.05 5.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 0.0 110.452 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.601 ' CE2' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.36 -25.48 49.61 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.187 -0.946 . . . . 0.0 109.101 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.601 ' CD1' ' CE2' ' B' ' 69' ' ' PHE . 1.5 mt -91.52 -19.86 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 109.195 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 54' ' ' TRP . 65.8 t60 -68.03 -30.92 70.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -86.58 -31.41 21.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.456 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.689 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.216 0.532 . . . . 0.0 109.835 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 55' ' ' THR . 18.3 m -50.78 -21.67 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 109.578 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 60' ' ' LEU . . . -63.75 -12.11 46.06 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 21.6 t -99.83 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -1.133 . . . . 0.0 109.77 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.543 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 2.8 pp20? -53.39 -37.42 62.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 110.198 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' CB ' ' OE2' ' A' ' 58' ' ' GLU . . . -86.04 -11.15 53.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.045 -1.035 . . . . 0.0 110.411 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 11.1 mt -96.99 -20.26 18.19 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.61 ' CG2' ' CB ' ' B' ' 65' ' ' GLN . 0.4 OUTLIER -81.64 -37.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 13.7 ptm180 -81.07 -41.56 22.4 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.316 0.579 . . . . 0.0 110.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.549 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -54.51 -35.47 31.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.605 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.598 ' HB3' ' CD1' ' B' ' 61' ' ' ILE . 24.0 mt -81.59 -39.87 23.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.073 -1.017 . . . . 0.0 108.914 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.604 ' CB ' ' CG2' ' B' ' 61' ' ' ILE . 0.1 OUTLIER -66.95 -37.92 85.16 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 5.6 tt0 -59.23 -54.4 47.3 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -42.72 75.28 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.139 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -62.25 -37.92 87.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 0.0 108.94 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -58.91 -21.33 57.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 108.97 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.81 -10.42 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.552 -0.718 . . . . 0.0 109.414 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.687 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -74.05 -47.41 36.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.808 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 8.3 p90 -77.9 -6.37 54.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' O ' ' NE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 109.895 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.687 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.157 0.503 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' B' ' 58' ' ' GLU . 18.3 m -50.85 -21.66 1.8 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' B' ' 60' ' ' LEU . . . -63.77 -12.06 45.95 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.58 ' HB ' ' CE3' ' B' ' 54' ' ' TRP . 21.7 t -99.89 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -1.103 . . . . 0.0 109.724 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.536 ' HB3' ' CZ2' ' B' ' 54' ' ' TRP . 2.8 pp20? -53.37 -37.43 62.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 0.0 110.146 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' OE2' ' B' ' 58' ' ' GLU . . . -86.19 -10.99 53.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.139 -0.975 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.537 ' CG ' ' O ' ' B' ' 56' ' ' GLY . 11.2 mt -96.99 -20.25 18.2 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.604 ' CG2' ' CB ' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -81.66 -37.62 15.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.536 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 13.7 ptm180 -81.05 -41.49 22.54 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.341 0.591 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.536 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -54.56 -35.44 31.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.603 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 24.2 mt -81.66 -39.81 23.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.044 -1.035 . . . . 0.0 108.902 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.61 ' CB ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -66.93 -37.93 85.23 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' B' ' 62' ' ' ARG . 5.6 tt0 -59.24 -54.43 46.93 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -42.79 75.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.131 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -62.19 -37.96 87.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 108.96 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -58.99 -21.27 58.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 108.933 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.83 -10.37 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.495 0.664 . . . . 0.0 109.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.689 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -74.17 -47.29 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 109.814 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 8.1 p90 -77.96 -6.36 54.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.468 ' O ' ' NE ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.696 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 36.7 m95 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.556 0.693 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -51.9 -19.01 1.53 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.696 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -91.18 -21.14 36.35 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.809 -2.116 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 54' ' ' TRP . 21.9 t -91.78 -54.46 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.783 -0.834 . . . . 0.0 108.775 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -43.74 -57.55 3.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.429 -0.794 . . . . 0.0 109.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HA ' ' CD ' ' A' ' 62' ' ' ARG . . . -61.5 -16.52 48.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 21.4 mt -95.19 -21.26 18.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.577 HG12 ' HB3' ' B' ' 64' ' ' LEU . 6.7 mt -81.36 -33.29 12.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 59' ' ' ALA . 8.8 ptm180 -82.81 -43.67 16.4 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.168 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -47.29 -32.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.076 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' B' ' 61' ' ' ILE . 6.8 mt -70.92 -55.48 8.31 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.649 0.738 . . . . 0.0 109.306 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.512 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.39 74.73 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.52 -0.872 . . . . 0.0 108.872 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.512 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 4.6 tt0 -68.2 -43.75 77.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.541 -0.724 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -73.8 -29.42 62.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.146 -0.971 . . . . 0.0 110.639 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -76.67 -32.19 57.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -71.81 -24.12 61.67 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.466 HG21 ' O ' ' A' ' 67' ' ' LEU . 1.3 tp -84.48 -36.02 11.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -40.73 -56.25 2.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.168 0.509 . . . . 0.0 110.29 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 3.7 p90 -75.48 -2.36 28.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.535 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.686 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 36.6 m95 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.511 0.672 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -51.86 -19.03 1.52 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.276 -0.969 . . . . 0.0 108.762 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -91.2 -21.13 36.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 54' ' ' TRP . 21.7 t -91.76 -54.54 7.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.749 -0.854 . . . . 0.0 108.727 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' B' ' 57' ' ' VAL . 0.2 OUTLIER -43.8 -57.46 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.513 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -61.47 -16.56 48.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.318 -0.864 . . . . 0.0 109.667 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 21.1 mt -95.15 -21.24 18.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 64' ' ' LEU . 6.7 mt -81.4 -33.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 8.7 ptm180 -82.72 -43.7 16.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.582 -0.699 . . . . 0.0 109.178 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.529 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -47.23 -32.46 2.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.103 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.577 ' HB3' HG12 ' A' ' 61' ' ' ILE . 6.7 mt -70.92 -55.53 8.2 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.659 0.742 . . . . 0.0 109.282 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.42 74.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.505 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 4.6 tt0 -68.19 -43.81 77.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 110.118 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 0.1 OUTLIER -73.66 -29.53 62.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -0.985 . . . . 0.0 110.699 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -76.61 -32.26 57.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.086 -1.009 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.587 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -71.75 -24.16 61.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.47 ' HA ' ' HB3' ' B' ' 73' ' ' ARG . 1.3 tp -84.44 -36.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' HIS . . . . . 0.696 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -40.66 -56.33 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.139 0.495 . . . . 0.0 110.339 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 3.6 p90 -75.41 -2.37 28.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 110.6 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.47 ' HB3' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.608 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' H2 ' ' H ' ' A' ' 53' ' ' THR . 28.6 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.234 0.54 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -47.5 -74.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.616 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 20.2 m95 -82.21 -43.9 17.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.431 ' HA ' ' CD ' ' A' ' 58' ' ' GLU . 3.2 m -49.65 -22.4 1.32 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.319 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -89.95 -15.77 57.26 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.528 ' CG1' HD23 ' B' ' 68' ' ' LEU . 21.9 t -99.3 -54.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.451 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HA ' HD13 ' A' ' 61' ' ' ILE . 12.5 pt-20 -50.59 -45.89 57.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.616 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -71.62 -19.5 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.997 . . . . 0.0 109.05 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 11.6 mt -88.06 -22.38 24.21 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' B' ' 64' ' ' LEU . 25.3 mt -71.92 -37.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 63' ' ' ILE . 11.3 ptp180 -87.96 -42.73 12.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 6.6 mm -53.83 -36.78 31.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.516 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 21.3 mt -76.61 -41.09 47.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.239 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 1.8 pt20 -68.93 -40.22 79.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.471 ' O ' HD12 ' A' ' 70' ' ' ILE . 8.0 tt0 -57.98 -53.67 55.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.438 -0.789 . . . . 0.0 109.301 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 14.5 mt -52.16 -61.87 2.0 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.814 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 HD21 ' CZ3' ' B' ' 54' ' ' TRP . 1.8 mm? -44.86 -48.68 11.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.079 -1.013 . . . . 0.0 109.874 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.563 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -47.29 -32.27 4.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.41 -0.806 . . . . 0.0 109.752 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 1.2 mp -82.95 -51.85 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.605 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 10.5 t60 -46.67 -45.79 19.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -74.27 -38.25 63.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.81 -0.93 55.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.508 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.538 HG12 ' CD ' ' A' ' 73' ' ' ARG . 10.5 mm -135.07 -2.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.0 110.378 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -122.96 -33.17 0.86 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.1 t -104.27 -3.87 23.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 109.952 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 72' ' ' PHE . 3.8 ptm180 -167.62 35.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' ILE . 6.2 p80 -51.57 156.34 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.28 154.0 18.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 110.274 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -90.91 46.06 1.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.26 110.37 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.23 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.18 -58.61 0.68 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.63 -62.4 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -1.103 . . . . 0.0 110.226 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.3 mm 46.85 71.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.186 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 59.15 69.82 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.62 75.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.17 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -48.01 142.12 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 89' ' ' THR . 8.6 mtm180 -72.62 63.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.278 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 88' ' ' ARG . 13.7 t 38.26 38.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 57.73 -176.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -44.28 97.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.79 83.85 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 39.77 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -1.141 . . . . 0.0 110.223 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.64 -160.85 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.255 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -133.97 124.45 26.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 110.226 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 t0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.262 0.553 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -47.56 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.605 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 20.4 m95 -82.09 -43.96 17.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.425 ' HA ' ' CD ' ' B' ' 58' ' ' GLU . 3.2 m -49.73 -22.31 1.35 Allowed 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.317 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -89.99 -15.7 57.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.525 ' CG1' HD23 ' A' ' 68' ' ' LEU . 21.8 t -99.34 -54.93 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -1.077 . . . . 0.0 109.448 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' B' ' 61' ' ' ILE . 12.5 pt-20 -50.7 -45.8 58.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.93 . . . . 0.0 109.611 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.515 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -71.67 -19.55 62.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.036 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 11.6 mt -88.09 -22.25 24.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.552 HG12 ' CB ' ' A' ' 64' ' ' LEU . 25.6 mt -71.95 -37.38 60.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.511 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 11.3 ptp180 -88.0 -42.69 12.27 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.391 0.615 . . . . 0.0 110.364 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' B' ' 59' ' ' ALA . 6.6 mm -53.82 -36.82 31.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 21.3 mt -76.57 -40.98 48.07 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 109.234 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 1.8 pt20 -69.16 -40.17 78.34 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.463 ' O ' HD12 ' B' ' 70' ' ' ILE . 7.9 tt0 -57.98 -53.67 55.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 14.5 mt -52.18 -61.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.557 ' CD2' ' CZ3' ' A' ' 54' ' ' TRP . 1.8 mm? -44.81 -48.74 10.99 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.234 -0.916 . . . . 0.0 109.839 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.579 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -47.22 -32.23 4.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.814 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.2 mp -83.04 -51.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 10.6 t60 -46.65 -45.79 19.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -0.864 . . . . 0.0 110.744 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.4 OUTLIER -74.33 -38.18 63.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.064 -1.022 . . . . 0.0 110.614 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.54 ' CD ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -84.94 -0.89 55.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.107 -0.996 . . . . 0.0 110.495 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.54 HG12 ' CD ' ' B' ' 73' ' ' ARG . 10.5 mm -135.03 -1.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.38 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -122.9 -33.29 0.86 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 t -104.19 -3.84 23.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -1.088 . . . . 0.0 109.983 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' B' ' 73' ' ' ARG . 3.8 ptm180 -167.65 35.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.833 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' B' ' 74' ' ' ILE . 6.2 p80 -51.55 156.4 1.32 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 154.0 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -90.87 45.92 1.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.24 110.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.235 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.13 -58.58 0.69 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.79 -62.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -1.108 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.408 ' HA ' HD11 ' B' ' 84' ' ' ILE . 32.4 mm 46.82 71.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 59.25 69.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.61 75.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -48.01 142.21 5.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.536 ' O ' ' CG2' ' B' ' 89' ' ' THR . 8.6 mtm180 -72.73 63.74 0.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' B' ' 88' ' ' ARG . 13.7 t 38.29 38.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.72 . . . . 0.0 110.616 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 57.63 -176.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -44.23 97.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.221 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.68 83.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.43 39.81 1.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -1.138 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.68 -160.84 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -133.97 124.41 26.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.179 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.268 0.556 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 p -72.6 -58.09 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.677 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 26.3 m95 -107.66 -44.05 4.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.806 . . . . 0.0 109.941 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -51.11 -22.3 2.41 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.441 -0.903 . . . . 0.0 108.749 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -86.19 -20.06 55.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TRP . 79.1 t -94.49 -51.57 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.522 -0.987 . . . . 0.0 108.996 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.462 ' HA ' HD11 ' A' ' 61' ' ' ILE . 2.7 mm-40 -46.61 -56.8 5.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.262 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 62' ' ' ARG . . . -62.89 -16.52 59.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.359 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 13.2 mt -91.26 -21.66 20.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CD1' ' CD1' ' B' ' 68' ' ' LEU . 83.5 mt -76.58 -34.42 24.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.51 ' HG3' HD11 ' A' ' 63' ' ' ILE . 16.8 ptp180 -88.44 -41.8 12.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.804 -0.56 . . . . 0.0 110.468 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.51 HD11 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -44.23 -41.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.426 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.545 ' CB ' HG12 ' B' ' 61' ' ' ILE . 37.9 mt -69.66 -49.79 50.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -63.38 -33.84 76.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.13 . . . . 0.0 108.093 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.04 -53.92 51.26 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -53.46 -50.77 64.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 108.971 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' CD1' ' CD1' ' B' ' 61' ' ' ILE . 3.1 mt -48.94 -53.46 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.84 . . . . 0.0 109.314 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.3 m-85 -43.78 -39.98 4.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.748 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 1.9 mp -71.65 -38.88 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CG ' ' CZ2' ' B' ' 54' ' ' TRP . 1.5 t60 -53.71 -47.03 70.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.594 -0.692 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -76.32 -15.6 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 0.0 111.051 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.51 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.83 1.82 19.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.998 -1.063 . . . . 0.0 110.597 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.578 ' CD1' ' CG2' ' A' ' 70' ' ' ILE . 6.1 mt -130.42 -29.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.45 -50.32 2.03 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.4 m -68.75 -7.93 38.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -1.109 . . . . 0.0 109.783 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.464 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -140.39 12.41 2.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.917 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 79' ' ' SER . 0.0 OUTLIER 67.72 145.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.493 -0.754 . . . . 0.0 109.914 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.573 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -70.24 -145.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.818 . . . . 0.0 110.417 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 84' ' ' ILE . 15.2 ttp180 -113.49 26.73 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 pp -69.62 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.16 -120.65 1.37 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -72.08 -100.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -1.107 . . . . 0.0 110.287 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' N ' ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -134.16 -94.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.561 -1.337 . . . . 0.0 110.158 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.08 15.36 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 46.67 52.67 10.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -130.37 -1.51 4.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.233 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -142.9 74.67 1.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 0.2 OUTLIER 65.35 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -85.69 49.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.67 85.32 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.4 104.97 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.93 102.1 5.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -1.159 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' LYS . 82.0 p -76.1 117.26 17.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER 43.02 55.75 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 95' ' ' LYS . 84.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.212 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.2 p -72.57 -58.1 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.672 ' CZ2' ' CG ' ' A' ' 71' ' ' HIS . 25.6 m95 -107.69 -44.01 4.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 109.953 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -51.1 -22.29 2.38 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.783 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -86.2 -20.07 55.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' B' ' 54' ' ' TRP . 79.1 t -94.53 -51.56 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.52 -0.988 . . . . 0.0 108.937 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.448 ' HA ' HD11 ' B' ' 61' ' ' ILE . 2.7 mm-40 -46.71 -56.71 5.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.491 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -62.89 -16.48 59.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 13.2 mt -91.28 -21.69 20.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 64' ' ' LEU . 82.7 mt -76.67 -34.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.514 ' HG3' HD11 ' B' ' 63' ' ' ILE . 16.8 ptp180 -88.51 -41.69 12.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.806 -0.559 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.514 HD11 ' HG3' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -44.29 -42.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.322 -179.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 64' ' ' LEU . 38.4 mt -69.58 -49.83 50.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.61 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -63.36 -33.84 76.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.998 -1.064 . . . . 0.0 108.163 178.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -61.02 -53.98 50.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.467 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -53.44 -50.74 64.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 108.987 178.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.542 ' CD1' ' CD1' ' A' ' 61' ' ' ILE . 3.0 mt -48.97 -53.4 20.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.323 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.3 m-85 -43.9 -39.93 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.575 ' CG2' ' CD1' ' B' ' 74' ' ' ILE . 1.8 mp -71.7 -38.82 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.677 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.5 t60 -53.75 -46.96 71.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.546 -0.721 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.8 OUTLIER -76.44 -15.45 59.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 111.078 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.518 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -109.83 1.77 19.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.084 . . . . 0.0 110.56 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.575 ' CD1' ' CG2' ' B' ' 70' ' ' ILE . 6.0 mt -130.39 -29.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 0.0 110.228 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.48 -50.35 2.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 76.5 m -68.67 -8.0 38.37 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -1.111 . . . . 0.0 109.809 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -140.44 12.45 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.873 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' B' ' 79' ' ' SER . 0.0 OUTLIER 67.79 145.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.914 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 0.7 OUTLIER -70.14 -145.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 110.412 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' B' ' 84' ' ' ILE . 15.3 ttp180 -113.5 26.65 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 pp -69.55 66.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.309 -0.869 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.21 -120.68 1.37 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.482 ' CG1' ' N ' ' B' ' 84' ' ' ILE . 0.2 OUTLIER -72.08 -100.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 110.354 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.482 ' N ' ' CG1' ' B' ' 83' ' ' ILE . 18.1 mt -134.25 -94.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.519 -1.363 . . . . 0.0 110.114 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.08 15.4 23.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 110.184 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 46.65 52.69 10.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.201 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -130.31 -1.54 4.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' B' ' 89' ' ' THR . 0.0 OUTLIER -142.94 74.79 1.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.94 . . . . 0.0 110.21 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.446 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 0.2 OUTLIER 65.26 132.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -85.64 49.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.74 85.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.51 105.02 3.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.98 102.07 5.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -1.195 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' SER . . . . . 0.411 ' O ' ' C ' ' B' ' 95' ' ' LYS . 81.6 p -76.22 117.37 17.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.201 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' B' ' 96' ' ' SER . 0.0 OUTLIER 42.9 55.8 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' B' ' 95' ' ' LYS . 84.9 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.193 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' H1 ' ' H ' ' A' ' 53' ' ' THR . 12.6 t70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.309 0.576 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 ' H ' ' H1 ' ' A' ' 52' ' ' ASP . 40.5 p -56.75 -63.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.668 ' CZ2' ' CG ' ' B' ' 71' ' ' HIS . 20.2 m95 -104.28 -44.96 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -52.19 -21.06 3.0 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.001 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -95.04 -17.51 37.31 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' ILE . 25.0 t -97.52 -53.18 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.995 . . . . 0.0 109.426 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 62' ' ' ARG . 4.8 tp10 -49.97 -54.15 21.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.307 -0.87 . . . . 0.0 109.409 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -65.02 -19.41 65.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.439 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 11.4 mt -89.06 -23.39 22.56 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.565 ' CD1' ' CD1' ' B' ' 68' ' ' LEU . 31.7 mt -71.59 -34.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 12.5 ptp180 -90.96 -41.7 10.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.563 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 9.1 mm -58.4 -33.24 47.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.027 -1.046 . . . . 0.0 110.042 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 26.3 mt -77.71 -37.1 50.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 66' ' ' GLN . 1.1 pt20 -78.67 -41.12 32.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -57.97 -47.94 81.44 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.434 -0.791 . . . . 0.0 108.996 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 9.4 tp -61.7 -46.19 90.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' CD1' ' CD1' ' B' ' 61' ' ' ILE . 1.1 mt -50.43 -54.99 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.8 m-85 -43.08 -40.35 3.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.416 -0.803 . . . . 0.0 110.067 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 1.3 mp -72.94 -47.44 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.659 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 2.5 t60 -46.05 -46.11 16.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -78.39 -14.64 59.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.856 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.574 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -114.65 14.08 17.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.981 -1.075 . . . . 0.0 110.557 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.594 ' HA ' ' CG ' ' A' ' 78' ' ' HIS . 10.2 mt -157.63 -34.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 0.0 110.357 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.32 -36.08 5.53 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 77' ' ' ARG . 5.8 t -48.28 -39.34 21.29 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.241 -1.152 . . . . 0.0 108.139 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER 150.96 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.594 ' CG ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.38 1.95 42.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.925 -1.109 . . . . 0.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -168.67 2.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.327 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 0.8 OUTLIER -72.45 0.24 10.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.395 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 80' ' ' ARG . 3.8 mt 62.0 10.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.574 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 81' ' ' ILE . . . 35.51 47.36 0.85 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.556 HG13 ' N ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -48.07 -86.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.256 . . . . 0.0 109.868 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.556 ' N ' HG13 ' A' ' 83' ' ' ILE . 35.5 pt 33.51 33.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.226 -0.921 . . . . 0.0 111.365 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' ILE . 12.1 pt20 -160.43 -170.24 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' GLN . 5.9 mt-30 44.15 -168.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -130.35 46.97 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.29 54.69 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.122 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 90' ' ' ARG . 5.7 t -133.94 -143.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' N ' ' OG1' ' A' ' 89' ' ' THR . 7.9 mtp180 -73.66 80.78 1.53 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.88 -31.15 38.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.272 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.69 -23.49 2.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.24 81.32 2.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -155.35 39.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 94' ' ' SER . 1.1 mttt -43.96 -40.74 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.245 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.293 0.568 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 40.5 p -56.78 -63.74 1.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.659 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 19.9 m95 -104.27 -45.04 4.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.7 m -52.14 -21.01 2.89 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.008 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' B' ' 60' ' ' LEU . . . -95.11 -17.49 37.21 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 61' ' ' ILE . 25.1 t -97.44 -53.21 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.38 -1.07 . . . . 0.0 109.417 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.523 ' OE2' ' CZ ' ' B' ' 62' ' ' ARG . 4.8 tp10 -49.99 -54.23 21.41 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -64.98 -19.38 65.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 11.4 mt -88.99 -23.46 22.62 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.558 ' CD1' ' CD1' ' A' ' 68' ' ' LEU . 32.1 mt -71.58 -34.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.523 ' CZ ' ' OE2' ' B' ' 58' ' ' GLU . 12.5 ptp180 -90.98 -41.63 11.0 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.597 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.521 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 9.1 mm -58.45 -33.18 47.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.074 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 26.9 mt -77.7 -37.1 50.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.561 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.49 ' CG ' ' N ' ' B' ' 66' ' ' GLN . 1.1 pt20 -78.59 -41.23 32.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.49 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -57.86 -48.0 81.07 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.437 -0.79 . . . . 0.0 108.988 178.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 9.4 tp -61.64 -46.23 90.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.565 ' CD1' ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -50.5 -54.92 18.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.8 m-85 -43.11 -40.33 3.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.3 mp -72.92 -47.43 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.668 ' CG ' ' CZ2' ' A' ' 54' ' ' TRP . 2.5 t60 -46.03 -46.16 16.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.529 -0.732 . . . . 0.0 110.767 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.3 OUTLIER -78.36 -14.71 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 110.925 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.576 ' O ' ' CG ' ' B' ' 78' ' ' HIS . 0.1 OUTLIER -114.54 13.95 17.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.09 . . . . 0.0 110.529 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.591 ' HA ' ' CG ' ' B' ' 78' ' ' HIS . 10.3 mt -157.62 -34.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 0.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' CYS . . . -95.4 -36.14 5.49 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.591 ' O ' ' CB ' ' B' ' 77' ' ' ARG . 5.7 t -48.23 -39.31 20.87 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.163 -1.198 . . . . 0.0 108.149 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.591 ' CB ' ' O ' ' B' ' 76' ' ' CYS . 0.0 OUTLIER 151.03 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.56 178.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.591 ' CG ' ' HA ' ' B' ' 74' ' ' ILE . 0.0 OUTLIER -84.36 2.05 42.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.928 -1.107 . . . . 0.0 110.062 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -168.74 2.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.272 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 0.8 OUTLIER -72.36 0.19 10.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 110.365 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' B' ' 80' ' ' ARG . 3.8 mt 61.84 11.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.392 -0.818 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 81' ' ' ILE . . . 35.45 47.43 0.84 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.554 HG13 ' N ' ' B' ' 84' ' ' ILE . 0.4 OUTLIER -48.07 -86.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -1.22 . . . . 0.0 109.8 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.554 ' N ' HG13 ' B' ' 83' ' ' ILE . 35.6 pt 33.55 33.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.0 111.339 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' B' ' 83' ' ' ILE . 12.1 pt20 -160.41 -170.27 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' B' ' 85' ' ' GLN . 5.9 mt-30 44.07 -168.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -130.33 47.08 2.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 110.15 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 54.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' B' ' 90' ' ' ARG . 5.7 t -133.86 -143.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.407 ' N ' ' OG1' ' B' ' 89' ' ' THR . 7.8 mtp180 -73.74 80.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.9 -31.21 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.194 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.72 -23.48 2.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.27 81.25 2.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -1.145 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' SER . . . . . 0.404 ' O ' ' C ' ' B' ' 95' ' ' LYS . 0.1 OUTLIER -155.31 39.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' B' ' 94' ' ' SER . 1.2 mttt -43.93 -40.78 4.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.172 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' TRP . 7.1 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 52' ' ' ASP . 2.0 m 65.93 -65.75 0.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.686 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -123.08 -26.95 4.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.8 m -51.91 -22.1 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.065 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 60' ' ' LEU . . . -58.26 -17.0 29.63 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.6 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 17.4 t -94.73 -55.79 5.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.421 -1.046 . . . . 0.0 109.026 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.536 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -45.52 -54.67 7.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . . . -66.44 -13.07 60.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.522 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 12.4 mt -96.26 -20.52 18.48 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.507 ' CD1' HG11 ' A' ' 57' ' ' VAL . 45.9 mt -81.56 -32.64 11.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 16.7 ptp180 -85.63 -43.98 12.99 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.47 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -51.07 -39.13 19.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.824 -1.151 . . . . 0.0 108.103 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.505 ' CD2' HG13 ' B' ' 61' ' ' ILE . 0.1 OUTLIER -64.45 -54.67 29.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -60.28 -40.23 89.69 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.54 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -56.81 -45.62 82.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.227 -0.92 . . . . 0.0 108.763 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HA ' HD11 ' A' ' 70' ' ' ILE . 1.4 tt -70.69 -42.01 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 109.756 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.522 ' CB ' HD12 ' B' ' 61' ' ' ILE . 0.2 OUTLIER -55.08 -33.16 62.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 108.717 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -60.36 -60.59 3.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.599 ' HA ' ' CG ' ' A' ' 73' ' ' ARG . 2.1 mp -52.39 -32.68 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.998 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.682 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 7.9 t60 -58.84 -32.79 69.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.375 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -91.07 -42.54 10.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.856 -1.153 . . . . 0.0 111.303 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.633 ' N ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -66.94 -6.97 18.8 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.475 -1.391 . . . . 0.0 110.39 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 70' ' ' ILE . 18.6 mt -122.01 -14.16 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.923 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.49 -57.42 0.75 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.2 m -82.89 -4.66 58.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -1.123 . . . . 0.0 109.809 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 78' ' ' HIS . 3.9 mtt180 -130.98 15.35 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.917 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' ARG . 28.7 t-80 -48.01 177.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.46 -0.775 . . . . 0.0 110.298 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -60.67 -147.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.64 9.39 29.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.184 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -73.34 55.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 83' ' ' ILE . . . -94.91 -100.39 1.74 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 84' ' ' ILE . 3.8 tp -178.16 -27.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.745 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.528 ' CG1' ' N ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -36.75 -85.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.528 ' N ' ' CG1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -62.84 97.58 0.11 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.641 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 70.43 147.06 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.987 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.442 ' O ' HD13 ' A' ' 83' ' ' ILE . 63.7 mtp180 -73.51 0.16 13.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' NH2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 42.95 70.86 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.22 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.7 p -75.74 -29.34 58.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -89.16 146.52 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.233 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -152.44 49.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.218 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -140.14 179.99 18.46 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.13 -177.81 3.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -1.119 . . . . 0.0 110.14 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -115.44 -81.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.5 156.15 2.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.197 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' B' ' 54' ' ' TRP . 7.1 p-10 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.235 0.541 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.458 ' CB ' ' O ' ' B' ' 52' ' ' ASP . 2.0 m 65.97 -65.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.682 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -123.09 -26.86 4.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.684 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 86.0 m -52.03 -22.01 3.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -58.24 -17.03 29.62 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 17.3 t -94.75 -55.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.489 -1.006 . . . . 0.0 109.004 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.548 ' HG3' ' CZ2' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -45.6 -54.61 7.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.499 ' HA ' ' NE ' ' B' ' 62' ' ' ARG . . . -66.43 -13.12 60.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 12.4 mt -96.35 -20.49 18.44 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.522 HD12 ' CB ' ' A' ' 68' ' ' LEU . 46.0 mt -81.64 -32.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 16.6 ptp180 -85.49 -44.01 13.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.526 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.509 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -51.14 -39.07 19.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.121 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.5 ' CD2' HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -64.45 -54.72 28.23 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -60.27 -40.25 89.71 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.534 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 0.0 OUTLIER -56.76 -45.7 81.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 108.756 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.59 -42.06 71.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.79 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -55.09 -33.2 62.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 108.655 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.603 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 0.3 OUTLIER -60.29 -60.61 3.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 108.413 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.608 ' HA ' ' CG ' ' B' ' 73' ' ' ARG . 2.1 mp -52.35 -32.82 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.686 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 7.9 t60 -58.73 -32.87 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.361 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -91.0 -42.64 10.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 111.248 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.634 ' N ' ' CD1' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -66.91 -6.95 18.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.486 -1.384 . . . . 0.0 110.361 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.517 HD13 ' CG2' ' B' ' 70' ' ' ILE . 18.6 mt -122.03 -14.12 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.222 -0.924 . . . . 0.0 109.994 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.58 -57.39 0.75 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -82.92 -4.69 58.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -1.095 . . . . 0.0 109.8 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' B' ' 78' ' ' HIS . 3.9 mtt180 -130.93 15.34 5.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.02 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.519 ' CE1' HD13 ' B' ' 81' ' ' ILE . 28.6 t-80 -48.03 177.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.335 -0.853 . . . . 0.0 110.288 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.426 ' O ' ' O ' ' B' ' 78' ' ' HIS . 0.1 OUTLIER -60.67 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -107.55 9.35 29.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.917 . . . . 0.0 110.274 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' B' ' 78' ' ' HIS . 2.8 pt -73.41 55.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.298 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' B' ' 83' ' ' ILE . . . -94.89 -100.31 1.73 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.472 ' O ' ' C ' ' B' ' 84' ' ' ILE . 3.8 tp -178.08 -27.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -1.102 . . . . 0.0 110.776 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' B' ' 85' ' ' GLN . 0.2 OUTLIER -36.67 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.788 . . . . 0.0 110.427 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.522 ' O ' ' CB ' ' B' ' 86' ' ' GLN . 0.7 OUTLIER -62.73 97.65 0.11 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.06 -1.025 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 85' ' ' GLN . 0.0 OUTLIER 70.28 147.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 109.976 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.415 ' HA ' HG13 ' B' ' 83' ' ' ILE . 63.7 mtp180 -73.47 0.16 13.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.943 . . . . 0.0 110.469 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' B' ' 85' ' ' GLN . 0.0 OUTLIER 42.8 70.93 0.25 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.253 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 43.7 p -75.74 -29.38 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -89.15 146.52 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -152.47 49.01 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.168 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -140.14 179.93 18.52 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.02 -177.88 3.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.242 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -115.39 -81.46 0.61 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.903 . . . . 0.0 110.243 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 156.14 2.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.251 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.266 0.555 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.521 ' HB ' ' NE2' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -54.46 -77.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CH2' HD11 ' B' ' 68' ' ' LEU . 14.4 m95 -92.53 -52.51 4.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -42.73 -25.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.783 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 60' ' ' LEU . . . -102.02 37.47 3.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' TRP . 93.4 t -157.98 -53.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.946 -0.737 . . . . 0.0 109.557 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -62.44 -46.51 88.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.0 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HA ' ' CD ' ' A' ' 62' ' ' ARG . . . -89.43 -5.14 57.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' CD1' HD12 ' B' ' 64' ' ' LEU . 0.2 OUTLIER -100.53 -21.29 15.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' B' ' 64' ' ' LEU . 44.0 mt -83.83 -37.33 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' CD ' ' HA ' ' A' ' 59' ' ' ALA . 12.4 ptm180 -78.97 -42.36 26.98 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -44.67 -42.29 2.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.184 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.611 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 25.4 mt -71.38 -44.65 64.57 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -56.66 -44.74 81.67 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.456 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -61.44 -47.39 85.97 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -60.83 -42.89 98.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.477 -0.765 . . . . 0.0 109.154 178.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.0 -43.62 81.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 108.78 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 1.8 m-85 -62.75 -17.27 60.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.807 . . . . 0.0 109.012 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.525 ' CG2' HD13 ' A' ' 74' ' ' ILE . 4.1 mt -95.88 -51.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.529 ' CD2' ' CD2' ' B' ' 54' ' ' TRP . 1.5 t60 -46.98 -45.17 20.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -60.74 -35.51 76.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.522 ' NE ' ' CG1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -91.0 -5.78 54.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.525 HD13 ' CG2' ' A' ' 70' ' ' ILE . 5.8 mt -113.37 -17.96 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.315 -0.866 . . . . 0.0 109.441 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -99.8 -58.93 0.87 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 77' ' ' ARG . 57.9 m -87.31 -1.8 58.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.123 . . . . 0.0 109.942 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 12.5 mmt180 -136.94 18.19 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 53.4 t-80 -45.87 152.68 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.2 m -108.49 -170.16 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' ILE . 5.9 mtp180 -119.01 49.6 1.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' ARG . 4.2 mt -43.4 111.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.46 -63.06 0.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.539 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 2.4 mp -120.02 -41.11 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 42.1 pt 36.64 58.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 110.718 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 1.6 mt-30 63.15 -70.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.285 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' ILE . 12.5 mt-30 -61.59 99.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -62.86 139.78 58.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.78 64.2 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.4 m -113.23 -55.1 2.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -124.24 -169.24 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 54.6 93.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.183 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.28 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.13 114.56 6.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -1.164 . . . . 0.0 110.149 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -168.49 169.39 10.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -75.4 -47.9 25.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.7 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.219 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.307 0.575 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.512 ' HB ' ' NE2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -54.36 -76.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' B' ' 57' ' ' VAL . 14.6 m95 -92.46 -52.6 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -42.71 -25.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.78 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' B' ' 57' ' ' VAL . . . -101.99 37.44 3.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' B' ' 54' ' ' TRP . 92.9 t -158.0 -53.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.845 -0.797 . . . . 0.0 109.539 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.952 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -89.49 -5.1 57.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.85 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.533 ' CD1' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.6 -21.26 15.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 64' ' ' LEU . 44.0 mt -83.75 -37.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.879 0.847 . . . . 0.0 108.799 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.4 ptm180 -79.09 -42.39 26.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.85 -0.531 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.533 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.8 OUTLIER -44.48 -42.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.091 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.611 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 24.8 mt -71.2 -44.71 64.88 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.07 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.476 ' HA ' HD22 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -56.6 -44.86 81.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -61.49 -47.23 86.59 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -61.0 -42.77 99.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.474 -0.766 . . . . 0.0 109.166 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.559 HD11 ' CH2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -56.99 -43.58 81.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 108.788 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 1.8 m-85 -62.83 -17.32 61.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.885 . . . . 0.0 109.008 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' B' ' 74' ' ' ILE . 4.0 mt -95.85 -51.84 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.537 ' CD2' ' CD2' ' A' ' 54' ' ' TRP . 1.5 t60 -46.93 -45.24 20.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.85 . . . . 0.0 110.133 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -60.72 -35.41 76.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 110.067 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.524 ' CZ ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -91.08 -5.73 54.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.95 . . . . 0.0 110.08 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.524 HG12 ' CZ ' ' B' ' 73' ' ' ARG . 5.9 mt -113.36 -18.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -99.85 -58.95 0.87 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.452 ' O ' ' HD3' ' B' ' 77' ' ' ARG . 58.0 m -87.3 -1.73 58.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.955 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' B' ' 73' ' ' ARG . 12.5 mmt180 -137.01 18.22 3.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 53.3 t-80 -45.87 152.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.296 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 65.5 m -108.56 -170.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' B' ' 81' ' ' ILE . 5.9 mtp180 -118.97 49.63 1.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' B' ' 80' ' ' ARG . 4.2 mt -43.33 111.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.228 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.56 -63.09 0.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.535 ' O ' ' CG1' ' B' ' 84' ' ' ILE . 2.4 mp -120.06 -41.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -1.177 . . . . 0.0 110.223 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' B' ' 83' ' ' ILE . 42.2 pt 36.66 58.17 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.749 -0.594 . . . . 0.0 110.739 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' B' ' 84' ' ' ILE . 1.6 mt-30 63.1 -70.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 84' ' ' ILE . 12.7 mt-30 -61.64 99.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 0.0 110.16 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -62.85 139.73 58.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.76 64.17 1.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.201 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -113.2 -55.07 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -124.24 -169.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 54.53 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.177 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.27 -92.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.13 114.61 6.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -1.163 . . . . 0.0 110.121 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -168.55 169.34 10.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -75.35 -47.94 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.163 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 86.8 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.223 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.197 0.522 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -50.63 -60.99 2.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.104 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.68 ' CD1' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -124.57 -32.69 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.767 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -44.59 -26.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -53.92 -23.39 22.92 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.585 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 34.9 t -97.57 -33.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.583 -0.951 . . . . 0.0 109.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.474 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 3.3 tp10 -61.75 -51.34 68.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.291 -0.88 . . . . 0.0 109.458 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' O ' HD11 ' A' ' 63' ' ' ILE . . . -63.51 -23.44 67.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.461 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.505 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 37.8 mt -86.52 -21.41 26.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.606 HG12 ' HB3' ' B' ' 64' ' ' LEU . 1.3 mm -76.09 -38.41 34.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.787 0.803 . . . . 0.0 108.991 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 15.2 ptm180 -84.04 -42.52 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -46.5 -42.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.828 -1.149 . . . . 0.0 108.743 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.608 ' HB3' HG12 ' B' ' 61' ' ' ILE . 49.4 mt -74.22 -41.87 60.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.08 -43.29 82.01 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 10.8 tt0 -62.43 -50.8 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 4.9 tt -59.09 -45.69 90.2 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.207 -0.933 . . . . 0.0 108.714 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.642 ' CD2' ' CH2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -47.82 -56.9 6.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.484 -0.76 . . . . 0.0 109.643 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 4.9 m-85 -45.28 -33.53 2.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 67' ' ' LEU . 30.9 mm -79.9 -22.71 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.949 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.675 ' CE1' ' CD1' ' B' ' 54' ' ' TRP . 27.7 t60 -67.37 -34.78 78.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -0.852 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 1.6 p90 -88.89 -30.38 18.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.222 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.552 ' HG3' ' CG1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -63.76 -19.88 65.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' CG1' ' HG3' ' A' ' 73' ' ' ARG . 4.5 mt -122.62 -17.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.139 -0.976 . . . . 0.0 109.344 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 -35.69 2.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.522 ' HB2' ' CA ' ' A' ' 72' ' ' PHE . 57.9 m -91.18 -12.18 36.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -1.184 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -136.9 15.04 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.324 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' ILE . 43.4 t-80 -159.16 49.24 0.33 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.211 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.84 120.84 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 110.028 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -79.37 6.66 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.204 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 81' ' ' ILE . 28.8 mm -134.28 65.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 83' ' ' ILE . . . -137.47 8.81 3.73 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -43.61 -74.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.522 ' N ' HG13 ' A' ' 83' ' ' ILE . 31.0 mm 40.86 31.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.105 -0.997 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . 18.2 mt-30 -122.23 -21.9 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 110.214 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 53.89 50.28 17.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.279 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -115.9 -6.04 12.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 59.72 86.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.192 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.3 t -145.0 20.52 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.89 134.9 50.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.86 30.52 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.29 15.04 72.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.43 18.54 5.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -1.17 . . . . 0.0 110.139 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -114.75 159.01 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.6 mttt 52.07 -172.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.233 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.283 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 91.1 m -50.58 -60.93 2.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.675 ' CD1' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -124.68 -32.66 3.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.766 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -44.58 -26.67 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -53.92 -23.37 22.82 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 35.1 t -97.5 -33.64 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.578 -0.954 . . . . 0.0 109.676 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.479 ' HB2' ' CZ2' ' B' ' 54' ' ' TRP . 3.4 tp10 -61.78 -51.35 68.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.486 ' O ' HD11 ' B' ' 63' ' ' ILE . . . -63.43 -23.47 67.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.441 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 38.3 mt -86.55 -21.4 26.91 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.608 HG12 ' HB3' ' A' ' 64' ' ' LEU . 1.3 mm -76.11 -38.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.771 0.796 . . . . 0.0 108.944 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 15.2 ptm180 -84.15 -42.51 15.94 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.512 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.7 OUTLIER -46.48 -42.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.844 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.606 ' HB3' HG12 ' A' ' 61' ' ' ILE . 49.1 mt -74.27 -41.8 60.65 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.296 -0.878 . . . . 0.0 108.735 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.513 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.01 -43.27 81.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.513 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 10.7 tt0 -62.57 -50.69 70.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 4.9 tt -59.12 -45.68 90.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.753 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 54' ' ' TRP . 0.9 OUTLIER -47.87 -56.88 6.5 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.368 -0.832 . . . . 0.0 109.631 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 4.9 m-85 -45.13 -33.64 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.325 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' B' ' 67' ' ' LEU . 31.5 mm -79.88 -22.74 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -0.764 . . . . 0.0 109.932 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.68 ' CE1' ' CD1' ' A' ' 54' ' ' TRP . 27.7 t60 -67.29 -34.82 78.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.258 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 1.6 p90 -88.81 -30.39 19.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 110.252 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.552 ' HG3' ' CG1' ' B' ' 74' ' ' ILE . 0.0 OUTLIER -63.87 -19.84 65.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.068 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.552 ' CG1' ' HG3' ' B' ' 73' ' ' ARG . 4.5 mt -122.54 -17.16 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.01 -35.71 2.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.532 ' HB2' ' CA ' ' B' ' 72' ' ' PHE . 58.0 m -91.16 -12.19 36.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -136.91 15.04 3.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.309 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' B' ' 74' ' ' ILE . 43.5 t-80 -159.17 49.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.188 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.91 120.85 40.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 110.012 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -79.33 6.64 9.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.195 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 29.0 mm -134.36 65.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' B' ' 83' ' ' ILE . . . -137.47 8.9 3.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' B' ' 85' ' ' GLN . 0.2 OUTLIER -43.57 -74.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 110.255 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.514 ' N ' HG13 ' B' ' 83' ' ' ILE . 30.8 mm 40.85 31.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.519 ' HB2' ' CD1' ' B' ' 83' ' ' ILE . 18.6 mt-30 -122.07 -22.03 5.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.993 . . . . 0.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.01 50.25 17.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.215 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -115.95 -6.04 12.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.206 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 59.74 86.66 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 10.3 t -145.0 20.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 110.231 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' B' ' 90' ' ' ARG . 0.0 OUTLIER -107.86 134.84 50.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.96 30.42 7.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.259 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 15.13 72.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.38 18.56 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -1.17 . . . . 0.0 110.181 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -114.76 159.06 21.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 17.6 mttt 51.93 -172.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.238 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 53' ' ' THR . 23.8 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.206 0.527 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 14.9 m 60.35 -118.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.971 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 18.1 m95 -75.63 -51.05 13.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.0 109.998 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.24 -23.69 1.46 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -82.99 -30.64 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 16.7 t -82.47 -38.72 15.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.658 -0.907 . . . . 0.0 108.568 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -59.12 -54.36 47.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' A' ' 63' ' ' ILE . . . -64.47 -17.43 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 108.746 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 56' ' ' GLY . 12.1 mt -88.29 -22.92 23.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' B' ' 64' ' ' LEU . 1.0 OUTLIER -72.09 -38.93 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' HG3' HD11 ' A' ' 63' ' ' ILE . 9.7 ptm180 -86.08 -41.75 14.51 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.802 -0.561 . . . . 0.0 110.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 59' ' ' ALA . 1.1 mp -43.91 -42.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.321 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 11.1 mt -70.68 -44.65 66.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -68.04 -30.51 69.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.134 -0.979 . . . . 0.0 108.805 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.541 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 32.5 tt0 -68.64 -53.97 19.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.436 -0.79 . . . . 0.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.7 -32.44 73.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.662 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 4.4 mt -63.61 -45.2 91.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.627 ' CZ ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -68.22 -25.28 65.12 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.278 -0.889 . . . . 0.0 109.195 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.627 ' CD1' ' CZ ' ' A' ' 69' ' ' PHE . 13.8 mm -85.32 -18.84 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.158 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -68.91 -51.57 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.563 -0.711 . . . . 0.0 110.154 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.551 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 2.1 p90 -71.02 -14.85 62.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.461 ' HG3' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -77.81 -37.06 49.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 4.7 mt -125.3 -34.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -64.1 -25.3 69.44 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' C ' ' CG ' ' A' ' 77' ' ' ARG . 48.5 t -116.28 -1.73 12.28 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.659 -0.906 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 72' ' ' PHE . 7.9 mtt180 -146.72 7.01 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.219 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 22.4 t60 -41.4 104.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.281 -0.887 . . . . 0.0 110.148 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.457 ' HB2' HG21 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -109.57 122.67 47.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.22 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 56.92 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 79' ' ' SER . 1.1 pt -92.41 65.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.13 39.45 0.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 84' ' ' ILE . 7.3 tp -79.16 -38.0 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -1.114 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.489 ' O ' ' CG2' ' A' ' 84' ' ' ILE . 6.1 mt 56.02 52.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 84' ' ' ILE . 16.8 mp0 41.58 67.43 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.345 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 87' ' ' ARG . 46.4 tt0 -106.04 6.94 31.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 86' ' ' GLN . 6.5 mmt85 44.02 57.96 3.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.29 35.38 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m 55.84 55.08 7.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.197 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 48.31 -166.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.176 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.61 153.62 16.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.265 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.33 14.07 66.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.98 -69.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.207 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t 46.39 35.19 2.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -114.76 85.93 2.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.152 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' B' ' 53' ' ' THR . 24.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.181 0.515 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' B' ' 52' ' ' ASP . 14.9 m 60.4 -118.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.576 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 17.9 m95 -75.84 -51.07 13.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.941 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.19 -23.71 1.42 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.657 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -82.93 -30.72 31.01 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 54' ' ' TRP . 16.9 t -82.39 -38.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.579 -0.954 . . . . 0.0 108.619 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.472 ' O ' ' HB ' ' B' ' 61' ' ' ILE . 0.2 OUTLIER -59.19 -54.29 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' B' ' 63' ' ' ILE . . . -64.51 -17.4 63.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 108.762 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 56' ' ' GLY . 12.2 mt -88.23 -22.8 23.78 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -72.28 -38.92 63.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.5 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 9.7 ptm180 -86.2 -41.61 14.52 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.368 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' B' ' 59' ' ' ALA . 1.1 mp -43.84 -42.18 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.355 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 11.4 mt -70.52 -44.78 66.85 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -68.06 -30.58 69.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 108.76 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.545 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 32.3 tt0 -68.61 -54.01 19.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.332 -0.855 . . . . 0.0 109.264 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.66 -32.46 73.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.647 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' B' ' 64' ' ' LEU . 4.4 mt -63.67 -45.24 91.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.981 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.634 ' CZ ' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -68.08 -25.45 65.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.22 -0.925 . . . . 0.0 109.212 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' B' ' 69' ' ' PHE . 13.9 mm -85.21 -18.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 109.217 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.608 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.0 OUTLIER -68.82 -51.66 38.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.539 -0.725 . . . . 0.0 110.168 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.549 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 2.1 p90 -71.03 -14.75 62.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.452 ' HG3' HG13 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -77.82 -37.03 49.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' HIS . 4.7 mt -125.36 -34.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.871 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -64.16 -25.25 69.49 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.463 ' C ' ' CG ' ' B' ' 77' ' ' ARG . 48.5 t -116.32 -1.72 12.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.653 -0.91 . . . . 0.0 109.782 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 72' ' ' PHE . 7.9 mtt180 -146.69 6.91 0.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 111.271 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 74' ' ' ILE . 22.5 t60 -41.24 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 110.133 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.437 ' HB2' HG21 ' B' ' 81' ' ' ILE . 0.1 OUTLIER -109.62 122.6 47.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 56.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.308 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' B' ' 79' ' ' SER . 1.1 pt -92.39 65.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.25 39.42 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' B' ' 84' ' ' ILE . 7.3 tp -79.08 -38.01 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -1.145 . . . . 0.0 110.219 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.502 ' O ' ' CG2' ' B' ' 84' ' ' ILE . 6.1 mt 56.04 52.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.257 -0.902 . . . . 0.0 110.367 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' ' 84' ' ' ILE . 16.7 mp0 41.55 67.42 0.56 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 87' ' ' ARG . 46.5 tt0 -106.04 6.89 31.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 86' ' ' GLN . 6.5 mmt85 44.02 57.98 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.26 35.37 1.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 24.3 m 55.81 55.15 7.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 48.23 -166.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.24 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.66 153.66 16.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 110.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.38 14.18 65.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.0 -69.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -1.184 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t 46.42 35.08 2.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -114.54 85.86 2.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 110.211 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.186 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.01 -67.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.162 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.648 ' CD2' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -113.3 -24.16 9.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 0.0 109.826 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 22.0 m -53.94 -19.1 4.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 109.729 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -68.69 -7.51 54.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 16.1 t -111.87 3.85 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -1.129 . . . . 0.0 110.269 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 55' ' ' THR . 11.0 pt-20 -121.86 -37.56 2.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.276 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -87.88 -20.34 26.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.982 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.54 ' CB ' HD12 ' B' ' 64' ' ' LEU . 23.1 mt -85.67 -25.34 26.61 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' B' ' 68' ' ' LEU . 3.9 mt -67.0 -45.11 87.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 7.6 ptm180 -78.97 -42.98 25.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.395 0.617 . . . . 0.0 109.857 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 2.6 mm -47.36 -41.01 6.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.937 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.537 ' CB ' HG12 ' B' ' 61' ' ' ILE . 95.5 mt -72.14 -45.49 60.33 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.41 -41.54 80.55 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.544 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 0.8 OUTLIER -56.34 -54.56 44.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -54.98 -51.09 67.29 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.123 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 ' CD1' ' CD1' ' B' ' 61' ' ' ILE . 0.6 OUTLIER -43.24 -53.12 5.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.36 -0.838 . . . . 0.0 110.426 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.35 -25.55 49.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 109.043 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.598 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.5 mt -91.47 -19.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.203 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.622 ' CE1' ' CD2' ' B' ' 54' ' ' TRP . 65.9 t60 -67.99 -30.93 70.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.649 -0.657 . . . . 0.0 110.52 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -86.62 -31.44 21.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.441 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' NE ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -82.68 -4.54 57.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.108 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.533 HG12 ' NE ' ' A' ' 73' ' ' ARG . 5.8 mm -116.29 -20.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.49 -46.28 1.24 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -72.27 -17.47 61.88 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.451 -1.029 . . . . 0.0 109.297 179.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.53 0.53 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.528 0.68 . . . . 0.0 109.661 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 1.8 t-160 -64.34 107.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -145.78 42.13 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.444 ' O ' HD13 ' A' ' 83' ' ' ILE . 13.6 mmt85 44.78 29.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mp 52.91 29.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.254 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.49 62.97 3.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' GLN . 84.4 mt -127.83 -32.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 83' ' ' ILE . 12.3 mt 63.98 -69.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.808 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' ILE . 9.8 mt-30 -113.07 -53.34 2.72 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.0 pt20 -174.64 164.4 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 86' ' ' GLN . 11.1 mtm180 56.7 -171.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' ARG . 7.5 mtt180 -134.67 102.61 5.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.219 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 t -64.57 69.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.237 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' ARG . 11.5 mtm180 -93.39 166.73 12.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.86 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -71.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.27 -96.24 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.27 77.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -1.141 . . . . 0.0 110.273 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -143.25 -171.29 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 14.03 16.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.209 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.219 0.533 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.88 -67.36 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.238 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.622 ' CD2' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -113.36 -24.11 9.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' B' ' 58' ' ' GLU . 22.1 m -53.85 -19.22 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' B' ' 60' ' ' LEU . . . -68.56 -7.49 53.77 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.58 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 16.2 t -111.91 3.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' B' ' 55' ' ' THR . 11.0 pt-20 -121.84 -37.58 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.331 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.512 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -87.9 -20.25 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.975 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.526 ' CB ' HD12 ' A' ' 64' ' ' LEU . 23.2 mt -85.77 -25.26 26.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 68' ' ' LEU . 3.9 mt -67.13 -45.06 87.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.541 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 7.6 ptm180 -78.86 -43.06 25.87 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.433 0.635 . . . . 0.0 109.835 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.541 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 2.5 mm -47.5 -40.95 7.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.896 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.552 ' CB ' HG12 ' A' ' 61' ' ' ILE . 95.2 mt -72.05 -45.59 60.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.4 -0.812 . . . . 0.0 109.067 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.35 -41.62 80.42 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.539 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 0.8 OUTLIER -56.12 -54.74 41.46 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -54.87 -51.2 66.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -43.29 -53.05 5.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 0.0 110.452 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.601 ' CE2' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.36 -25.48 49.61 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.187 -0.946 . . . . 0.0 109.101 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.601 ' CD1' ' CE2' ' B' ' 69' ' ' PHE . 1.5 mt -91.52 -19.86 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 109.195 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 54' ' ' TRP . 65.8 t60 -68.03 -30.92 70.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -86.58 -31.41 21.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.456 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.528 ' NE ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -82.76 -4.56 58.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.528 HG12 ' NE ' ' B' ' 73' ' ' ARG . 5.8 mm -116.16 -20.86 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 0.0 109.074 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.53 -46.37 1.22 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -72.17 -17.55 61.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -1.076 . . . . 0.0 109.279 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -110.47 0.63 17.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.695 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 1.8 t-160 -64.44 107.84 1.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.124 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -145.77 42.06 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.353 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.404 ' O ' HD13 ' B' ' 83' ' ' ILE . 13.6 mmt85 44.71 29.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.456 ' O ' HG21 ' B' ' 81' ' ' ILE . 2.5 mp 52.82 29.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.189 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.46 62.98 3.41 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' B' ' 85' ' ' GLN . 84.7 mt -127.86 -32.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -1.102 . . . . 0.0 110.235 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.516 HD11 HG22 ' B' ' 84' ' ' ILE . 12.3 mt 63.92 -69.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.82 . . . . 0.0 110.424 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' B' ' 83' ' ' ILE . 9.8 mt-30 -113.05 -53.4 2.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.474 -0.766 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' B' ' 87' ' ' ARG . 3.0 pt20 -174.61 164.35 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' B' ' 86' ' ' GLN . 11.1 mtm180 56.64 -171.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' B' ' 90' ' ' ARG . 7.5 mtt180 -134.58 102.66 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 2.7 t -64.56 69.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' B' ' 88' ' ' ARG . 11.5 mtm180 -93.45 166.68 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.88 -71.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.33 -96.17 0.16 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.33 77.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -143.2 -171.3 3.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.19 14.0 16.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.229 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.222 0.534 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.95 -69.73 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 110.162 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.689 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -125.17 -28.56 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.835 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 55' ' ' THR . 18.3 m -50.78 -21.67 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 109.578 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 60' ' ' LEU . . . -63.75 -12.11 46.06 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 21.6 t -99.83 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -1.133 . . . . 0.0 109.77 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.543 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 2.8 pp20? -53.39 -37.42 62.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 110.198 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' CB ' ' OE2' ' A' ' 58' ' ' GLU . . . -86.04 -11.15 53.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.045 -1.035 . . . . 0.0 110.411 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 11.1 mt -96.99 -20.26 18.19 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.61 ' CG2' ' CB ' ' B' ' 65' ' ' GLN . 0.4 OUTLIER -81.64 -37.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 13.7 ptm180 -81.07 -41.56 22.4 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.316 0.579 . . . . 0.0 110.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.549 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -54.51 -35.47 31.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.605 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.598 ' HB3' ' CD1' ' B' ' 61' ' ' ILE . 24.0 mt -81.59 -39.87 23.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.073 -1.017 . . . . 0.0 108.914 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.604 ' CB ' ' CG2' ' B' ' 61' ' ' ILE . 0.1 OUTLIER -66.95 -37.92 85.16 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 5.6 tt0 -59.23 -54.4 47.3 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -42.72 75.28 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.139 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -62.25 -37.92 87.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 0.0 108.94 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -58.91 -21.33 57.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 108.97 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.462 HG21 ' HB ' ' A' ' 74' ' ' ILE . 16.9 mm -95.81 -10.42 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.552 -0.718 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.687 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -74.05 -47.41 36.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.808 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 8.3 p90 -77.9 -6.37 54.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' NE ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -109.34 -28.32 9.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 109.895 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.53 HG13 ' NE ' ' A' ' 73' ' ' ARG . 3.0 mt -129.18 -2.64 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.172 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -116.52 -19.29 5.44 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' CB ' ' HA ' ' A' ' 72' ' ' PHE . 26.9 t -117.47 -8.98 10.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 109.707 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 73' ' ' ARG . 9.4 ptp180 -154.04 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.344 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 24.6 t60 -60.66 99.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.0 109.864 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.93 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 110.081 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -1.72 18.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 83' ' ' ILE . 30.9 mt -79.74 125.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.16 60.38 0.24 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 81' ' ' ILE . 1.3 tp -109.35 -21.36 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -1.082 . . . . 0.0 110.026 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 83' ' ' ILE . 1.9 mp 63.26 115.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.237 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.17 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.138 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -50.89 133.22 26.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -129.22 -64.49 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.212 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 87' ' ' ARG . 9.2 mtp180 42.52 30.53 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 p -109.58 -70.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 110.198 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -70.77 -152.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.208 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.8 94.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.73 -154.9 16.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.62 150.97 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.205 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 p -62.78 -171.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -63.68 -53.63 48.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.129 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.234 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.25 0.548 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.687 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -125.12 -28.49 3.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' B' ' 58' ' ' GLU . 18.3 m -50.85 -21.66 1.8 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' B' ' 60' ' ' LEU . . . -63.77 -12.06 45.95 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.58 ' HB ' ' CE3' ' B' ' 54' ' ' TRP . 21.7 t -99.89 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -1.103 . . . . 0.0 109.724 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.536 ' HB3' ' CZ2' ' B' ' 54' ' ' TRP . 2.8 pp20? -53.37 -37.43 62.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 0.0 110.146 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' OE2' ' B' ' 58' ' ' GLU . . . -86.19 -10.99 53.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.139 -0.975 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.537 ' CG ' ' O ' ' B' ' 56' ' ' GLY . 11.2 mt -96.99 -20.25 18.2 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.604 ' CG2' ' CB ' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -81.66 -37.62 15.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.536 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 13.7 ptm180 -81.05 -41.49 22.54 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.341 0.591 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.536 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -54.56 -35.44 31.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.603 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 24.2 mt -81.66 -39.81 23.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.044 -1.035 . . . . 0.0 108.902 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.61 ' CB ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -66.93 -37.93 85.23 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' B' ' 62' ' ' ARG . 5.6 tt0 -59.24 -54.43 46.93 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -42.79 75.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.131 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -62.19 -37.96 87.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 108.96 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -58.99 -21.27 58.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 108.933 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' B' ' 74' ' ' ILE . 16.9 mm -95.83 -10.37 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.495 0.664 . . . . 0.0 109.422 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.689 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -74.17 -47.29 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 109.814 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 8.1 p90 -77.96 -6.36 54.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.518 ' NE ' HG13 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -109.21 -28.51 8.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.518 HG13 ' NE ' ' B' ' 73' ' ' ARG . 2.9 mt -129.13 -2.65 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.399 -0.813 . . . . 0.0 109.197 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -116.54 -19.23 5.45 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.516 ' CB ' ' HA ' ' B' ' 72' ' ' PHE . 27.4 t -117.52 -8.99 10.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.462 -1.022 . . . . 0.0 109.748 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 73' ' ' ARG . 9.4 ptp180 -154.04 23.18 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 111.433 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 24.9 t60 -60.67 99.06 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 109.874 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.88 87.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.88 -1.78 18.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.922 . . . . 0.0 110.243 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' B' ' 83' ' ' ILE . 30.8 mt -79.67 125.37 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.236 -0.915 . . . . 0.0 110.021 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.22 60.43 0.25 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' B' ' 81' ' ' ILE . 1.3 tp -109.39 -21.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' B' ' 83' ' ' ILE . 1.9 mp 63.1 115.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.322 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.17 100.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -50.82 133.32 26.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' B' ' 88' ' ' ARG . 0.0 OUTLIER -129.27 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 110.174 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' B' ' 87' ' ' ARG . 9.1 mtp180 42.59 30.39 0.22 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 1.6 p -109.53 -70.54 0.8 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -70.76 -152.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.114 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.86 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.274 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.65 -154.82 16.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 150.96 2.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 1.1 p -62.8 -171.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 110.156 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -63.62 -53.56 49.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.267 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.236 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.49 0.662 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.464 ' O ' HG22 ' A' ' 57' ' ' VAL . 82.5 p -53.43 -34.58 58.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.696 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 36.7 m95 -112.56 -50.56 2.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.109 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -51.9 -19.01 1.53 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.696 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -91.18 -21.14 36.35 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.809 -2.116 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 54' ' ' TRP . 21.9 t -91.78 -54.46 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.783 -0.834 . . . . 0.0 108.775 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -43.74 -57.55 3.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.429 -0.794 . . . . 0.0 109.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HA ' ' CD ' ' A' ' 62' ' ' ARG . . . -61.5 -16.52 48.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 21.4 mt -95.19 -21.26 18.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.577 HG12 ' HB3' ' B' ' 64' ' ' LEU . 6.7 mt -81.36 -33.29 12.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 59' ' ' ALA . 8.8 ptm180 -82.81 -43.67 16.4 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.168 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -47.29 -32.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.076 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' B' ' 61' ' ' ILE . 6.8 mt -70.92 -55.48 8.31 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.649 0.738 . . . . 0.0 109.306 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.512 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.39 74.73 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.52 -0.872 . . . . 0.0 108.872 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.512 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 4.6 tt0 -68.2 -43.75 77.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.541 -0.724 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -73.8 -29.42 62.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.146 -0.971 . . . . 0.0 110.639 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -76.67 -32.19 57.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -71.81 -24.12 61.67 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.466 HG21 ' O ' ' A' ' 67' ' ' LEU . 1.3 tp -84.48 -36.02 11.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -40.73 -56.25 2.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.168 0.509 . . . . 0.0 110.29 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 3.7 p90 -75.48 -2.36 28.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -96.11 -27.26 15.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.535 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 78' ' ' HIS . 6.5 mt -132.27 -6.87 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.848 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -106.26 -44.75 1.33 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 72' ' ' PHE . 48.2 t -81.26 -17.46 49.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -1.113 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 7.8 ptp180 -133.85 25.45 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.618 -0.676 . . . . 0.0 109.829 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 9.5 p80 -40.07 140.39 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 110.541 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.71 114.87 27.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.405 -0.809 . . . . 0.0 109.883 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.522 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . 58.0 mtm180 -86.73 33.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.7 mm 47.66 89.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CD1' ' A' ' 83' ' ' ILE . . . 100.96 36.74 3.84 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 80' ' ' ARG . 2.6 mp -139.66 7.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -1.175 . . . . 0.0 110.211 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 1.1 pt -75.49 65.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.1 156.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.57 40.81 31.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -139.18 -61.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.23 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' HB3' ' CB ' ' A' ' 91' ' ' ASN . 15.2 mtt180 57.13 92.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -67.76 -33.13 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -72.55 -11.97 60.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.418 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 24.9 t30 -87.35 -80.14 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.229 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.36 169.21 52.44 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.423 ' O ' ' OG ' ' A' ' 94' ' ' SER . . . -80.9 -85.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -1.189 . . . . 0.0 110.184 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 93' ' ' ALA . 45.3 p 46.31 58.24 4.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.234 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -44.31 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.156 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.149 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.384 0.611 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 82.5 p -53.37 -34.57 58.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.179 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.686 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 36.6 m95 -112.57 -50.63 2.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.091 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -51.86 -19.03 1.52 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.276 -0.969 . . . . 0.0 108.762 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD1' ' B' ' 60' ' ' LEU . . . -91.2 -21.13 36.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 54' ' ' TRP . 21.7 t -91.76 -54.54 7.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.749 -0.854 . . . . 0.0 108.727 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' B' ' 57' ' ' VAL . 0.2 OUTLIER -43.8 -57.46 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.513 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -61.47 -16.56 48.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.318 -0.864 . . . . 0.0 109.667 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' B' ' 56' ' ' GLY . 21.1 mt -95.15 -21.24 18.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 64' ' ' LEU . 6.7 mt -81.4 -33.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 8.7 ptm180 -82.72 -43.7 16.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.582 -0.699 . . . . 0.0 109.178 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.529 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -47.23 -32.46 2.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.103 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.577 ' HB3' HG12 ' A' ' 61' ' ' ILE . 6.7 mt -70.92 -55.53 8.2 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.659 0.742 . . . . 0.0 109.282 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.42 74.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.505 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 4.6 tt0 -68.19 -43.81 77.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 110.118 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 0.1 OUTLIER -73.66 -29.53 62.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -0.985 . . . . 0.0 110.699 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -76.61 -32.26 57.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.086 -1.009 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.587 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -71.75 -24.16 61.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.47 ' HA ' ' HB3' ' B' ' 73' ' ' ARG . 1.3 tp -84.44 -36.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.696 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -40.66 -56.33 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.139 0.495 . . . . 0.0 110.339 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 3.6 p90 -75.41 -2.37 28.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 110.6 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' ARG . 0.1 OUTLIER -96.1 -27.16 15.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.608 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' B' ' 78' ' ' HIS . 6.5 mt -132.35 -6.78 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.84 . . . . 0.0 109.899 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -106.32 -44.72 1.32 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.53 ' CB ' ' HA ' ' B' ' 72' ' ' PHE . 49.1 t -81.21 -17.5 49.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.29 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 7.8 ptp180 -133.85 25.47 3.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 109.847 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' B' ' 78' ' ' HIS . 9.5 p80 -40.1 140.41 0.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.489 -0.757 . . . . 0.0 110.551 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.76 114.85 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.927 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.527 ' HB2' ' CD1' ' B' ' 83' ' ' ILE . 58.1 mtm180 -86.73 33.53 0.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 110.133 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.46 HG21 HD11 ' B' ' 81' ' ' ILE . 26.6 mm 47.58 90.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.304 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 83' ' ' ILE . . . 101.01 36.67 3.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' B' ' 80' ' ' ARG . 2.6 mp -139.61 7.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.234 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.428 ' O ' ' CG1' ' B' ' 84' ' ' ILE . 1.1 pt -75.48 65.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' B' ' 84' ' ' ILE . 0.1 OUTLIER 63.18 156.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.912 . . . . 0.0 110.047 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.51 40.88 31.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -139.18 -61.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.244 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' B' ' 91' ' ' ASN . 15.3 mtt180 57.03 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -67.66 -33.22 74.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -72.66 -11.82 60.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.269 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.416 ' CB ' ' HB3' ' B' ' 88' ' ' ARG . 25.0 t30 -87.33 -80.17 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.3 169.19 52.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' B' ' 94' ' ' SER . . . -80.88 -85.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 93' ' ' ALA . 45.8 p 46.38 58.18 4.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' B' ' 95' ' ' LYS . 0.0 OUTLIER -44.2 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.176 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.652 ' CZ3' HD22 ' B' ' 68' ' ' LEU . 20.2 m95 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.542 0.687 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' CD ' ' A' ' 58' ' ' GLU . 3.2 m -49.65 -22.4 1.32 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.319 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -89.95 -15.77 57.26 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 HD21 ' B' ' 68' ' ' LEU . 21.9 t -99.3 -54.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.451 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 59' ' ' ALA . 12.5 pt-20 -50.59 -45.89 57.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.616 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.514 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -71.62 -19.5 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.997 . . . . 0.0 109.05 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.6 mt -88.06 -22.38 24.21 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.638 HD11 ' HG ' ' B' ' 68' ' ' LEU . 25.3 mt -71.92 -37.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 11.3 ptp180 -87.96 -42.73 12.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 6.6 mm -53.83 -36.78 31.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.516 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 60' ' ' LEU . 21.3 mt -76.61 -41.09 47.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.239 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD13 ' B' ' 61' ' ' ILE . 1.8 pt20 -68.93 -40.22 79.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' HD13 ' A' ' 70' ' ' ILE . 46.0 tt0 -57.98 -53.67 55.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.438 -0.789 . . . . 0.0 109.301 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 14.5 mt -52.16 -61.87 2.0 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.814 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD21 HG11 ' B' ' 57' ' ' VAL . 1.8 mm? -44.86 -48.68 11.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.079 -1.013 . . . . 0.0 109.874 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.563 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -47.29 -32.27 4.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.41 -0.806 . . . . 0.0 109.752 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 1.2 mp -82.95 -51.85 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.605 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 10.5 t60 -46.67 -45.79 19.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -74.27 -38.25 63.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.508 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.67 ' CZ3' HD22 ' A' ' 68' ' ' LEU . 20.4 m95 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.643 0.735 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.425 ' HA ' ' CD ' ' B' ' 58' ' ' GLU . 3.2 m -49.73 -22.31 1.35 Allowed 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.317 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.646 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -89.99 -15.7 57.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 68' ' ' LEU . 21.8 t -99.34 -54.93 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -1.077 . . . . 0.0 109.448 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' B' ' 61' ' ' ILE . 12.5 pt-20 -50.7 -45.8 58.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.93 . . . . 0.0 109.611 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.515 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -71.67 -19.55 62.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.036 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.895 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.6 mt -88.09 -22.25 24.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 65' ' ' GLN . 25.6 mt -71.95 -37.38 60.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 11.3 ptp180 -88.0 -42.69 12.27 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.391 0.615 . . . . 0.0 110.364 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.526 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 6.6 mm -53.82 -36.82 31.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.895 HD12 ' O ' ' B' ' 60' ' ' LEU . 21.3 mt -76.57 -40.98 48.07 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 109.234 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 61' ' ' ILE . 1.8 pt20 -69.16 -40.17 78.34 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.487 ' O ' HD13 ' B' ' 70' ' ' ILE . 46.0 tt0 -57.98 -53.67 55.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 14.5 mt -52.18 -61.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.747 HD21 HG11 ' A' ' 57' ' ' VAL . 1.8 mm? -44.81 -48.74 10.99 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.234 -0.916 . . . . 0.0 109.839 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.579 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -47.22 -32.23 4.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.814 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.2 mp -83.04 -51.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 10.6 t60 -46.65 -45.79 19.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -0.864 . . . . 0.0 110.744 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.4 OUTLIER -74.33 -38.18 63.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.064 -1.022 . . . . 0.0 110.614 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.506 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.107 -0.996 . . . . 0.0 110.495 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.677 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 26.3 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.548 0.689 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -51.11 -22.3 2.41 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.441 -0.903 . . . . 0.0 108.749 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -86.19 -20.06 55.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.526 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 79.1 t -94.49 -51.57 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.522 -0.987 . . . . 0.0 108.996 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 61' ' ' ILE . 2.7 mm-40 -46.61 -56.8 5.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.262 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.856 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -62.89 -16.52 59.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.359 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 56' ' ' GLY . 13.2 mt -91.26 -21.66 20.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CD1' HD12 ' B' ' 68' ' ' LEU . 83.5 mt -76.58 -34.42 24.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' CG ' ' N ' ' A' ' 63' ' ' ILE . 16.8 ptp180 -88.44 -41.8 12.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.804 -0.56 . . . . 0.0 110.468 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.23 -41.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.426 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' B' ' 64' ' ' LEU . 37.9 mt -69.66 -49.79 50.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -63.38 -33.84 76.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.13 . . . . 0.0 108.093 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.657 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.04 -53.92 51.26 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -53.46 -50.77 64.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 108.971 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.905 HD12 ' CD1' ' B' ' 61' ' ' ILE . 3.1 mt -48.94 -53.46 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.84 . . . . 0.0 109.314 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.3 m-85 -43.78 -39.98 4.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.748 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 66' ' ' GLN . 1.9 mp -71.65 -38.88 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CG ' ' CZ2' ' B' ' 54' ' ' TRP . 1.5 t60 -53.71 -47.03 70.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.594 -0.692 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -76.32 -15.6 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 0.0 111.051 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 120.998 -1.063 . . . . 0.0 110.597 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.672 ' CZ2' ' CG ' ' A' ' 71' ' ' HIS . 25.6 m95 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -51.1 -22.29 2.38 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.783 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.621 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -86.2 -20.07 55.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 60' ' ' LEU . 79.1 t -94.53 -51.56 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.52 -0.988 . . . . 0.0 108.937 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' B' ' 61' ' ' ILE . 2.7 mm-40 -46.71 -56.71 5.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.843 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -62.89 -16.48 59.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.621 HD12 ' O ' ' B' ' 56' ' ' GLY . 13.2 mt -91.28 -21.69 20.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.905 ' CD1' HD12 ' A' ' 68' ' ' LEU . 82.7 mt -76.67 -34.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.506 ' CD ' ' HA ' ' B' ' 59' ' ' ALA . 16.8 ptp180 -88.51 -41.69 12.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.806 -0.559 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.843 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -44.29 -42.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.322 -179.014 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' A' ' 64' ' ' LEU . 38.4 mt -69.58 -49.83 50.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.61 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -63.36 -33.84 76.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.998 -1.064 . . . . 0.0 108.163 178.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.662 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -61.02 -53.98 50.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -53.44 -50.74 64.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 108.987 178.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.919 HD12 ' CD1' ' A' ' 61' ' ' ILE . 3.0 mt -48.97 -53.4 20.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.323 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.3 m-85 -43.9 -39.93 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.662 HD12 ' O ' ' B' ' 66' ' ' GLN . 1.8 mp -71.7 -38.82 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.677 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.5 t60 -53.75 -46.96 71.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.546 -0.721 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.8 OUTLIER -76.44 -15.45 59.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 111.078 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.561 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.084 . . . . 0.0 110.56 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.668 ' CZ2' ' CG ' ' B' ' 71' ' ' HIS . 20.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.431 0.634 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -52.19 -21.06 3.0 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.001 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -95.04 -17.51 37.31 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' ILE . 25.0 t -97.52 -53.18 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.995 . . . . 0.0 109.426 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 62' ' ' ARG . 4.8 tp10 -49.97 -54.15 21.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.307 -0.87 . . . . 0.0 109.409 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -65.02 -19.41 65.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.439 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.4 mt -89.06 -23.39 22.56 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 68' ' ' LEU . 31.7 mt -71.59 -34.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.5 ptp180 -90.96 -41.7 10.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.563 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 9.1 mm -58.4 -33.24 47.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.027 -1.046 . . . . 0.0 110.042 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 60' ' ' LEU . 26.3 mt -77.71 -37.1 50.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' ARG . 5.0 pt20 -78.67 -41.12 32.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -57.97 -47.94 81.44 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.434 -0.791 . . . . 0.0 108.996 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 9.4 tp -61.7 -46.19 90.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.982 HD12 ' CD1' ' B' ' 61' ' ' ILE . 1.1 mt -50.43 -54.99 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.8 m-85 -43.08 -40.35 3.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.416 -0.803 . . . . 0.0 110.067 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 1.3 mp -72.94 -47.44 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.659 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 2.5 t60 -46.05 -46.11 16.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -78.39 -14.64 59.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.856 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.981 -1.075 . . . . 0.0 110.557 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.659 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 19.9 m95 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.7 m -52.14 -21.01 2.89 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.008 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.64 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -95.11 -17.49 37.21 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 61' ' ' ILE . 25.1 t -97.44 -53.21 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.38 -1.07 . . . . 0.0 109.417 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.523 ' OE2' ' CZ ' ' B' ' 62' ' ' ARG . 4.8 tp10 -49.99 -54.23 21.41 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -64.98 -19.38 65.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.885 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.4 mt -88.99 -23.46 22.62 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.982 ' CD1' HD12 ' A' ' 68' ' ' LEU . 32.1 mt -71.58 -34.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.5 ptp180 -90.98 -41.63 11.0 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.597 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 9.1 mm -58.45 -33.18 47.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.074 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.885 HD12 ' O ' ' B' ' 60' ' ' LEU . 26.9 mt -77.7 -37.1 50.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.561 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' B' ' 62' ' ' ARG . 5.0 pt20 -78.59 -41.23 32.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.512 ' O ' HD13 ' B' ' 70' ' ' ILE . 0.7 OUTLIER -57.86 -48.0 81.07 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.437 -0.79 . . . . 0.0 108.988 178.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 9.4 tp -61.64 -46.23 90.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -50.5 -54.92 18.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.8 m-85 -43.11 -40.33 3.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.3 mp -72.92 -47.43 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.668 ' CG ' ' CZ2' ' A' ' 54' ' ' TRP . 2.5 t60 -46.03 -46.16 16.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.529 -0.732 . . . . 0.0 110.767 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.3 OUTLIER -78.36 -14.71 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 110.925 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.561 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.09 . . . . 0.0 110.529 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.686 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.19 0.519 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.8 m -51.91 -22.1 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.065 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -58.26 -17.0 29.63 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.898 HG12 HD11 ' A' ' 61' ' ' ILE . 17.4 t -94.73 -55.79 5.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.421 -1.046 . . . . 0.0 109.026 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -45.52 -54.67 7.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -66.44 -13.07 60.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 56' ' ' GLY . 12.4 mt -96.26 -20.52 18.48 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.898 HD11 HG12 ' A' ' 57' ' ' VAL . 45.9 mt -81.56 -32.64 11.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 16.7 ptp180 -85.63 -43.98 12.99 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.47 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.532 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -51.07 -39.13 19.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.824 -1.151 . . . . 0.0 108.103 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' B' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.67 29.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 1.039 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -60.28 -40.23 89.69 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.743 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.81 -45.62 82.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.227 -0.92 . . . . 0.0 108.763 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.69 -42.01 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 109.756 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -55.08 -33.16 62.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 108.717 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -60.36 -60.59 3.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.743 HD12 ' O ' ' A' ' 66' ' ' GLN . 2.1 mp -52.39 -32.68 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.998 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.682 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 7.9 t60 -58.84 -32.79 69.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.375 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -91.07 -42.54 10.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.856 -1.153 . . . . 0.0 111.303 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.633 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 O-C-N 120.475 -1.391 . . . . 0.0 110.39 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.682 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.165 0.507 . . . . 0.0 109.684 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 86.0 m -52.03 -22.01 3.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -58.24 -17.03 29.62 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.893 HG12 HD11 ' B' ' 61' ' ' ILE . 17.3 t -94.75 -55.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.489 -1.006 . . . . 0.0 109.004 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.837 ' HA ' HD12 ' B' ' 61' ' ' ILE . 0.4 OUTLIER -45.6 -54.61 7.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -66.43 -13.12 60.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.647 HD12 ' O ' ' B' ' 56' ' ' GLY . 12.4 mt -96.35 -20.49 18.44 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.893 HD11 HG12 ' B' ' 57' ' ' VAL . 46.0 mt -81.64 -32.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 16.6 ptp180 -85.49 -44.01 13.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.526 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -51.14 -39.07 19.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.121 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.72 28.23 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.976 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -60.27 -40.25 89.71 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.756 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.76 -45.7 81.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 108.756 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.59 -42.06 71.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.79 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.976 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -55.09 -33.2 62.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 108.655 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.603 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 0.3 OUTLIER -60.29 -60.61 3.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 108.413 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.756 HD12 ' O ' ' B' ' 66' ' ' GLN . 2.1 mp -52.35 -32.82 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.686 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 7.9 t60 -58.73 -32.87 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.361 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -91.0 -42.64 10.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 111.248 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.943 0 O-C-N 120.486 -1.384 . . . . 0.0 110.361 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.551 ' O ' ' N ' ' A' ' 57' ' ' VAL . 14.4 m95 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.651 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -42.73 -25.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.783 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.812 ' O ' HD23 ' A' ' 60' ' ' LEU . . . -102.02 37.47 3.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 61' ' ' ILE . 93.4 t -157.98 -53.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.946 -0.737 . . . . 0.0 109.557 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -62.44 -46.51 88.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.0 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.651 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -89.43 -5.14 57.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.922 HD21 HD22 ' B' ' 64' ' ' LEU . 0.2 OUTLIER -100.53 -21.29 15.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.639 HD11 ' CG1' ' A' ' 57' ' ' VAL . 44.0 mt -83.83 -37.33 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.4 ptm180 -78.97 -42.36 26.98 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.67 -42.29 2.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.184 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.898 HD22 HD21 ' B' ' 60' ' ' LEU . 25.4 mt -71.38 -44.65 64.57 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.805 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.66 -44.74 81.67 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.456 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -61.44 -47.39 85.97 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -60.83 -42.89 98.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.477 -0.765 . . . . 0.0 109.154 178.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -57.0 -43.62 81.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 108.78 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 1.8 m-85 -62.75 -17.27 60.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.807 . . . . 0.0 109.012 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 4.1 mt -95.88 -51.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.425 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 6.4 t-160 -46.98 -45.17 20.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -60.74 -35.51 76.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' B' ' 57' ' ' VAL . 14.6 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.436 0.636 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -42.71 -25.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.78 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.816 ' O ' HD23 ' B' ' 60' ' ' LEU . . . -101.99 37.44 3.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' B' ' 61' ' ' ILE . 92.9 t -158.0 -53.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.845 -0.797 . . . . 0.0 109.539 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.952 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.666 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -89.49 -5.1 57.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.85 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.898 HD21 HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.6 -21.26 15.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' B' ' 57' ' ' VAL . 44.0 mt -83.75 -37.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.879 0.847 . . . . 0.0 108.799 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.4 ptm180 -79.09 -42.39 26.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.85 -0.531 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.666 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -44.48 -42.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.091 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.922 HD22 HD21 ' A' ' 60' ' ' LEU . 24.8 mt -71.2 -44.71 64.88 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.07 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.812 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -56.6 -44.86 81.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -61.49 -47.23 86.59 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -61.0 -42.77 99.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.474 -0.766 . . . . 0.0 109.166 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -56.99 -43.58 81.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 108.788 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 1.8 m-85 -62.83 -17.32 61.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.885 . . . . 0.0 109.008 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 4.0 mt -95.85 -51.84 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' B' ' 71' ' ' HIS . 6.4 t-160 -46.93 -45.24 20.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.85 . . . . 0.0 110.133 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -60.72 -35.41 76.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 110.067 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.95 . . . . 0.0 110.08 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.809 ' CH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.114 0.483 . . . . 0.0 109.767 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -44.59 -26.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -53.92 -23.39 22.92 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.593 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 34.9 t -97.57 -33.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.583 -0.951 . . . . 0.0 109.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 3.3 tp10 -61.75 -51.34 68.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.291 -0.88 . . . . 0.0 109.458 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.528 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -63.51 -23.44 67.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.461 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.505 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 37.8 mt -86.52 -21.41 26.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 68' ' ' LEU . 1.3 mm -76.09 -38.41 34.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.787 0.803 . . . . 0.0 108.991 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 15.2 ptm180 -84.04 -42.52 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -46.5 -42.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.828 -1.149 . . . . 0.0 108.743 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.645 ' HB3' HG12 ' B' ' 61' ' ' ILE . 49.4 mt -74.22 -41.87 60.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.9 OUTLIER -57.08 -43.29 82.01 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.532 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 10.8 tt0 -62.43 -50.8 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 67' ' ' LEU . 4.9 tt -59.09 -45.69 90.2 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.207 -0.933 . . . . 0.0 108.714 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 HD12 ' B' ' 61' ' ' ILE . 0.9 OUTLIER -47.82 -56.9 6.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.484 -0.76 . . . . 0.0 109.643 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 4.9 m-85 -45.28 -33.53 2.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 67' ' ' LEU . 30.9 mm -79.9 -22.71 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.949 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 68' ' ' LEU . 9.4 t-80 -67.37 -34.78 78.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -0.852 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 1.6 p90 -88.89 -30.38 18.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.222 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.804 ' CH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.134 0.492 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 58' ' ' GLU . 0.2 OUTLIER -44.58 -26.67 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -53.92 -23.37 22.82 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.596 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 35.1 t -97.5 -33.64 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.578 -0.954 . . . . 0.0 109.676 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HB2' ' CZ2' ' B' ' 54' ' ' TRP . 3.4 tp10 -61.78 -51.35 68.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -63.43 -23.47 67.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.441 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 64' ' ' LEU . 38.3 mt -86.55 -21.4 26.91 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.861 HD12 HD12 ' A' ' 68' ' ' LEU . 1.3 mm -76.11 -38.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.771 0.796 . . . . 0.0 108.944 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 15.2 ptm180 -84.15 -42.51 15.94 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.533 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.7 OUTLIER -46.48 -42.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.844 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' A' ' 61' ' ' ILE . 49.1 mt -74.27 -41.8 60.65 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.296 -0.878 . . . . 0.0 108.735 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.9 OUTLIER -57.01 -43.27 81.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 10.7 tt0 -62.57 -50.69 70.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 67' ' ' LEU . 4.9 tt -59.12 -45.68 90.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.753 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -47.87 -56.88 6.5 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.368 -0.832 . . . . 0.0 109.631 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 4.9 m-85 -45.13 -33.64 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.325 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' B' ' 67' ' ' LEU . 31.5 mm -79.88 -22.74 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -0.764 . . . . 0.0 109.932 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' B' ' 68' ' ' LEU . 9.4 t-80 -67.29 -34.82 78.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.258 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 1.6 p90 -88.81 -30.39 19.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 110.252 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.068 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 18.1 m95 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.453 0.644 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.24 -23.69 1.46 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -82.99 -30.64 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 16.7 t -82.47 -38.72 15.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.658 -0.907 . . . . 0.0 108.568 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -59.12 -54.36 47.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -64.47 -17.43 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 108.746 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' HD12 ' A' ' 64' ' ' LEU . 12.1 mt -88.29 -22.92 23.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.849 ' CD1' HD12 ' B' ' 68' ' ' LEU . 1.0 OUTLIER -72.09 -38.93 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.7 ptm180 -86.08 -41.75 14.51 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.802 -0.561 . . . . 0.0 110.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.1 mp -43.91 -42.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.321 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 11.1 mt -70.68 -44.65 66.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -68.04 -30.51 69.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.134 -0.979 . . . . 0.0 108.805 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.53 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 32.5 tt0 -68.64 -53.97 19.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.436 -0.79 . . . . 0.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.7 -32.44 73.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.662 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' B' ' 61' ' ' ILE . 4.4 mt -63.61 -45.2 91.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -68.22 -25.28 65.12 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.278 -0.889 . . . . 0.0 109.195 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 13.8 mm -85.32 -18.84 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.158 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -68.91 -51.57 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.563 -0.711 . . . . 0.0 110.154 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 2.1 p90 -71.02 -14.85 62.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.576 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 17.9 m95 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.394 0.616 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.19 -23.71 1.42 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.657 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.546 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -82.93 -30.72 31.01 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 54' ' ' TRP . 16.9 t -82.39 -38.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.579 -0.954 . . . . 0.0 108.619 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' B' ' 61' ' ' ILE . 0.2 OUTLIER -59.19 -54.29 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -64.51 -17.4 63.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 108.762 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.553 ' O ' HD12 ' B' ' 64' ' ' LEU . 12.2 mt -88.23 -22.8 23.78 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.834 ' CD1' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -72.28 -38.92 63.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.5 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 9.7 ptm180 -86.2 -41.61 14.52 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.368 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.1 mp -43.84 -42.18 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.355 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 11.4 mt -70.52 -44.78 66.85 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -68.06 -30.58 69.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 108.76 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.534 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 32.3 tt0 -68.61 -54.01 19.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.332 -0.855 . . . . 0.0 109.264 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.66 -32.46 73.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.647 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 61' ' ' ILE . 4.4 mt -63.67 -45.24 91.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.981 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -68.08 -25.45 65.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.22 -0.925 . . . . 0.0 109.212 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 69' ' ' PHE . 13.9 mm -85.21 -18.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 109.217 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.608 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.0 OUTLIER -68.82 -51.66 38.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.539 -0.725 . . . . 0.0 110.168 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.549 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 2.1 p90 -71.03 -14.75 62.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.788 ' HH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.251 0.548 . . . . 0.0 109.826 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 22.0 m -53.94 -19.1 4.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 109.729 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.69 -7.51 54.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 16.1 t -111.87 3.85 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -1.129 . . . . 0.0 110.269 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' THR . 11.0 pt-20 -121.86 -37.56 2.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.276 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -87.88 -20.34 26.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.982 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 56' ' ' GLY . 23.1 mt -85.67 -25.34 26.61 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.924 ' CD1' HD12 ' B' ' 68' ' ' LEU . 3.9 mt -67.0 -45.11 87.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 7.6 ptm180 -78.97 -42.98 25.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.395 0.617 . . . . 0.0 109.857 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.583 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 2.6 mm -47.36 -41.01 6.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.937 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' B' ' 64' ' ' LEU . 95.5 mt -72.14 -45.49 60.33 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.41 -41.54 80.55 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -56.34 -54.56 44.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -54.98 -51.09 67.29 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.123 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' B' ' 61' ' ' ILE . 0.6 OUTLIER -43.24 -53.12 5.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.36 -0.838 . . . . 0.0 110.426 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.35 -25.55 49.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 109.043 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 66' ' ' GLN . 1.5 mt -91.47 -19.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.203 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.457 ' CD2' ' CE3' ' B' ' 54' ' ' TRP . 21.3 t-80 -67.99 -30.93 70.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.649 -0.657 . . . . 0.0 110.52 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -86.62 -31.44 21.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.441 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.787 ' HH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.203 0.525 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' B' ' 58' ' ' GLU . 22.1 m -53.85 -19.22 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.671 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -68.56 -7.49 53.77 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 16.2 t -111.91 3.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' B' ' 55' ' ' THR . 11.0 pt-20 -121.84 -37.58 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.331 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' B' ' 62' ' ' ARG . . . -87.9 -20.25 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.975 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.671 HD12 ' O ' ' B' ' 56' ' ' GLY . 23.2 mt -85.77 -25.26 26.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.914 ' CD1' HD12 ' A' ' 68' ' ' LEU . 3.9 mt -67.13 -45.06 87.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 7.6 ptm180 -78.86 -43.06 25.87 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.433 0.635 . . . . 0.0 109.835 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 2.5 mm -47.5 -40.95 7.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.896 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' A' ' 64' ' ' LEU . 95.2 mt -72.05 -45.59 60.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.4 -0.812 . . . . 0.0 109.067 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.35 -41.62 80.42 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.592 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.8 OUTLIER -56.12 -54.74 41.46 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -54.87 -51.2 66.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.924 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -43.29 -53.05 5.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 0.0 110.452 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.601 ' CE2' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.36 -25.48 49.61 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.187 -0.946 . . . . 0.0 109.101 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.601 ' CD1' ' CE2' ' B' ' 69' ' ' PHE . 1.5 mt -91.52 -19.86 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 109.195 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.483 ' CD2' ' CE3' ' A' ' 54' ' ' TRP . 21.2 t-80 -68.03 -30.92 70.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -86.58 -31.41 21.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.456 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.899 ' HH2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.216 0.532 . . . . 0.0 109.835 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' A' ' 58' ' ' GLU . 18.3 m -50.78 -21.67 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 109.578 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.75 -12.11 46.06 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 21.6 t -99.83 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -1.133 . . . . 0.0 109.77 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.92 ' OE2' ' HB2' ' A' ' 59' ' ' ALA . 2.8 pp20? -53.39 -37.42 62.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 110.198 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.92 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . . . -86.04 -11.15 53.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.045 -1.035 . . . . 0.0 110.411 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 56' ' ' GLY . 11.1 mt -96.99 -20.26 18.19 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.767 HD12 ' CB ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -81.64 -37.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG3' HD13 ' A' ' 63' ' ' ILE . 13.7 ptm180 -81.07 -41.56 22.4 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.316 0.579 . . . . 0.0 110.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.58 HD13 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -54.51 -35.47 31.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.605 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.757 ' CB ' HD12 ' B' ' 61' ' ' ILE . 24.0 mt -81.59 -39.87 23.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.073 -1.017 . . . . 0.0 108.914 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.981 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.9 pt20 -66.95 -37.92 85.16 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 5.6 tt0 -59.23 -54.4 47.3 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -42.72 75.28 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.139 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.981 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -62.25 -37.92 87.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 0.0 108.94 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -58.91 -21.33 57.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 108.97 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.81 -10.42 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.552 -0.718 . . . . 0.0 109.414 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -74.05 -47.41 36.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.808 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 8.3 p90 -77.9 -6.37 54.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' O ' ' NE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 109.895 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.911 ' HH2' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.157 0.503 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' B' ' 58' ' ' GLU . 18.3 m -50.85 -21.66 1.8 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.692 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -63.77 -12.06 45.95 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CE3' ' B' ' 54' ' ' TRP . 21.7 t -99.89 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -1.103 . . . . 0.0 109.724 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.905 ' OE2' ' HB2' ' B' ' 59' ' ' ALA . 2.8 pp20? -53.37 -37.43 62.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 0.0 110.146 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.905 ' HB2' ' OE2' ' B' ' 58' ' ' GLU . . . -86.19 -10.99 53.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.139 -0.975 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.692 HD12 ' O ' ' B' ' 56' ' ' GLY . 11.2 mt -96.99 -20.25 18.2 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.759 HD13 ' N ' ' B' ' 61' ' ' ILE . 0.4 OUTLIER -81.66 -37.62 15.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.556 ' HG3' HD13 ' B' ' 63' ' ' ILE . 13.7 ptm180 -81.05 -41.49 22.54 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.341 0.591 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.556 HD13 ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -54.56 -35.44 31.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.603 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.767 ' CB ' HD12 ' A' ' 61' ' ' ILE . 24.2 mt -81.66 -39.81 23.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.044 -1.035 . . . . 0.0 108.902 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.95 ' HA ' HD23 ' B' ' 68' ' ' LEU . 2.9 pt20 -66.93 -37.93 85.23 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -59.24 -54.43 46.93 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -55.52 -42.79 75.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.131 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.95 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -62.19 -37.96 87.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 108.96 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -58.99 -21.27 58.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 108.933 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' B' ' 70' ' ' ILE . 16.9 mm -95.83 -10.37 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.495 0.664 . . . . 0.0 109.422 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.489 ' NE2' ' CG ' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -74.17 -47.29 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 109.814 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 8.1 p90 -77.96 -6.36 54.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.468 ' O ' ' NE ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.696 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 36.7 m95 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.556 0.693 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -51.9 -19.01 1.53 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.696 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.602 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -91.18 -21.14 36.35 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.809 -2.116 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 54' ' ' TRP . 21.9 t -91.78 -54.46 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.783 -0.834 . . . . 0.0 108.775 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -43.74 -57.55 3.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.429 -0.794 . . . . 0.0 109.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.703 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -61.5 -16.52 48.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 56' ' ' GLY . 21.4 mt -95.19 -21.26 18.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.917 HG12 HD22 ' B' ' 64' ' ' LEU . 6.7 mt -81.36 -33.29 12.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 8.8 ptm180 -82.81 -43.67 16.4 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.168 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -47.29 -32.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.076 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 HG12 ' B' ' 61' ' ' ILE . 6.8 mt -70.92 -55.48 8.31 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.649 0.738 . . . . 0.0 109.306 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.39 74.73 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.52 -0.872 . . . . 0.0 108.872 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 4.6 tt0 -68.2 -43.75 77.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.541 -0.724 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.8 -29.42 62.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.146 -0.971 . . . . 0.0 110.639 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -76.67 -32.19 57.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -71.81 -24.12 61.67 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 1.3 tp -84.48 -36.02 11.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -40.73 -56.25 2.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.168 0.509 . . . . 0.0 110.29 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 3.7 p90 -75.48 -2.36 28.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.535 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.686 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 36.6 m95 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.511 0.672 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -51.86 -19.03 1.52 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.276 -0.969 . . . . 0.0 108.762 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.613 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -91.2 -21.13 36.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 54' ' ' TRP . 21.7 t -91.76 -54.54 7.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.749 -0.854 . . . . 0.0 108.727 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' B' ' 57' ' ' VAL . 0.2 OUTLIER -43.8 -57.46 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.709 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -61.47 -16.56 48.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.318 -0.864 . . . . 0.0 109.667 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.613 HD12 ' O ' ' B' ' 56' ' ' GLY . 21.1 mt -95.15 -21.24 18.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 64' ' ' LEU . 6.7 mt -81.4 -33.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.548 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 8.7 ptm180 -82.72 -43.7 16.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.582 -0.699 . . . . 0.0 109.178 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.709 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.0 OUTLIER -47.23 -32.46 2.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.103 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 61' ' ' ILE . 6.7 mt -70.92 -55.53 8.2 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.659 0.742 . . . . 0.0 109.282 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.42 74.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.522 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 4.6 tt0 -68.19 -43.81 77.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 110.118 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.485 ' O ' HG22 ' B' ' 70' ' ' ILE . 0.1 OUTLIER -73.66 -29.53 62.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -0.985 . . . . 0.0 110.699 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.679 ' O ' HD12 ' B' ' 68' ' ' LEU . 0.1 OUTLIER -76.61 -32.26 57.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.086 -1.009 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.587 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -71.75 -24.16 61.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' B' ' 73' ' ' ARG . 1.3 tp -84.44 -36.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' HIS . . . . . 0.696 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -40.66 -56.33 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.139 0.495 . . . . 0.0 110.339 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 3.6 p90 -75.41 -2.37 28.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 110.6 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.608 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.234 0.54 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -47.5 -74.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.652 ' CZ3' HD22 ' B' ' 68' ' ' LEU . 20.2 m95 -82.21 -43.9 17.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' CD ' ' A' ' 58' ' ' GLU . 3.2 m -49.65 -22.4 1.32 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.319 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -89.95 -15.77 57.26 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 HD21 ' B' ' 68' ' ' LEU . 21.9 t -99.3 -54.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.451 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 59' ' ' ALA . 12.5 pt-20 -50.59 -45.89 57.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.616 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -71.62 -19.5 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.997 . . . . 0.0 109.05 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.6 mt -88.06 -22.38 24.21 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.638 HD11 ' HG ' ' B' ' 68' ' ' LEU . 25.3 mt -71.92 -37.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 11.3 ptp180 -87.96 -42.73 12.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 6.6 mm -53.83 -36.78 31.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.516 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 60' ' ' LEU . 21.3 mt -76.61 -41.09 47.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.239 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD13 ' B' ' 61' ' ' ILE . 1.8 pt20 -68.93 -40.22 79.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' HD13 ' A' ' 70' ' ' ILE . 46.0 tt0 -57.98 -53.67 55.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.438 -0.789 . . . . 0.0 109.301 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 14.5 mt -52.16 -61.87 2.0 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.814 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD21 HG11 ' B' ' 57' ' ' VAL . 1.8 mm? -44.86 -48.68 11.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.079 -1.013 . . . . 0.0 109.874 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.563 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -47.29 -32.27 4.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.41 -0.806 . . . . 0.0 109.752 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 1.2 mp -82.95 -51.85 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.605 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 10.5 t60 -46.67 -45.79 19.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -74.27 -38.25 63.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.556 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.81 -0.93 55.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.508 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG12 ' CD ' ' A' ' 73' ' ' ARG . 10.5 mm -135.07 -2.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.0 110.378 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -122.96 -33.17 0.86 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.1 t -104.27 -3.87 23.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 109.952 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 72' ' ' PHE . 3.8 ptm180 -167.62 35.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' ILE . 6.2 p80 -51.57 156.34 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.508 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -99.28 154.0 18.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 110.274 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -90.91 46.06 1.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' A' ' 79' ' ' SER . 1.0 OUTLIER -56.26 110.37 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.23 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.18 -58.61 0.68 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.63 -62.4 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -1.103 . . . . 0.0 110.226 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.3 mm 46.85 71.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.186 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 59.15 69.82 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.62 75.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.17 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -48.01 142.12 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.659 ' O ' HG22 ' A' ' 89' ' ' THR . 8.6 mtm180 -72.62 63.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.278 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 88' ' ' ARG . 13.7 t 38.26 38.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 57.73 -176.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -61.63 -44.28 97.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.79 83.85 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 39.77 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -1.141 . . . . 0.0 110.223 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.64 -160.85 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.255 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -133.97 124.45 26.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 110.226 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 t0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.262 0.553 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.618 ' O ' HG23 ' B' ' 57' ' ' VAL . 0.7 OUTLIER -47.56 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.67 ' CZ3' HD22 ' A' ' 68' ' ' LEU . 20.4 m95 -82.09 -43.96 17.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.425 ' HA ' ' CD ' ' B' ' 58' ' ' GLU . 3.2 m -49.73 -22.31 1.35 Allowed 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.317 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.646 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -89.99 -15.7 57.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 68' ' ' LEU . 21.8 t -99.34 -54.93 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -1.077 . . . . 0.0 109.448 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' B' ' 61' ' ' ILE . 12.5 pt-20 -50.7 -45.8 58.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.93 . . . . 0.0 109.611 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.515 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -71.67 -19.55 62.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.036 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.895 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.6 mt -88.09 -22.25 24.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 65' ' ' GLN . 25.6 mt -71.95 -37.38 60.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 11.3 ptp180 -88.0 -42.69 12.27 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.391 0.615 . . . . 0.0 110.364 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.526 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 6.6 mm -53.82 -36.82 31.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.895 HD12 ' O ' ' B' ' 60' ' ' LEU . 21.3 mt -76.57 -40.98 48.07 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 109.234 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 61' ' ' ILE . 1.8 pt20 -69.16 -40.17 78.34 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.487 ' O ' HD13 ' B' ' 70' ' ' ILE . 46.0 tt0 -57.98 -53.67 55.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 14.5 mt -52.18 -61.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.747 HD21 HG11 ' A' ' 57' ' ' VAL . 1.8 mm? -44.81 -48.74 10.99 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.234 -0.916 . . . . 0.0 109.839 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.579 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -47.22 -32.23 4.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.814 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.2 mp -83.04 -51.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 10.6 t60 -46.65 -45.79 19.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -0.864 . . . . 0.0 110.744 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.4 OUTLIER -74.33 -38.18 63.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.064 -1.022 . . . . 0.0 110.614 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.558 ' CD ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -84.94 -0.89 55.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.107 -0.996 . . . . 0.0 110.495 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.558 HG12 ' CD ' ' B' ' 73' ' ' ARG . 10.5 mm -135.03 -1.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.38 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -122.9 -33.29 0.86 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 t -104.19 -3.84 23.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -1.088 . . . . 0.0 109.983 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' B' ' 73' ' ' ARG . 3.8 ptm180 -167.65 35.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.833 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' B' ' 74' ' ' ILE . 6.2 p80 -51.55 156.4 1.32 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.503 ' HB3' HG23 ' B' ' 81' ' ' ILE . 0.3 OUTLIER -99.37 154.0 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.239 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -90.87 45.92 1.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' B' ' 79' ' ' SER . 1.0 OUTLIER -56.24 110.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.235 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.13 -58.58 0.69 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.79 -62.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -1.108 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 32.4 mm 46.82 71.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 59.25 69.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.61 75.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -48.01 142.21 5.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.665 ' O ' HG22 ' B' ' 89' ' ' THR . 8.6 mtm180 -72.73 63.74 0.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.665 HG22 ' O ' ' B' ' 88' ' ' ARG . 13.7 t 38.29 38.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.72 . . . . 0.0 110.616 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 57.63 -176.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -61.57 -44.23 97.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.221 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.68 83.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.43 39.81 1.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -1.138 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.68 -160.84 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -133.97 124.41 26.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.179 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.268 0.556 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 p -72.6 -58.09 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.677 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 26.3 m95 -107.66 -44.05 4.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.806 . . . . 0.0 109.941 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -51.11 -22.3 2.41 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.441 -0.903 . . . . 0.0 108.749 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -86.19 -20.06 55.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.526 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 79.1 t -94.49 -51.57 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.522 -0.987 . . . . 0.0 108.996 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 61' ' ' ILE . 2.7 mm-40 -46.61 -56.8 5.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.262 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.856 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -62.89 -16.52 59.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.359 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 56' ' ' GLY . 13.2 mt -91.26 -21.66 20.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CD1' HD12 ' B' ' 68' ' ' LEU . 83.5 mt -76.58 -34.42 24.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' CG ' ' N ' ' A' ' 63' ' ' ILE . 16.8 ptp180 -88.44 -41.8 12.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.804 -0.56 . . . . 0.0 110.468 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.23 -41.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.426 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' B' ' 64' ' ' LEU . 37.9 mt -69.66 -49.79 50.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -63.38 -33.84 76.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.13 . . . . 0.0 108.093 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.657 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.04 -53.92 51.26 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -53.46 -50.77 64.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 108.971 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.905 HD12 ' CD1' ' B' ' 61' ' ' ILE . 3.1 mt -48.94 -53.46 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.84 . . . . 0.0 109.314 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.3 m-85 -43.78 -39.98 4.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.748 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.063 ' CG2' HD12 ' A' ' 74' ' ' ILE . 1.9 mp -71.65 -38.88 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CG ' ' CZ2' ' B' ' 54' ' ' TRP . 1.5 t60 -53.71 -47.03 70.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.594 -0.692 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -76.32 -15.6 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 0.0 111.051 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.83 1.82 19.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.998 -1.063 . . . . 0.0 110.597 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.063 HD12 ' CG2' ' A' ' 70' ' ' ILE . 6.1 mt -130.42 -29.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.45 -50.32 2.03 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.4 m -68.75 -7.93 38.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -1.109 . . . . 0.0 109.783 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.464 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -140.39 12.41 2.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.917 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.709 ' CE1' ' O ' ' A' ' 79' ' ' SER . 0.0 OUTLIER 67.72 145.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.493 -0.754 . . . . 0.0 109.914 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.709 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -70.24 -145.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.818 . . . . 0.0 110.417 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 84' ' ' ILE . 15.2 ttp180 -113.49 26.73 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 81' ' ' ILE . 1.2 pp -69.62 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -145.16 -120.65 1.37 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.678 HG23 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -72.08 -100.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -1.107 . . . . 0.0 110.287 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.678 ' H ' HG23 ' A' ' 83' ' ' ILE . 18.1 mt -134.16 -94.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.561 -1.337 . . . . 0.0 110.158 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' N ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -109.08 15.36 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 46.67 52.67 10.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -130.37 -1.51 4.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.233 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' NH1' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -142.9 74.67 1.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 0.2 OUTLIER 65.35 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -85.69 49.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.67 85.32 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.4 104.97 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.93 102.1 5.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -1.159 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' LYS . 82.0 p -76.1 117.26 17.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER 43.02 55.75 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 95' ' ' LYS . 84.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.212 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.2 p -72.57 -58.1 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.672 ' CZ2' ' CG ' ' A' ' 71' ' ' HIS . 25.6 m95 -107.69 -44.01 4.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 109.953 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -51.1 -22.29 2.38 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.783 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.621 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -86.2 -20.07 55.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 60' ' ' LEU . 79.1 t -94.53 -51.56 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.52 -0.988 . . . . 0.0 108.937 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' B' ' 61' ' ' ILE . 2.7 mm-40 -46.71 -56.71 5.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.843 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -62.89 -16.48 59.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.621 HD12 ' O ' ' B' ' 56' ' ' GLY . 13.2 mt -91.28 -21.69 20.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.905 ' CD1' HD12 ' A' ' 68' ' ' LEU . 82.7 mt -76.67 -34.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.506 ' CD ' ' HA ' ' B' ' 59' ' ' ALA . 16.8 ptp180 -88.51 -41.69 12.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.806 -0.559 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.843 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -44.29 -42.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.322 -179.014 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' A' ' 64' ' ' LEU . 38.4 mt -69.58 -49.83 50.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.61 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -63.36 -33.84 76.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.998 -1.064 . . . . 0.0 108.163 178.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.662 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -61.02 -53.98 50.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -53.44 -50.74 64.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 108.987 178.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.919 HD12 ' CD1' ' A' ' 61' ' ' ILE . 3.0 mt -48.97 -53.4 20.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.323 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.3 m-85 -43.9 -39.93 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 1.062 ' CG2' HD12 ' B' ' 74' ' ' ILE . 1.8 mp -71.7 -38.82 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.677 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.5 t60 -53.75 -46.96 71.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.546 -0.721 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.8 OUTLIER -76.44 -15.45 59.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 111.078 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.561 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -109.83 1.77 19.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.084 . . . . 0.0 110.56 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 1.062 HD12 ' CG2' ' B' ' 70' ' ' ILE . 6.0 mt -130.39 -29.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 0.0 110.228 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.48 -50.35 2.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 76.5 m -68.67 -8.0 38.37 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -1.111 . . . . 0.0 109.809 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -140.44 12.45 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.873 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.716 ' CE1' ' O ' ' B' ' 79' ' ' SER . 0.0 OUTLIER 67.79 145.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.914 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.716 ' O ' ' CE1' ' B' ' 78' ' ' HIS . 0.7 OUTLIER -70.14 -145.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 110.412 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' B' ' 84' ' ' ILE . 15.3 ttp180 -113.5 26.65 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.593 ' O ' HD12 ' B' ' 81' ' ' ILE . 1.2 pp -69.55 66.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.309 -0.869 . . . . 0.0 110.378 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.21 -120.68 1.37 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.663 HG23 ' H ' ' B' ' 84' ' ' ILE . 0.2 OUTLIER -72.08 -100.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 110.354 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.663 ' H ' HG23 ' B' ' 83' ' ' ILE . 18.1 mt -134.25 -94.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.519 -1.363 . . . . 0.0 110.114 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.56 ' N ' HG22 ' B' ' 84' ' ' ILE . 0.0 OUTLIER -109.08 15.4 23.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 110.184 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 46.65 52.69 10.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.201 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -130.31 -1.54 4.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.498 ' NH1' HD13 ' B' ' 84' ' ' ILE . 0.0 OUTLIER -142.94 74.79 1.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.94 . . . . 0.0 110.21 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.446 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 0.2 OUTLIER 65.26 132.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -85.64 49.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.74 85.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.51 105.02 3.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.98 102.07 5.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -1.195 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' SER . . . . . 0.411 ' O ' ' C ' ' B' ' 95' ' ' LYS . 81.6 p -76.22 117.37 17.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.201 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' B' ' 96' ' ' SER . 0.0 OUTLIER 42.9 55.8 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' B' ' 95' ' ' LYS . 84.9 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.193 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.309 0.576 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 p -56.75 -63.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.668 ' CZ2' ' CG ' ' B' ' 71' ' ' HIS . 20.2 m95 -104.28 -44.96 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -52.19 -21.06 3.0 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.001 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -95.04 -17.51 37.31 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' ILE . 25.0 t -97.52 -53.18 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.995 . . . . 0.0 109.426 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 62' ' ' ARG . 4.8 tp10 -49.97 -54.15 21.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.307 -0.87 . . . . 0.0 109.409 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -65.02 -19.41 65.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.439 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.4 mt -89.06 -23.39 22.56 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 68' ' ' LEU . 31.7 mt -71.59 -34.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.5 ptp180 -90.96 -41.7 10.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.563 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 9.1 mm -58.4 -33.24 47.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.027 -1.046 . . . . 0.0 110.042 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 60' ' ' LEU . 26.3 mt -77.71 -37.1 50.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' ARG . 5.0 pt20 -78.67 -41.12 32.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -57.97 -47.94 81.44 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.434 -0.791 . . . . 0.0 108.996 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 9.4 tp -61.7 -46.19 90.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.982 HD12 ' CD1' ' B' ' 61' ' ' ILE . 1.1 mt -50.43 -54.99 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.8 m-85 -43.08 -40.35 3.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.416 -0.803 . . . . 0.0 110.067 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.769 HG23 HD12 ' A' ' 74' ' ' ILE . 1.3 mp -72.94 -47.44 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.659 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 2.5 t60 -46.05 -46.11 16.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -78.39 -14.64 59.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.856 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.574 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -114.65 14.08 17.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.981 -1.075 . . . . 0.0 110.557 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.769 HD12 HG23 ' A' ' 70' ' ' ILE . 10.2 mt -157.63 -34.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 0.0 110.357 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.32 -36.08 5.53 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 77' ' ' ARG . 5.8 t -48.28 -39.34 21.29 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.241 -1.152 . . . . 0.0 108.139 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER 150.96 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.596 ' CG ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.38 1.95 42.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.925 -1.109 . . . . 0.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -168.67 2.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.327 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 0.8 OUTLIER -72.45 0.24 10.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.395 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' HA ' ' NH2' ' A' ' 77' ' ' ARG . 3.8 mt 62.0 10.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.574 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 81' ' ' ILE . . . 35.51 47.36 0.85 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.733 HG23 ' H ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -48.07 -86.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.256 . . . . 0.0 109.868 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.733 ' H ' HG23 ' A' ' 83' ' ' ILE . 35.5 pt 33.51 33.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.226 -0.921 . . . . 0.0 111.365 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' ILE . 7.6 pt20 -160.43 -170.24 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' GLN . 5.9 mt-30 44.15 -168.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -130.35 46.97 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.29 54.69 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.122 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 90' ' ' ARG . 5.7 t -133.94 -143.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' N ' ' OG1' ' A' ' 89' ' ' THR . 7.9 mtp180 -73.66 80.78 1.53 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.88 -31.15 38.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.272 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.69 -23.49 2.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.24 81.32 2.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -155.35 39.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 94' ' ' SER . 1.1 mttt -43.96 -40.74 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.245 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.293 0.568 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 40.5 p -56.78 -63.74 1.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.659 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 19.9 m95 -104.27 -45.04 4.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.7 m -52.14 -21.01 2.89 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.008 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.64 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -95.11 -17.49 37.21 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 61' ' ' ILE . 25.1 t -97.44 -53.21 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.38 -1.07 . . . . 0.0 109.417 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.523 ' OE2' ' CZ ' ' B' ' 62' ' ' ARG . 4.8 tp10 -49.99 -54.23 21.41 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -64.98 -19.38 65.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.885 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.4 mt -88.99 -23.46 22.62 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.982 ' CD1' HD12 ' A' ' 68' ' ' LEU . 32.1 mt -71.58 -34.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.5 ptp180 -90.98 -41.63 11.0 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.597 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 9.1 mm -58.45 -33.18 47.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.074 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.885 HD12 ' O ' ' B' ' 60' ' ' LEU . 26.9 mt -77.7 -37.1 50.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.561 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' B' ' 62' ' ' ARG . 5.0 pt20 -78.59 -41.23 32.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.512 ' O ' HD13 ' B' ' 70' ' ' ILE . 0.7 OUTLIER -57.86 -48.0 81.07 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.437 -0.79 . . . . 0.0 108.988 178.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 9.4 tp -61.64 -46.23 90.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -50.5 -54.92 18.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.8 m-85 -43.11 -40.33 3.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.785 HG23 HD12 ' B' ' 74' ' ' ILE . 1.3 mp -72.92 -47.43 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.668 ' CG ' ' CZ2' ' A' ' 54' ' ' TRP . 2.5 t60 -46.03 -46.16 16.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.529 -0.732 . . . . 0.0 110.767 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.3 OUTLIER -78.36 -14.71 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 110.925 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.576 ' O ' ' CG ' ' B' ' 78' ' ' HIS . 0.1 OUTLIER -114.54 13.95 17.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.09 . . . . 0.0 110.529 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.785 HD12 HG23 ' B' ' 70' ' ' ILE . 10.3 mt -157.62 -34.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 0.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' CYS . . . -95.4 -36.14 5.49 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.591 ' O ' ' CB ' ' B' ' 77' ' ' ARG . 5.7 t -48.23 -39.31 20.87 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.163 -1.198 . . . . 0.0 108.149 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.591 ' CB ' ' O ' ' B' ' 76' ' ' CYS . 0.0 OUTLIER 151.03 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.56 178.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.587 ' CG ' ' HA ' ' B' ' 74' ' ' ILE . 0.0 OUTLIER -84.36 2.05 42.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.928 -1.107 . . . . 0.0 110.062 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -168.74 2.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.272 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 0.8 OUTLIER -72.36 0.19 10.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 110.365 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.512 ' HA ' ' NH2' ' B' ' 77' ' ' ARG . 3.8 mt 61.84 11.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.392 -0.818 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.485 ' O ' HG12 ' B' ' 84' ' ' ILE . . . 35.45 47.43 0.84 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.73 HG23 ' H ' ' B' ' 84' ' ' ILE . 0.4 OUTLIER -48.07 -86.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -1.22 . . . . 0.0 109.8 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.73 ' H ' HG23 ' B' ' 83' ' ' ILE . 35.6 pt 33.55 33.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.0 111.339 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' B' ' 83' ' ' ILE . 7.6 pt20 -160.41 -170.27 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' B' ' 85' ' ' GLN . 5.9 mt-30 44.07 -168.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -130.33 47.08 2.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 110.15 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 54.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' B' ' 90' ' ' ARG . 5.7 t -133.86 -143.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' B' ' 89' ' ' THR . 7.8 mtp180 -73.74 80.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.9 -31.21 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.194 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.72 -23.48 2.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.27 81.25 2.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -1.145 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' SER . . . . . 0.404 ' O ' ' C ' ' B' ' 95' ' ' LYS . 0.1 OUTLIER -155.31 39.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' B' ' 94' ' ' SER . 1.2 mttt -43.93 -40.78 4.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.172 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' TRP . 7.1 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 52' ' ' ASP . 2.0 m 65.93 -65.75 0.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.686 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -123.08 -26.95 4.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.8 m -51.91 -22.1 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.065 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -58.26 -17.0 29.63 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.898 HG12 HD11 ' A' ' 61' ' ' ILE . 17.4 t -94.73 -55.79 5.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.421 -1.046 . . . . 0.0 109.026 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -45.52 -54.67 7.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -66.44 -13.07 60.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 56' ' ' GLY . 12.4 mt -96.26 -20.52 18.48 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.898 HD11 HG12 ' A' ' 57' ' ' VAL . 45.9 mt -81.56 -32.64 11.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 16.7 ptp180 -85.63 -43.98 12.99 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.47 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.532 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -51.07 -39.13 19.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.824 -1.151 . . . . 0.0 108.103 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' B' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.67 29.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 1.039 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -60.28 -40.23 89.69 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.743 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.81 -45.62 82.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.227 -0.92 . . . . 0.0 108.763 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.69 -42.01 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 109.756 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -55.08 -33.16 62.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 108.717 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -60.36 -60.59 3.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.743 HD12 ' O ' ' A' ' 66' ' ' GLN . 2.1 mp -52.39 -32.68 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.998 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.682 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 7.9 t60 -58.84 -32.79 69.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.375 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -91.07 -42.54 10.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.856 -1.153 . . . . 0.0 111.303 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.633 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -66.94 -6.97 18.8 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.475 -1.391 . . . . 0.0 110.39 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.588 HD12 ' CG2' ' A' ' 70' ' ' ILE . 18.6 mt -122.01 -14.16 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.923 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.49 -57.42 0.75 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.2 m -82.89 -4.66 58.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -1.123 . . . . 0.0 109.809 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 78' ' ' HIS . 3.9 mtt180 -130.98 15.35 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.917 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 81' ' ' ILE . 28.7 t-80 -48.01 177.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.46 -0.775 . . . . 0.0 110.298 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -60.67 -147.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.64 9.39 29.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.184 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 78' ' ' HIS . 2.8 pt -73.34 55.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.0 110.251 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 83' ' ' ILE . . . -94.91 -100.39 1.74 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 82' ' ' GLY . 3.8 tp -178.16 -27.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.745 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.634 HG23 ' H ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -36.75 -85.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.634 ' H ' HG23 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -62.84 97.58 0.11 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.641 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 70.43 147.06 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.987 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' HA ' HG13 ' A' ' 83' ' ' ILE . 63.7 mtp180 -73.51 0.16 13.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' NH2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 42.95 70.86 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.22 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.7 p -75.74 -29.34 58.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -89.16 146.52 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.233 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -152.44 49.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.218 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -140.14 179.99 18.46 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.13 -177.81 3.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -1.119 . . . . 0.0 110.14 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -115.44 -81.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.5 156.15 2.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.197 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' B' ' 54' ' ' TRP . 7.1 p-10 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.235 0.541 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.458 ' CB ' ' O ' ' B' ' 52' ' ' ASP . 2.0 m 65.97 -65.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.682 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -123.09 -26.86 4.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.684 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 86.0 m -52.03 -22.01 3.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -58.24 -17.03 29.62 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.893 HG12 HD11 ' B' ' 61' ' ' ILE . 17.3 t -94.75 -55.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.489 -1.006 . . . . 0.0 109.004 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.837 ' HA ' HD12 ' B' ' 61' ' ' ILE . 0.4 OUTLIER -45.6 -54.61 7.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -66.43 -13.12 60.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.647 HD12 ' O ' ' B' ' 56' ' ' GLY . 12.4 mt -96.35 -20.49 18.44 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.893 HD11 HG12 ' B' ' 57' ' ' VAL . 46.0 mt -81.64 -32.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 16.6 ptp180 -85.49 -44.01 13.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.526 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -51.14 -39.07 19.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.121 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.72 28.23 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.976 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -60.27 -40.25 89.71 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.756 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.76 -45.7 81.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 108.756 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.59 -42.06 71.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.79 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.976 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -55.09 -33.2 62.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 108.655 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.603 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 0.3 OUTLIER -60.29 -60.61 3.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 108.413 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.756 HD12 ' O ' ' B' ' 66' ' ' GLN . 2.1 mp -52.35 -32.82 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.686 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 7.9 t60 -58.73 -32.87 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.361 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -91.0 -42.64 10.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 111.248 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -66.91 -6.95 18.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.486 -1.384 . . . . 0.0 110.361 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.601 HD12 ' CG2' ' B' ' 70' ' ' ILE . 18.6 mt -122.03 -14.12 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.222 -0.924 . . . . 0.0 109.994 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.58 -57.39 0.75 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -82.92 -4.69 58.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -1.095 . . . . 0.0 109.8 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' B' ' 78' ' ' HIS . 3.9 mtt180 -130.93 15.34 5.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.02 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.528 ' CE1' HD11 ' B' ' 81' ' ' ILE . 28.6 t-80 -48.03 177.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.335 -0.853 . . . . 0.0 110.288 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.426 ' O ' ' O ' ' B' ' 78' ' ' HIS . 0.1 OUTLIER -60.67 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -107.55 9.35 29.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.917 . . . . 0.0 110.274 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.528 HD11 ' CE1' ' B' ' 78' ' ' HIS . 2.8 pt -73.41 55.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.298 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' B' ' 83' ' ' ILE . . . -94.89 -100.31 1.73 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.472 ' O ' ' C ' ' B' ' 84' ' ' ILE . 3.8 tp -178.08 -27.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -1.102 . . . . 0.0 110.776 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.629 HG23 ' H ' ' B' ' 85' ' ' GLN . 0.2 OUTLIER -36.67 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.788 . . . . 0.0 110.427 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.629 ' H ' HG23 ' B' ' 84' ' ' ILE . 0.7 OUTLIER -62.73 97.65 0.11 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.06 -1.025 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 85' ' ' GLN . 0.0 OUTLIER 70.28 147.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 109.976 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.431 ' HA ' HG13 ' B' ' 83' ' ' ILE . 63.7 mtp180 -73.47 0.16 13.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.943 . . . . 0.0 110.469 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' B' ' 85' ' ' GLN . 0.0 OUTLIER 42.8 70.93 0.25 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.253 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 43.7 p -75.74 -29.38 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -89.15 146.52 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -152.47 49.01 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.168 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -140.14 179.93 18.52 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.02 -177.88 3.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.242 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -115.39 -81.46 0.61 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.903 . . . . 0.0 110.243 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 156.14 2.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.251 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.266 0.555 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.72 ' HB ' ' CE1' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -54.46 -77.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.551 ' O ' ' N ' ' A' ' 57' ' ' VAL . 14.4 m95 -92.53 -52.51 4.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -42.73 -25.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.783 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.812 ' O ' HD23 ' A' ' 60' ' ' LEU . . . -102.02 37.47 3.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 61' ' ' ILE . 93.4 t -157.98 -53.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.946 -0.737 . . . . 0.0 109.557 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -62.44 -46.51 88.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.0 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.651 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -89.43 -5.14 57.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.922 HD21 HD22 ' B' ' 64' ' ' LEU . 0.2 OUTLIER -100.53 -21.29 15.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.639 HD11 ' CG1' ' A' ' 57' ' ' VAL . 44.0 mt -83.83 -37.33 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.4 ptm180 -78.97 -42.36 26.98 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.67 -42.29 2.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.184 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.898 HD22 HD21 ' B' ' 60' ' ' LEU . 25.4 mt -71.38 -44.65 64.57 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.805 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.66 -44.74 81.67 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.456 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -61.44 -47.39 85.97 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -60.83 -42.89 98.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.477 -0.765 . . . . 0.0 109.154 178.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -57.0 -43.62 81.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 108.78 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 1.8 m-85 -62.75 -17.27 60.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.807 . . . . 0.0 109.012 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.767 HG22 HD12 ' A' ' 74' ' ' ILE . 4.1 mt -95.88 -51.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.635 ' CE1' HG22 ' B' ' 53' ' ' THR . 1.5 t60 -46.98 -45.17 20.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -60.74 -35.51 76.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.542 ' NE ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -91.0 -5.78 54.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.767 HD12 HG22 ' A' ' 70' ' ' ILE . 5.8 mt -113.37 -17.96 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.315 -0.866 . . . . 0.0 109.441 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -99.8 -58.93 0.87 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 77' ' ' ARG . 57.9 m -87.31 -1.8 58.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.123 . . . . 0.0 109.942 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 73' ' ' ARG . 12.5 mmt180 -136.94 18.19 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 53.4 t-80 -45.87 152.68 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.2 m -108.49 -170.16 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' ILE . 5.9 mtp180 -119.01 49.6 1.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' ARG . 4.2 mt -43.4 111.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.46 -63.06 0.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.539 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 2.4 mp -120.02 -41.11 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 42.1 pt 36.64 58.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 110.718 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 1.6 mt-30 63.15 -70.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.285 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' ILE . 12.5 mt-30 -61.59 99.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -62.86 139.78 58.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.78 64.2 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.4 m -113.23 -55.1 2.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -124.24 -169.24 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 54.6 93.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.183 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.28 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.13 114.56 6.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -1.164 . . . . 0.0 110.149 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -168.49 169.39 10.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -75.4 -47.9 25.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.7 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.219 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.307 0.575 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.635 HG22 ' CE1' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -54.36 -76.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' B' ' 57' ' ' VAL . 14.6 m95 -92.46 -52.6 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -42.71 -25.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.78 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.816 ' O ' HD23 ' B' ' 60' ' ' LEU . . . -101.99 37.44 3.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' B' ' 61' ' ' ILE . 92.9 t -158.0 -53.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.845 -0.797 . . . . 0.0 109.539 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.952 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.666 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -89.49 -5.1 57.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.85 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.898 HD21 HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.6 -21.26 15.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' B' ' 57' ' ' VAL . 44.0 mt -83.75 -37.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.879 0.847 . . . . 0.0 108.799 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.4 ptm180 -79.09 -42.39 26.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.85 -0.531 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.666 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -44.48 -42.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.091 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.922 HD22 HD21 ' A' ' 60' ' ' LEU . 24.8 mt -71.2 -44.71 64.88 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.07 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.812 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -56.6 -44.86 81.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -61.49 -47.23 86.59 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -61.0 -42.77 99.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.474 -0.766 . . . . 0.0 109.166 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -56.99 -43.58 81.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 108.788 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 1.8 m-85 -62.83 -17.32 61.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.885 . . . . 0.0 109.008 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.784 HG22 HD12 ' B' ' 74' ' ' ILE . 4.0 mt -95.85 -51.84 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.72 ' CE1' ' HB ' ' A' ' 53' ' ' THR . 6.4 t-160 -46.93 -45.24 20.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.85 . . . . 0.0 110.133 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -60.72 -35.41 76.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 110.067 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.547 ' CZ ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -91.08 -5.73 54.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.95 . . . . 0.0 110.08 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.784 HD12 HG22 ' B' ' 70' ' ' ILE . 5.9 mt -113.36 -18.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -99.85 -58.95 0.87 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.425 ' O ' ' HD3' ' B' ' 77' ' ' ARG . 58.0 m -87.3 -1.73 58.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.955 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' B' ' 73' ' ' ARG . 12.5 mmt180 -137.01 18.22 3.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 53.3 t-80 -45.87 152.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.296 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 65.5 m -108.56 -170.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' B' ' 81' ' ' ILE . 5.9 mtp180 -118.97 49.63 1.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' B' ' 80' ' ' ARG . 4.2 mt -43.33 111.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.228 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.56 -63.09 0.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.535 ' O ' ' CG1' ' B' ' 84' ' ' ILE . 2.4 mp -120.06 -41.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -1.177 . . . . 0.0 110.223 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' B' ' 83' ' ' ILE . 42.2 pt 36.66 58.17 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.749 -0.594 . . . . 0.0 110.739 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' B' ' 84' ' ' ILE . 1.6 mt-30 63.1 -70.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 84' ' ' ILE . 12.7 mt-30 -61.64 99.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 0.0 110.16 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -62.85 139.73 58.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.76 64.17 1.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.201 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -113.2 -55.07 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -124.24 -169.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 54.53 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.177 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.27 -92.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.13 114.61 6.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -1.163 . . . . 0.0 110.121 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -168.55 169.34 10.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -75.35 -47.94 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.163 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 86.8 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.223 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.197 0.522 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -50.63 -60.99 2.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.104 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.809 ' CH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -124.57 -32.69 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.767 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -44.59 -26.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -53.92 -23.39 22.92 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.593 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 34.9 t -97.57 -33.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.583 -0.951 . . . . 0.0 109.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 3.3 tp10 -61.75 -51.34 68.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.291 -0.88 . . . . 0.0 109.458 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.528 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -63.51 -23.44 67.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.461 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.505 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 37.8 mt -86.52 -21.41 26.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 68' ' ' LEU . 1.3 mm -76.09 -38.41 34.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.787 0.803 . . . . 0.0 108.991 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 15.2 ptm180 -84.04 -42.52 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -46.5 -42.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.828 -1.149 . . . . 0.0 108.743 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.645 ' HB3' HG12 ' B' ' 61' ' ' ILE . 49.4 mt -74.22 -41.87 60.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.9 OUTLIER -57.08 -43.29 82.01 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.532 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 10.8 tt0 -62.43 -50.8 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 67' ' ' LEU . 4.9 tt -59.09 -45.69 90.2 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.207 -0.933 . . . . 0.0 108.714 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 HD12 ' B' ' 61' ' ' ILE . 0.9 OUTLIER -47.82 -56.9 6.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.484 -0.76 . . . . 0.0 109.643 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 4.9 m-85 -45.28 -33.53 2.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 67' ' ' LEU . 30.9 mm -79.9 -22.71 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.949 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 68' ' ' LEU . 9.4 t-80 -67.37 -34.78 78.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -0.852 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 1.6 p90 -88.89 -30.38 18.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.222 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -63.76 -19.88 65.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.572 ' CG1' ' HG3' ' A' ' 73' ' ' ARG . 4.5 mt -122.62 -17.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.139 -0.976 . . . . 0.0 109.344 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 -35.69 2.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.515 ' HB2' ' CA ' ' A' ' 72' ' ' PHE . 57.9 m -91.18 -12.18 36.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -1.184 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -136.9 15.04 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.324 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 43.4 t-80 -159.16 49.24 0.33 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.211 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.84 120.84 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 110.028 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -79.37 6.66 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.204 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 81' ' ' ILE . 28.8 mm -134.28 65.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 83' ' ' ILE . . . -137.47 8.81 3.73 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -43.61 -74.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.714 ' H ' HG23 ' A' ' 83' ' ' ILE . 31.0 mm 40.86 31.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.105 -0.997 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.728 ' HB2' HD12 ' A' ' 83' ' ' ILE . 18.2 mt-30 -122.23 -21.9 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 110.214 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 53.89 50.28 17.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.279 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -115.9 -6.04 12.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 59.72 86.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.192 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.3 t -145.0 20.52 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -107.89 134.9 50.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 110.202 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.86 30.52 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . 70.29 15.04 72.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 92' ' ' GLY . . . 58.43 18.54 5.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -1.17 . . . . 0.0 110.139 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -114.75 159.01 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.6 mttt 52.07 -172.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.233 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.283 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 91.1 m -50.58 -60.93 2.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.804 ' CH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -124.68 -32.66 3.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.766 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 58' ' ' GLU . 0.2 OUTLIER -44.58 -26.67 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -53.92 -23.37 22.82 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.596 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 35.1 t -97.5 -33.64 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.578 -0.954 . . . . 0.0 109.676 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HB2' ' CZ2' ' B' ' 54' ' ' TRP . 3.4 tp10 -61.78 -51.35 68.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -63.43 -23.47 67.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.441 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 64' ' ' LEU . 38.3 mt -86.55 -21.4 26.91 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.861 HD12 HD12 ' A' ' 68' ' ' LEU . 1.3 mm -76.11 -38.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.771 0.796 . . . . 0.0 108.944 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 15.2 ptm180 -84.15 -42.51 15.94 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.533 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.7 OUTLIER -46.48 -42.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.844 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' A' ' 61' ' ' ILE . 49.1 mt -74.27 -41.8 60.65 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.296 -0.878 . . . . 0.0 108.735 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.9 OUTLIER -57.01 -43.27 81.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 10.7 tt0 -62.57 -50.69 70.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 67' ' ' LEU . 4.9 tt -59.12 -45.68 90.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.753 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -47.87 -56.88 6.5 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.368 -0.832 . . . . 0.0 109.631 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 4.9 m-85 -45.13 -33.64 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.325 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' B' ' 67' ' ' LEU . 31.5 mm -79.88 -22.74 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -0.764 . . . . 0.0 109.932 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' B' ' 68' ' ' LEU . 9.4 t-80 -67.29 -34.82 78.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.258 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 1.6 p90 -88.81 -30.39 19.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 110.252 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.574 ' HA ' ' HG2' ' B' ' 77' ' ' ARG . 0.0 OUTLIER -63.87 -19.84 65.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.068 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.572 ' CG1' ' HG3' ' B' ' 73' ' ' ARG . 4.5 mt -122.54 -17.16 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.01 -35.71 2.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.526 ' HB2' ' CA ' ' B' ' 72' ' ' PHE . 58.0 m -91.16 -12.19 36.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -136.91 15.04 3.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.309 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' B' ' 74' ' ' ILE . 43.5 t-80 -159.17 49.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.188 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.91 120.85 40.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 110.012 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -79.33 6.64 9.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.195 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.424 HG22 ' O ' ' B' ' 81' ' ' ILE . 29.0 mm -134.36 65.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' B' ' 83' ' ' ILE . . . -137.47 8.9 3.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.716 HD12 ' HB2' ' B' ' 85' ' ' GLN . 0.2 OUTLIER -43.57 -74.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 110.255 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.702 ' H ' HG23 ' B' ' 83' ' ' ILE . 30.8 mm 40.85 31.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.716 ' HB2' HD12 ' B' ' 83' ' ' ILE . 18.6 mt-30 -122.07 -22.03 5.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.993 . . . . 0.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.01 50.25 17.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.215 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -115.95 -6.04 12.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.206 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 59.74 86.66 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 10.3 t -145.0 20.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 110.231 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' B' ' 90' ' ' ARG . 0.0 OUTLIER -107.86 134.84 50.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.96 30.42 7.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.259 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' B' ' 93' ' ' ALA . . . 70.24 15.13 72.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 92' ' ' GLY . . . 58.38 18.56 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -1.17 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -114.76 159.06 21.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 17.6 mttt 51.93 -172.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.238 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 53' ' ' THR . 23.8 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.206 0.527 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 14.9 m 60.35 -118.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.971 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 18.1 m95 -75.63 -51.05 13.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.0 109.998 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.24 -23.69 1.46 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -82.99 -30.64 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 16.7 t -82.47 -38.72 15.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.658 -0.907 . . . . 0.0 108.568 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -59.12 -54.36 47.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -64.47 -17.43 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 108.746 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' HD12 ' A' ' 64' ' ' LEU . 12.1 mt -88.29 -22.92 23.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.849 ' CD1' HD12 ' B' ' 68' ' ' LEU . 1.0 OUTLIER -72.09 -38.93 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.7 ptm180 -86.08 -41.75 14.51 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.802 -0.561 . . . . 0.0 110.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.1 mp -43.91 -42.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.321 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 11.1 mt -70.68 -44.65 66.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -68.04 -30.51 69.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.134 -0.979 . . . . 0.0 108.805 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.53 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 32.5 tt0 -68.64 -53.97 19.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.436 -0.79 . . . . 0.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.7 -32.44 73.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.662 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' B' ' 61' ' ' ILE . 4.4 mt -63.61 -45.2 91.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -68.22 -25.28 65.12 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.278 -0.889 . . . . 0.0 109.195 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 13.8 mm -85.32 -18.84 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.158 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -68.91 -51.57 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.563 -0.711 . . . . 0.0 110.154 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 2.1 p90 -71.02 -14.85 62.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -77.81 -37.06 49.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 4.7 mt -125.3 -34.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -64.1 -25.3 69.44 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' C ' ' CG ' ' A' ' 77' ' ' ARG . 48.5 t -116.28 -1.73 12.28 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.659 -0.906 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 72' ' ' PHE . 7.9 mtt180 -146.72 7.01 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.219 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.53 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 6.4 t-80 -41.4 104.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.281 -0.887 . . . . 0.0 110.148 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -109.57 122.67 47.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.22 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 56.92 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.636 HG23 ' HB2' ' A' ' 79' ' ' SER . 1.1 pt -92.41 65.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.13 39.45 0.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 84' ' ' ILE . 7.3 tp -79.16 -38.0 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -1.114 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 84' ' ' ILE . 6.1 mt 56.02 52.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 84' ' ' ILE . 16.8 mp0 41.58 67.43 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.345 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 87' ' ' ARG . 46.4 tt0 -106.04 6.94 31.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 86' ' ' GLN . 6.5 mmt85 44.02 57.96 3.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.29 35.38 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m 55.84 55.08 7.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.197 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 48.31 -166.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.176 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.61 153.62 16.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.265 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.33 14.07 66.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.98 -69.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.207 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t 46.39 35.19 2.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -114.76 85.93 2.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.152 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' B' ' 53' ' ' THR . 24.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.181 0.515 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 52' ' ' ASP . 14.9 m 60.4 -118.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.576 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 17.9 m95 -75.84 -51.07 13.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.941 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.19 -23.71 1.42 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.657 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.546 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -82.93 -30.72 31.01 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 54' ' ' TRP . 16.9 t -82.39 -38.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.579 -0.954 . . . . 0.0 108.619 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' B' ' 61' ' ' ILE . 0.2 OUTLIER -59.19 -54.29 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -64.51 -17.4 63.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 108.762 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.553 ' O ' HD12 ' B' ' 64' ' ' LEU . 12.2 mt -88.23 -22.8 23.78 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.834 ' CD1' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -72.28 -38.92 63.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.5 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 9.7 ptm180 -86.2 -41.61 14.52 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.368 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.1 mp -43.84 -42.18 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.355 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 11.4 mt -70.52 -44.78 66.85 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -68.06 -30.58 69.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 108.76 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.534 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 32.3 tt0 -68.61 -54.01 19.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.332 -0.855 . . . . 0.0 109.264 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.66 -32.46 73.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.647 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 61' ' ' ILE . 4.4 mt -63.67 -45.24 91.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.981 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -68.08 -25.45 65.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.22 -0.925 . . . . 0.0 109.212 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 69' ' ' PHE . 13.9 mm -85.21 -18.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 109.217 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.608 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.0 OUTLIER -68.82 -51.66 38.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.539 -0.725 . . . . 0.0 110.168 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.549 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 2.1 p90 -71.03 -14.75 62.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' B' ' 77' ' ' ARG . 0.0 OUTLIER -77.82 -37.03 49.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' HIS . 4.7 mt -125.36 -34.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.871 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -64.16 -25.25 69.49 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.463 ' C ' ' CG ' ' B' ' 77' ' ' ARG . 48.5 t -116.32 -1.72 12.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.653 -0.91 . . . . 0.0 109.782 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' B' ' 72' ' ' PHE . 7.9 mtt180 -146.69 6.91 0.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 111.271 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 74' ' ' ILE . 6.4 t-80 -41.24 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 110.133 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.627 ' HB2' HG23 ' B' ' 81' ' ' ILE . 0.1 OUTLIER -109.62 122.6 47.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 56.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.308 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' B' ' 79' ' ' SER . 1.1 pt -92.39 65.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.25 39.42 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.507 HG23 ' N ' ' B' ' 84' ' ' ILE . 7.3 tp -79.08 -38.01 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -1.145 . . . . 0.0 110.219 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.752 ' O ' HG22 ' B' ' 84' ' ' ILE . 6.1 mt 56.04 52.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.257 -0.902 . . . . 0.0 110.367 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' ' 84' ' ' ILE . 16.7 mp0 41.55 67.42 0.56 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 87' ' ' ARG . 46.5 tt0 -106.04 6.89 31.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 86' ' ' GLN . 6.5 mmt85 44.02 57.98 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.26 35.37 1.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 24.3 m 55.81 55.15 7.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 48.23 -166.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.24 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.66 153.66 16.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 110.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.38 14.18 65.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.0 -69.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -1.184 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t 46.42 35.08 2.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -114.54 85.86 2.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 110.211 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.186 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.01 -67.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.162 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.788 ' HH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -113.3 -24.16 9.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 0.0 109.826 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 22.0 m -53.94 -19.1 4.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 109.729 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.69 -7.51 54.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 16.1 t -111.87 3.85 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -1.129 . . . . 0.0 110.269 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' THR . 11.0 pt-20 -121.86 -37.56 2.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.276 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -87.88 -20.34 26.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.982 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 56' ' ' GLY . 23.1 mt -85.67 -25.34 26.61 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.924 ' CD1' HD12 ' B' ' 68' ' ' LEU . 3.9 mt -67.0 -45.11 87.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 7.6 ptm180 -78.97 -42.98 25.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.395 0.617 . . . . 0.0 109.857 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.583 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 2.6 mm -47.36 -41.01 6.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.937 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' B' ' 64' ' ' LEU . 95.5 mt -72.14 -45.49 60.33 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.41 -41.54 80.55 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -56.34 -54.56 44.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -54.98 -51.09 67.29 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.123 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' B' ' 61' ' ' ILE . 0.6 OUTLIER -43.24 -53.12 5.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.36 -0.838 . . . . 0.0 110.426 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.35 -25.55 49.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 109.043 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 66' ' ' GLN . 1.5 mt -91.47 -19.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.203 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.457 ' CD2' ' CE3' ' B' ' 54' ' ' TRP . 21.3 t-80 -67.99 -30.93 70.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.649 -0.657 . . . . 0.0 110.52 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -86.62 -31.44 21.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.441 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.543 ' NE ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -82.68 -4.54 57.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.108 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.543 HG12 ' NE ' ' A' ' 73' ' ' ARG . 5.8 mm -116.29 -20.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.49 -46.28 1.24 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -72.27 -17.47 61.88 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.451 -1.029 . . . . 0.0 109.297 179.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.53 0.53 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.528 0.68 . . . . 0.0 109.661 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 1.8 t-160 -64.34 107.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -145.78 42.13 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 83' ' ' ILE . 13.6 mmt85 44.78 29.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 81' ' ' ILE . 2.5 mp 52.91 29.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.49 62.97 3.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' GLN . 84.4 mt -127.83 -32.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 83' ' ' ILE . 12.3 mt 63.98 -69.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.808 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' ILE . 9.8 mt-30 -113.07 -53.34 2.72 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.0 pt20 -174.64 164.4 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 86' ' ' GLN . 11.1 mtm180 56.7 -171.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' ARG . 7.5 mtt180 -134.67 102.61 5.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.219 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 t -64.57 69.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.237 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' ARG . 11.5 mtm180 -93.39 166.73 12.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.86 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -71.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.27 -96.24 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.27 77.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -1.141 . . . . 0.0 110.273 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -143.25 -171.29 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 14.03 16.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.209 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.219 0.533 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.88 -67.36 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.238 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.787 ' HH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -113.36 -24.11 9.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' B' ' 58' ' ' GLU . 22.1 m -53.85 -19.22 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.671 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -68.56 -7.49 53.77 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 16.2 t -111.91 3.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' B' ' 55' ' ' THR . 11.0 pt-20 -121.84 -37.58 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.331 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' B' ' 62' ' ' ARG . . . -87.9 -20.25 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.975 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.671 HD12 ' O ' ' B' ' 56' ' ' GLY . 23.2 mt -85.77 -25.26 26.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.914 ' CD1' HD12 ' A' ' 68' ' ' LEU . 3.9 mt -67.13 -45.06 87.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 7.6 ptm180 -78.86 -43.06 25.87 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.433 0.635 . . . . 0.0 109.835 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 2.5 mm -47.5 -40.95 7.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.896 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' A' ' 64' ' ' LEU . 95.2 mt -72.05 -45.59 60.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.4 -0.812 . . . . 0.0 109.067 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.35 -41.62 80.42 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.592 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.8 OUTLIER -56.12 -54.74 41.46 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -54.87 -51.2 66.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.924 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -43.29 -53.05 5.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 0.0 110.452 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.601 ' CE2' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.36 -25.48 49.61 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.187 -0.946 . . . . 0.0 109.101 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.601 ' CD1' ' CE2' ' B' ' 69' ' ' PHE . 1.5 mt -91.52 -19.86 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 109.195 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.483 ' CD2' ' CE3' ' A' ' 54' ' ' TRP . 21.2 t-80 -68.03 -30.92 70.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -86.58 -31.41 21.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.456 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.536 ' NE ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -82.76 -4.56 58.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.536 HG12 ' NE ' ' B' ' 73' ' ' ARG . 5.8 mm -116.16 -20.86 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 0.0 109.074 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.53 -46.37 1.22 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -72.17 -17.55 61.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -1.076 . . . . 0.0 109.279 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 0.0 OUTLIER -110.47 0.63 17.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.695 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 1.8 t-160 -64.44 107.84 1.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.124 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -145.77 42.06 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.353 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.474 ' O ' HD12 ' B' ' 83' ' ' ILE . 13.6 mmt85 44.71 29.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.59 HG22 ' O ' ' B' ' 81' ' ' ILE . 2.5 mp 52.82 29.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.189 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.46 62.98 3.41 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' B' ' 85' ' ' GLN . 84.7 mt -127.86 -32.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -1.102 . . . . 0.0 110.235 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' B' ' 83' ' ' ILE . 12.3 mt 63.92 -69.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.82 . . . . 0.0 110.424 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 83' ' ' ILE . 9.8 mt-30 -113.05 -53.4 2.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.474 -0.766 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 87' ' ' ARG . 3.0 pt20 -174.61 164.35 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' B' ' 86' ' ' GLN . 11.1 mtm180 56.64 -171.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' B' ' 90' ' ' ARG . 7.5 mtt180 -134.58 102.66 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 2.7 t -64.56 69.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' B' ' 88' ' ' ARG . 11.5 mtm180 -93.45 166.68 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.88 -71.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.33 -96.17 0.16 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.33 77.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -143.2 -171.3 3.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.19 14.0 16.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.229 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.222 0.534 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.95 -69.73 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 110.162 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.899 ' HH2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -125.17 -28.56 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.835 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' A' ' 58' ' ' GLU . 18.3 m -50.78 -21.67 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 109.578 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.75 -12.11 46.06 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 21.6 t -99.83 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -1.133 . . . . 0.0 109.77 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.92 ' OE2' ' HB2' ' A' ' 59' ' ' ALA . 2.8 pp20? -53.39 -37.42 62.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 110.198 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.92 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . . . -86.04 -11.15 53.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.045 -1.035 . . . . 0.0 110.411 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 56' ' ' GLY . 11.1 mt -96.99 -20.26 18.19 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.767 HD12 ' CB ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -81.64 -37.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG3' HD13 ' A' ' 63' ' ' ILE . 13.7 ptm180 -81.07 -41.56 22.4 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.316 0.579 . . . . 0.0 110.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.58 HD13 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -54.51 -35.47 31.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.605 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.757 ' CB ' HD12 ' B' ' 61' ' ' ILE . 24.0 mt -81.59 -39.87 23.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.073 -1.017 . . . . 0.0 108.914 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.981 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.9 pt20 -66.95 -37.92 85.16 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 5.6 tt0 -59.23 -54.4 47.3 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -42.72 75.28 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.139 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.981 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -62.25 -37.92 87.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 0.0 108.94 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -58.91 -21.33 57.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 108.97 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 16.9 mm -95.81 -10.42 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.552 -0.718 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 76' ' ' CYS . 0.3 OUTLIER -74.05 -47.41 36.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.808 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 8.3 p90 -77.9 -6.37 54.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.556 ' NE ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -109.34 -28.32 9.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 109.895 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG13 ' NE ' ' A' ' 73' ' ' ARG . 3.0 mt -129.18 -2.64 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.172 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -116.52 -19.29 5.44 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.555 ' CB ' ' HA ' ' A' ' 72' ' ' PHE . 26.9 t -117.47 -8.98 10.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 109.707 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 73' ' ' ARG . 9.4 ptp180 -154.04 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.344 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 5.1 t-80 -60.66 99.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.0 109.864 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.93 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 110.081 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -1.72 18.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 83' ' ' ILE . 30.9 mt -79.74 125.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.16 60.38 0.24 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.3 tp -109.35 -21.36 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -1.082 . . . . 0.0 110.026 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.563 HD12 ' C ' ' A' ' 83' ' ' ILE . 1.9 mp 63.26 115.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.237 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.17 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.138 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -50.89 133.22 26.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -129.22 -64.49 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.212 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 87' ' ' ARG . 9.2 mtp180 42.52 30.53 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 87' ' ' ARG . 1.6 p -109.58 -70.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 110.198 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -70.77 -152.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.208 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.8 94.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.73 -154.9 16.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.62 150.97 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.205 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 p -62.78 -171.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -63.68 -53.63 48.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.129 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.234 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.25 0.548 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.911 ' HH2' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -125.12 -28.49 3.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' B' ' 58' ' ' GLU . 18.3 m -50.85 -21.66 1.8 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.692 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -63.77 -12.06 45.95 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CE3' ' B' ' 54' ' ' TRP . 21.7 t -99.89 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -1.103 . . . . 0.0 109.724 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.905 ' OE2' ' HB2' ' B' ' 59' ' ' ALA . 2.8 pp20? -53.37 -37.43 62.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 0.0 110.146 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.905 ' HB2' ' OE2' ' B' ' 58' ' ' GLU . . . -86.19 -10.99 53.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.139 -0.975 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.692 HD12 ' O ' ' B' ' 56' ' ' GLY . 11.2 mt -96.99 -20.25 18.2 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.759 HD13 ' N ' ' B' ' 61' ' ' ILE . 0.4 OUTLIER -81.66 -37.62 15.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.556 ' HG3' HD13 ' B' ' 63' ' ' ILE . 13.7 ptm180 -81.05 -41.49 22.54 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.341 0.591 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.556 HD13 ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -54.56 -35.44 31.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.603 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.767 ' CB ' HD12 ' A' ' 61' ' ' ILE . 24.2 mt -81.66 -39.81 23.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.044 -1.035 . . . . 0.0 108.902 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.95 ' HA ' HD23 ' B' ' 68' ' ' LEU . 2.9 pt20 -66.93 -37.93 85.23 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -59.24 -54.43 46.93 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -55.52 -42.79 75.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.131 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.95 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -62.19 -37.96 87.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 108.96 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -58.99 -21.27 58.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 108.933 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' B' ' 70' ' ' ILE . 16.9 mm -95.83 -10.37 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.495 0.664 . . . . 0.0 109.422 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' B' ' 75' ' ' GLY . 0.3 OUTLIER -74.17 -47.29 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 109.814 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 8.1 p90 -77.96 -6.36 54.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.544 ' NE ' HG13 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -109.21 -28.51 8.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.544 HG13 ' NE ' ' B' ' 73' ' ' ARG . 2.9 mt -129.13 -2.65 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.399 -0.813 . . . . 0.0 109.197 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -116.54 -19.23 5.45 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.555 ' CB ' ' HA ' ' B' ' 72' ' ' PHE . 27.4 t -117.52 -8.99 10.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.462 -1.022 . . . . 0.0 109.748 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' B' ' 73' ' ' ARG . 9.4 ptp180 -154.04 23.18 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 111.433 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 5.2 t-80 -60.67 99.06 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 109.874 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.88 87.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.88 -1.78 18.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.922 . . . . 0.0 110.243 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' B' ' 83' ' ' ILE . 30.8 mt -79.67 125.37 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.236 -0.915 . . . . 0.0 110.021 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.22 60.43 0.25 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.559 ' C ' HD12 ' B' ' 84' ' ' ILE . 1.3 tp -109.39 -21.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.559 HD12 ' C ' ' B' ' 83' ' ' ILE . 1.9 mp 63.1 115.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.322 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.17 100.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -50.82 133.32 26.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.521 ' O ' HG23 ' B' ' 89' ' ' THR . 0.0 OUTLIER -129.27 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 110.174 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' B' ' 87' ' ' ARG . 9.1 mtp180 42.59 30.39 0.22 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.521 HG23 ' O ' ' B' ' 87' ' ' ARG . 1.6 p -109.53 -70.54 0.8 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -70.76 -152.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.114 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.86 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.274 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.65 -154.82 16.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 150.96 2.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 1.1 p -62.8 -171.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 110.156 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -63.62 -53.56 49.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.267 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.236 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.49 0.662 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 p -53.43 -34.58 58.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.696 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 36.7 m95 -112.56 -50.56 2.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.109 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -51.9 -19.01 1.53 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.696 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.602 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -91.18 -21.14 36.35 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.809 -2.116 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 54' ' ' TRP . 21.9 t -91.78 -54.46 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.783 -0.834 . . . . 0.0 108.775 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -43.74 -57.55 3.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.429 -0.794 . . . . 0.0 109.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.703 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -61.5 -16.52 48.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 56' ' ' GLY . 21.4 mt -95.19 -21.26 18.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.917 HG12 HD22 ' B' ' 64' ' ' LEU . 6.7 mt -81.36 -33.29 12.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 8.8 ptm180 -82.81 -43.67 16.4 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.168 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -47.29 -32.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.076 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 HG12 ' B' ' 61' ' ' ILE . 6.8 mt -70.92 -55.48 8.31 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.649 0.738 . . . . 0.0 109.306 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.39 74.73 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.52 -0.872 . . . . 0.0 108.872 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 4.6 tt0 -68.2 -43.75 77.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.541 -0.724 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.8 -29.42 62.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.146 -0.971 . . . . 0.0 110.639 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -76.67 -32.19 57.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -71.81 -24.12 61.67 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 1.3 tp -84.48 -36.02 11.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -40.73 -56.25 2.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.168 0.509 . . . . 0.0 110.29 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 3.7 p90 -75.48 -2.36 28.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -96.11 -27.26 15.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.535 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 78' ' ' HIS . 6.5 mt -132.27 -6.87 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.848 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -106.26 -44.75 1.33 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.567 ' CB ' ' HA ' ' A' ' 72' ' ' PHE . 48.2 t -81.26 -17.46 49.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -1.113 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 7.8 ptp180 -133.85 25.45 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.618 -0.676 . . . . 0.0 109.829 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 9.5 p80 -40.07 140.39 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 110.541 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.71 114.87 27.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.405 -0.809 . . . . 0.0 109.883 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.666 ' HB2' HD13 ' A' ' 83' ' ' ILE . 58.0 mtm180 -86.73 33.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.7 mm 47.66 89.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.946 ' C ' HD12 ' A' ' 83' ' ' ILE . . . 100.96 36.74 3.84 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.946 HD12 ' C ' ' A' ' 82' ' ' GLY . 2.6 mp -139.66 7.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -1.175 . . . . 0.0 110.211 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 1.1 pt -75.49 65.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.1 156.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.57 40.81 31.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -139.18 -61.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.23 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HB3' ' CB ' ' A' ' 91' ' ' ASN . 15.2 mtt180 57.13 92.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -67.76 -33.13 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -72.55 -11.97 60.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.439 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 24.9 t30 -87.35 -80.14 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.229 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.36 169.21 52.44 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.423 ' O ' ' OG ' ' A' ' 94' ' ' SER . . . -80.9 -85.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -1.189 . . . . 0.0 110.184 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 93' ' ' ALA . 45.3 p 46.31 58.24 4.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.234 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -44.31 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.156 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.149 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.384 0.611 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 82.5 p -53.37 -34.57 58.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.179 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.686 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 36.6 m95 -112.57 -50.63 2.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.091 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -51.86 -19.03 1.52 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.276 -0.969 . . . . 0.0 108.762 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.613 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -91.2 -21.13 36.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 54' ' ' TRP . 21.7 t -91.76 -54.54 7.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.749 -0.854 . . . . 0.0 108.727 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' B' ' 57' ' ' VAL . 0.2 OUTLIER -43.8 -57.46 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.709 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -61.47 -16.56 48.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.318 -0.864 . . . . 0.0 109.667 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.613 HD12 ' O ' ' B' ' 56' ' ' GLY . 21.1 mt -95.15 -21.24 18.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 64' ' ' LEU . 6.7 mt -81.4 -33.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.548 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 8.7 ptm180 -82.72 -43.7 16.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.582 -0.699 . . . . 0.0 109.178 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.709 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.0 OUTLIER -47.23 -32.46 2.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.103 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 61' ' ' ILE . 6.7 mt -70.92 -55.53 8.2 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.659 0.742 . . . . 0.0 109.282 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.42 74.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.522 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 4.6 tt0 -68.19 -43.81 77.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 110.118 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.485 ' O ' HG22 ' B' ' 70' ' ' ILE . 0.1 OUTLIER -73.66 -29.53 62.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -0.985 . . . . 0.0 110.699 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.679 ' O ' HD12 ' B' ' 68' ' ' LEU . 0.1 OUTLIER -76.61 -32.26 57.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.086 -1.009 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.587 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -71.75 -24.16 61.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' B' ' 73' ' ' ARG . 1.3 tp -84.44 -36.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.696 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -40.66 -56.33 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.139 0.495 . . . . 0.0 110.339 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 3.6 p90 -75.41 -2.37 28.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 110.6 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -96.1 -27.16 15.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.608 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' B' ' 78' ' ' HIS . 6.5 mt -132.35 -6.78 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.84 . . . . 0.0 109.899 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -106.32 -44.72 1.32 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.56 ' CB ' ' HA ' ' B' ' 72' ' ' PHE . 49.1 t -81.21 -17.5 49.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.29 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 7.8 ptp180 -133.85 25.47 3.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 109.847 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' B' ' 78' ' ' HIS . 9.5 p80 -40.1 140.41 0.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.489 -0.757 . . . . 0.0 110.551 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.76 114.85 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.927 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.658 ' CB ' HD13 ' B' ' 83' ' ' ILE . 58.1 mtm180 -86.73 33.53 0.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 110.133 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm 47.58 90.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.304 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.955 ' C ' HD12 ' B' ' 83' ' ' ILE . . . 101.01 36.67 3.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.955 HD12 ' C ' ' B' ' 82' ' ' GLY . 2.6 mp -139.61 7.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.234 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.428 ' O ' ' CG1' ' B' ' 84' ' ' ILE . 1.1 pt -75.48 65.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' B' ' 84' ' ' ILE . 0.1 OUTLIER 63.18 156.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.912 . . . . 0.0 110.047 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.51 40.88 31.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -139.18 -61.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.244 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.435 ' HB3' ' CB ' ' B' ' 91' ' ' ASN . 15.3 mtt180 57.03 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -67.66 -33.22 74.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -72.66 -11.82 60.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.269 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' B' ' 88' ' ' ARG . 25.0 t30 -87.33 -80.17 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.3 169.19 52.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' B' ' 94' ' ' SER . . . -80.88 -85.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 93' ' ' ALA . 45.8 p 46.38 58.18 4.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' B' ' 95' ' ' LYS . 0.0 OUTLIER -44.2 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.176 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.652 ' CZ3' HD22 ' B' ' 68' ' ' LEU . 20.2 m95 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.542 0.687 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' CD ' ' A' ' 58' ' ' GLU . 3.2 m -49.65 -22.4 1.32 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.319 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -89.95 -15.77 57.26 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 HD21 ' B' ' 68' ' ' LEU . 21.9 t -99.3 -54.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.451 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 59' ' ' ALA . 12.5 pt-20 -50.59 -45.89 57.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.616 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.514 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -71.62 -19.5 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.997 . . . . 0.0 109.05 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.6 mt -88.06 -22.38 24.21 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.638 HD11 ' HG ' ' B' ' 68' ' ' LEU . 25.3 mt -71.92 -37.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 11.3 ptp180 -87.96 -42.73 12.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 6.6 mm -53.83 -36.78 31.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.516 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 60' ' ' LEU . 21.3 mt -76.61 -41.09 47.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.239 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD13 ' B' ' 61' ' ' ILE . 1.8 pt20 -68.93 -40.22 79.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' HD13 ' A' ' 70' ' ' ILE . 8.0 tt0 -57.98 -53.67 55.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.438 -0.789 . . . . 0.0 109.301 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 14.5 mt -52.16 -61.87 2.0 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.814 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD21 HG11 ' B' ' 57' ' ' VAL . 1.8 mm? -44.86 -48.68 11.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.079 -1.013 . . . . 0.0 109.874 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.563 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -47.29 -32.27 4.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.41 -0.806 . . . . 0.0 109.752 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 1.2 mp -82.95 -51.85 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.605 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 10.5 t60 -46.67 -45.79 19.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -74.27 -38.25 63.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.508 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.67 ' CZ3' HD22 ' A' ' 68' ' ' LEU . 20.4 m95 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.643 0.735 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.425 ' HA ' ' CD ' ' B' ' 58' ' ' GLU . 3.2 m -49.73 -22.31 1.35 Allowed 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.317 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.646 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -89.99 -15.7 57.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 68' ' ' LEU . 21.8 t -99.34 -54.93 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -1.077 . . . . 0.0 109.448 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' B' ' 61' ' ' ILE . 12.5 pt-20 -50.7 -45.8 58.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.93 . . . . 0.0 109.611 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.515 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -71.67 -19.55 62.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.036 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.895 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.6 mt -88.09 -22.25 24.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 65' ' ' GLN . 25.6 mt -71.95 -37.38 60.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 11.3 ptp180 -88.0 -42.69 12.27 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.391 0.615 . . . . 0.0 110.364 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.526 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 6.6 mm -53.82 -36.82 31.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.895 HD12 ' O ' ' B' ' 60' ' ' LEU . 21.3 mt -76.57 -40.98 48.07 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 109.234 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 61' ' ' ILE . 1.8 pt20 -69.16 -40.17 78.34 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.487 ' O ' HD13 ' B' ' 70' ' ' ILE . 7.9 tt0 -57.98 -53.67 55.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 14.5 mt -52.18 -61.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.747 HD21 HG11 ' A' ' 57' ' ' VAL . 1.8 mm? -44.81 -48.74 10.99 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.234 -0.916 . . . . 0.0 109.839 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.579 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -47.22 -32.23 4.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.814 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.2 mp -83.04 -51.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 10.6 t60 -46.65 -45.79 19.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -0.864 . . . . 0.0 110.744 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.4 OUTLIER -74.33 -38.18 63.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.064 -1.022 . . . . 0.0 110.614 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.506 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.107 -0.996 . . . . 0.0 110.495 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.677 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 26.3 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.548 0.689 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -51.11 -22.3 2.41 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.441 -0.903 . . . . 0.0 108.749 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -86.19 -20.06 55.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.526 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 79.1 t -94.49 -51.57 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.522 -0.987 . . . . 0.0 108.996 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 61' ' ' ILE . 2.7 mm-40 -46.61 -56.8 5.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.262 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.856 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -62.89 -16.52 59.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.359 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 56' ' ' GLY . 13.2 mt -91.26 -21.66 20.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CD1' HD12 ' B' ' 68' ' ' LEU . 83.5 mt -76.58 -34.42 24.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' CG ' ' N ' ' A' ' 63' ' ' ILE . 16.8 ptp180 -88.44 -41.8 12.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.804 -0.56 . . . . 0.0 110.468 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.23 -41.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.426 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' B' ' 64' ' ' LEU . 37.9 mt -69.66 -49.79 50.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -63.38 -33.84 76.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.13 . . . . 0.0 108.093 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.657 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.04 -53.92 51.26 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -53.46 -50.77 64.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 108.971 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.905 HD12 ' CD1' ' B' ' 61' ' ' ILE . 3.1 mt -48.94 -53.46 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.84 . . . . 0.0 109.314 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.3 m-85 -43.78 -39.98 4.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.748 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 66' ' ' GLN . 1.9 mp -71.65 -38.88 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CG ' ' CZ2' ' B' ' 54' ' ' TRP . 1.5 t60 -53.71 -47.03 70.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.594 -0.692 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -76.32 -15.6 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 0.0 111.051 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 120.998 -1.063 . . . . 0.0 110.597 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.672 ' CZ2' ' CG ' ' A' ' 71' ' ' HIS . 25.6 m95 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -51.1 -22.29 2.38 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.783 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.621 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -86.2 -20.07 55.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 60' ' ' LEU . 79.1 t -94.53 -51.56 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.52 -0.988 . . . . 0.0 108.937 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' B' ' 61' ' ' ILE . 2.7 mm-40 -46.71 -56.71 5.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.843 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -62.89 -16.48 59.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.621 HD12 ' O ' ' B' ' 56' ' ' GLY . 13.2 mt -91.28 -21.69 20.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.905 ' CD1' HD12 ' A' ' 68' ' ' LEU . 82.7 mt -76.67 -34.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.506 ' CD ' ' HA ' ' B' ' 59' ' ' ALA . 16.8 ptp180 -88.51 -41.69 12.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.806 -0.559 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.843 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -44.29 -42.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.322 -179.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' A' ' 64' ' ' LEU . 38.4 mt -69.58 -49.83 50.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.61 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -63.36 -33.84 76.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.998 -1.064 . . . . 0.0 108.163 178.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.662 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -61.02 -53.98 50.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -53.44 -50.74 64.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 108.987 178.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.919 HD12 ' CD1' ' A' ' 61' ' ' ILE . 3.0 mt -48.97 -53.4 20.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.323 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.3 m-85 -43.9 -39.93 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.662 HD12 ' O ' ' B' ' 66' ' ' GLN . 1.8 mp -71.7 -38.82 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.677 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.5 t60 -53.75 -46.96 71.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.546 -0.721 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.8 OUTLIER -76.44 -15.45 59.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 111.078 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.561 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.084 . . . . 0.0 110.56 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.668 ' CZ2' ' CG ' ' B' ' 71' ' ' HIS . 20.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.431 0.634 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -52.19 -21.06 3.0 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.001 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -95.04 -17.51 37.31 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' ILE . 25.0 t -97.52 -53.18 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.995 . . . . 0.0 109.426 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 62' ' ' ARG . 4.8 tp10 -49.97 -54.15 21.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.307 -0.87 . . . . 0.0 109.409 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -65.02 -19.41 65.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.439 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.4 mt -89.06 -23.39 22.56 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 68' ' ' LEU . 31.7 mt -71.59 -34.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.5 ptp180 -90.96 -41.7 10.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.563 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 9.1 mm -58.4 -33.24 47.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.027 -1.046 . . . . 0.0 110.042 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 60' ' ' LEU . 26.3 mt -77.71 -37.1 50.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' ARG . 1.1 pt20 -78.67 -41.12 32.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -57.97 -47.94 81.44 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.434 -0.791 . . . . 0.0 108.996 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 9.4 tp -61.7 -46.19 90.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.982 HD12 ' CD1' ' B' ' 61' ' ' ILE . 1.1 mt -50.43 -54.99 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.8 m-85 -43.08 -40.35 3.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.416 -0.803 . . . . 0.0 110.067 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 1.3 mp -72.94 -47.44 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.659 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 2.5 t60 -46.05 -46.11 16.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -78.39 -14.64 59.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.856 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.981 -1.075 . . . . 0.0 110.557 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.659 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 19.9 m95 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.7 m -52.14 -21.01 2.89 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.008 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.64 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -95.11 -17.49 37.21 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 61' ' ' ILE . 25.1 t -97.44 -53.21 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.38 -1.07 . . . . 0.0 109.417 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.523 ' OE2' ' CZ ' ' B' ' 62' ' ' ARG . 4.8 tp10 -49.99 -54.23 21.41 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -64.98 -19.38 65.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.885 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.4 mt -88.99 -23.46 22.62 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.982 ' CD1' HD12 ' A' ' 68' ' ' LEU . 32.1 mt -71.58 -34.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.5 ptp180 -90.98 -41.63 11.0 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.597 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 9.1 mm -58.45 -33.18 47.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.074 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.885 HD12 ' O ' ' B' ' 60' ' ' LEU . 26.9 mt -77.7 -37.1 50.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.561 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' B' ' 62' ' ' ARG . 1.1 pt20 -78.59 -41.23 32.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.512 ' O ' HD13 ' B' ' 70' ' ' ILE . 0.1 OUTLIER -57.86 -48.0 81.07 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.437 -0.79 . . . . 0.0 108.988 178.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 9.4 tp -61.64 -46.23 90.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -50.5 -54.92 18.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.8 m-85 -43.11 -40.33 3.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.3 mp -72.92 -47.43 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.668 ' CG ' ' CZ2' ' A' ' 54' ' ' TRP . 2.5 t60 -46.03 -46.16 16.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.529 -0.732 . . . . 0.0 110.767 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.3 OUTLIER -78.36 -14.71 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 110.925 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.561 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.09 . . . . 0.0 110.529 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.686 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.19 0.519 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.8 m -51.91 -22.1 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.065 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -58.26 -17.0 29.63 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.898 HG12 HD11 ' A' ' 61' ' ' ILE . 17.4 t -94.73 -55.79 5.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.421 -1.046 . . . . 0.0 109.026 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -45.52 -54.67 7.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -66.44 -13.07 60.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 56' ' ' GLY . 12.4 mt -96.26 -20.52 18.48 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.898 HD11 HG12 ' A' ' 57' ' ' VAL . 45.9 mt -81.56 -32.64 11.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 16.7 ptp180 -85.63 -43.98 12.99 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.47 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.532 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -51.07 -39.13 19.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.824 -1.151 . . . . 0.0 108.103 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' B' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.67 29.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 1.039 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -60.28 -40.23 89.69 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.743 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.81 -45.62 82.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.227 -0.92 . . . . 0.0 108.763 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.69 -42.01 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 109.756 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -55.08 -33.16 62.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 108.717 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -60.36 -60.59 3.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.743 HD12 ' O ' ' A' ' 66' ' ' GLN . 2.1 mp -52.39 -32.68 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.998 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.682 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 7.9 t60 -58.84 -32.79 69.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.375 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -91.07 -42.54 10.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.856 -1.153 . . . . 0.0 111.303 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.633 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 O-C-N 120.475 -1.391 . . . . 0.0 110.39 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.682 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.165 0.507 . . . . 0.0 109.684 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 86.0 m -52.03 -22.01 3.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -58.24 -17.03 29.62 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.893 HG12 HD11 ' B' ' 61' ' ' ILE . 17.3 t -94.75 -55.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.489 -1.006 . . . . 0.0 109.004 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.837 ' HA ' HD12 ' B' ' 61' ' ' ILE . 0.4 OUTLIER -45.6 -54.61 7.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -66.43 -13.12 60.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.647 HD12 ' O ' ' B' ' 56' ' ' GLY . 12.4 mt -96.35 -20.49 18.44 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.893 HD11 HG12 ' B' ' 57' ' ' VAL . 46.0 mt -81.64 -32.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 16.6 ptp180 -85.49 -44.01 13.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.526 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -51.14 -39.07 19.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.121 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.72 28.23 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.976 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -60.27 -40.25 89.71 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.756 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.76 -45.7 81.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 108.756 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.59 -42.06 71.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.79 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.976 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -55.09 -33.2 62.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 108.655 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.603 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 0.3 OUTLIER -60.29 -60.61 3.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 108.413 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.756 HD12 ' O ' ' B' ' 66' ' ' GLN . 2.1 mp -52.35 -32.82 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.686 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 7.9 t60 -58.73 -32.87 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.361 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -91.0 -42.64 10.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 111.248 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.943 0 O-C-N 120.486 -1.384 . . . . 0.0 110.361 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.551 ' O ' ' N ' ' A' ' 57' ' ' VAL . 14.4 m95 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.651 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -42.73 -25.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.783 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.812 ' O ' HD23 ' A' ' 60' ' ' LEU . . . -102.02 37.47 3.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 61' ' ' ILE . 93.4 t -157.98 -53.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.946 -0.737 . . . . 0.0 109.557 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -62.44 -46.51 88.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.0 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.651 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -89.43 -5.14 57.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.922 HD21 HD22 ' B' ' 64' ' ' LEU . 0.2 OUTLIER -100.53 -21.29 15.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.639 HD11 ' CG1' ' A' ' 57' ' ' VAL . 44.0 mt -83.83 -37.33 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.4 ptm180 -78.97 -42.36 26.98 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.67 -42.29 2.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.184 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.898 HD22 HD21 ' B' ' 60' ' ' LEU . 25.4 mt -71.38 -44.65 64.57 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.805 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.66 -44.74 81.67 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.456 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -61.44 -47.39 85.97 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -60.83 -42.89 98.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.477 -0.765 . . . . 0.0 109.154 178.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -57.0 -43.62 81.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 108.78 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 1.8 m-85 -62.75 -17.27 60.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.807 . . . . 0.0 109.012 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 4.1 mt -95.88 -51.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.529 ' CD2' ' CD2' ' B' ' 54' ' ' TRP . 1.5 t60 -46.98 -45.17 20.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -60.74 -35.51 76.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' B' ' 57' ' ' VAL . 14.6 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.436 0.636 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -42.71 -25.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.78 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.816 ' O ' HD23 ' B' ' 60' ' ' LEU . . . -101.99 37.44 3.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' B' ' 61' ' ' ILE . 92.9 t -158.0 -53.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.845 -0.797 . . . . 0.0 109.539 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.952 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.666 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -89.49 -5.1 57.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.85 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.898 HD21 HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.6 -21.26 15.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' B' ' 57' ' ' VAL . 44.0 mt -83.75 -37.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.879 0.847 . . . . 0.0 108.799 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.4 ptm180 -79.09 -42.39 26.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.85 -0.531 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.666 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -44.48 -42.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.091 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.922 HD22 HD21 ' A' ' 60' ' ' LEU . 24.8 mt -71.2 -44.71 64.88 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.07 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.812 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -56.6 -44.86 81.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -61.49 -47.23 86.59 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -61.0 -42.77 99.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.474 -0.766 . . . . 0.0 109.166 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -56.99 -43.58 81.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 108.788 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 1.8 m-85 -62.83 -17.32 61.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.885 . . . . 0.0 109.008 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 4.0 mt -95.85 -51.84 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.537 ' CD2' ' CD2' ' A' ' 54' ' ' TRP . 1.5 t60 -46.93 -45.24 20.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.85 . . . . 0.0 110.133 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -60.72 -35.41 76.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 110.067 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.95 . . . . 0.0 110.08 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.809 ' CH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.114 0.483 . . . . 0.0 109.767 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -44.59 -26.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -53.92 -23.39 22.92 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.593 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 34.9 t -97.57 -33.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.583 -0.951 . . . . 0.0 109.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 3.3 tp10 -61.75 -51.34 68.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.291 -0.88 . . . . 0.0 109.458 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.528 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -63.51 -23.44 67.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.461 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.505 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 37.8 mt -86.52 -21.41 26.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 68' ' ' LEU . 1.3 mm -76.09 -38.41 34.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.787 0.803 . . . . 0.0 108.991 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 15.2 ptm180 -84.04 -42.52 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -46.5 -42.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.828 -1.149 . . . . 0.0 108.743 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.645 ' HB3' HG12 ' B' ' 61' ' ' ILE . 49.4 mt -74.22 -41.87 60.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.08 -43.29 82.01 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.532 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 10.8 tt0 -62.43 -50.8 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 67' ' ' LEU . 4.9 tt -59.09 -45.69 90.2 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.207 -0.933 . . . . 0.0 108.714 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 HD12 ' B' ' 61' ' ' ILE . 0.9 OUTLIER -47.82 -56.9 6.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.484 -0.76 . . . . 0.0 109.643 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 4.9 m-85 -45.28 -33.53 2.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 67' ' ' LEU . 30.9 mm -79.9 -22.71 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.949 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.675 ' CE1' ' CD1' ' B' ' 54' ' ' TRP . 27.7 t60 -67.37 -34.78 78.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -0.852 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 1.6 p90 -88.89 -30.38 18.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.222 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.804 ' CH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.134 0.492 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 58' ' ' GLU . 0.2 OUTLIER -44.58 -26.67 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -53.92 -23.37 22.82 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.596 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 35.1 t -97.5 -33.64 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.578 -0.954 . . . . 0.0 109.676 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HB2' ' CZ2' ' B' ' 54' ' ' TRP . 3.4 tp10 -61.78 -51.35 68.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -63.43 -23.47 67.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.441 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 64' ' ' LEU . 38.3 mt -86.55 -21.4 26.91 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.861 HD12 HD12 ' A' ' 68' ' ' LEU . 1.3 mm -76.11 -38.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.771 0.796 . . . . 0.0 108.944 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 15.2 ptm180 -84.15 -42.51 15.94 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.533 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.7 OUTLIER -46.48 -42.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.844 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' A' ' 61' ' ' ILE . 49.1 mt -74.27 -41.8 60.65 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.296 -0.878 . . . . 0.0 108.735 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.01 -43.27 81.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 10.7 tt0 -62.57 -50.69 70.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 67' ' ' LEU . 4.9 tt -59.12 -45.68 90.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.753 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -47.87 -56.88 6.5 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.368 -0.832 . . . . 0.0 109.631 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 4.9 m-85 -45.13 -33.64 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.325 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' B' ' 67' ' ' LEU . 31.5 mm -79.88 -22.74 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -0.764 . . . . 0.0 109.932 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.68 ' CE1' ' CD1' ' A' ' 54' ' ' TRP . 27.7 t60 -67.29 -34.82 78.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.258 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 1.6 p90 -88.81 -30.39 19.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 110.252 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.068 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 18.1 m95 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.453 0.644 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.24 -23.69 1.46 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -82.99 -30.64 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 16.7 t -82.47 -38.72 15.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.658 -0.907 . . . . 0.0 108.568 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -59.12 -54.36 47.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -64.47 -17.43 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 108.746 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' HD12 ' A' ' 64' ' ' LEU . 12.1 mt -88.29 -22.92 23.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.849 ' CD1' HD12 ' B' ' 68' ' ' LEU . 1.0 OUTLIER -72.09 -38.93 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.7 ptm180 -86.08 -41.75 14.51 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.802 -0.561 . . . . 0.0 110.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.1 mp -43.91 -42.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.321 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 11.1 mt -70.68 -44.65 66.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -68.04 -30.51 69.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.134 -0.979 . . . . 0.0 108.805 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.53 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 32.5 tt0 -68.64 -53.97 19.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.436 -0.79 . . . . 0.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.7 -32.44 73.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.662 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' B' ' 61' ' ' ILE . 4.4 mt -63.61 -45.2 91.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -68.22 -25.28 65.12 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.278 -0.889 . . . . 0.0 109.195 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 13.8 mm -85.32 -18.84 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.158 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -68.91 -51.57 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.563 -0.711 . . . . 0.0 110.154 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 2.1 p90 -71.02 -14.85 62.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.576 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 17.9 m95 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.394 0.616 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.19 -23.71 1.42 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.657 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.546 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -82.93 -30.72 31.01 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 54' ' ' TRP . 16.9 t -82.39 -38.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.579 -0.954 . . . . 0.0 108.619 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' B' ' 61' ' ' ILE . 0.2 OUTLIER -59.19 -54.29 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -64.51 -17.4 63.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 108.762 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.553 ' O ' HD12 ' B' ' 64' ' ' LEU . 12.2 mt -88.23 -22.8 23.78 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.834 ' CD1' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -72.28 -38.92 63.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.5 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 9.7 ptm180 -86.2 -41.61 14.52 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.368 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.1 mp -43.84 -42.18 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.355 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 11.4 mt -70.52 -44.78 66.85 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -68.06 -30.58 69.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 108.76 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.534 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 32.3 tt0 -68.61 -54.01 19.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.332 -0.855 . . . . 0.0 109.264 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.66 -32.46 73.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.647 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 61' ' ' ILE . 4.4 mt -63.67 -45.24 91.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.981 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -68.08 -25.45 65.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.22 -0.925 . . . . 0.0 109.212 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 69' ' ' PHE . 13.9 mm -85.21 -18.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 109.217 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.608 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.0 OUTLIER -68.82 -51.66 38.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.539 -0.725 . . . . 0.0 110.168 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.549 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 2.1 p90 -71.03 -14.75 62.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.788 ' HH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.251 0.548 . . . . 0.0 109.826 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 22.0 m -53.94 -19.1 4.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 109.729 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.69 -7.51 54.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 16.1 t -111.87 3.85 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -1.129 . . . . 0.0 110.269 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' THR . 11.0 pt-20 -121.86 -37.56 2.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.276 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -87.88 -20.34 26.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.982 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 56' ' ' GLY . 23.1 mt -85.67 -25.34 26.61 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.924 ' CD1' HD12 ' B' ' 68' ' ' LEU . 3.9 mt -67.0 -45.11 87.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 7.6 ptm180 -78.97 -42.98 25.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.395 0.617 . . . . 0.0 109.857 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.583 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 2.6 mm -47.36 -41.01 6.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.937 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' B' ' 64' ' ' LEU . 95.5 mt -72.14 -45.49 60.33 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.41 -41.54 80.55 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -56.34 -54.56 44.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -54.98 -51.09 67.29 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.123 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' B' ' 61' ' ' ILE . 0.6 OUTLIER -43.24 -53.12 5.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.36 -0.838 . . . . 0.0 110.426 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.35 -25.55 49.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 109.043 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 66' ' ' GLN . 1.5 mt -91.47 -19.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.203 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.622 ' CE1' ' CD2' ' B' ' 54' ' ' TRP . 65.9 t60 -67.99 -30.93 70.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.649 -0.657 . . . . 0.0 110.52 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -86.62 -31.44 21.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.441 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.787 ' HH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.203 0.525 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' B' ' 58' ' ' GLU . 22.1 m -53.85 -19.22 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.671 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -68.56 -7.49 53.77 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 16.2 t -111.91 3.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' B' ' 55' ' ' THR . 11.0 pt-20 -121.84 -37.58 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.331 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' B' ' 62' ' ' ARG . . . -87.9 -20.25 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.975 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.671 HD12 ' O ' ' B' ' 56' ' ' GLY . 23.2 mt -85.77 -25.26 26.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.914 ' CD1' HD12 ' A' ' 68' ' ' LEU . 3.9 mt -67.13 -45.06 87.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 7.6 ptm180 -78.86 -43.06 25.87 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.433 0.635 . . . . 0.0 109.835 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 2.5 mm -47.5 -40.95 7.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.896 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' A' ' 64' ' ' LEU . 95.2 mt -72.05 -45.59 60.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.4 -0.812 . . . . 0.0 109.067 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.35 -41.62 80.42 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.592 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.8 OUTLIER -56.12 -54.74 41.46 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -54.87 -51.2 66.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.924 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -43.29 -53.05 5.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 0.0 110.452 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.601 ' CE2' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.36 -25.48 49.61 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.187 -0.946 . . . . 0.0 109.101 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.601 ' CD1' ' CE2' ' B' ' 69' ' ' PHE . 1.5 mt -91.52 -19.86 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 109.195 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 54' ' ' TRP . 65.8 t60 -68.03 -30.92 70.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -86.58 -31.41 21.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.456 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.899 ' HH2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.216 0.532 . . . . 0.0 109.835 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' A' ' 58' ' ' GLU . 18.3 m -50.78 -21.67 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 109.578 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.75 -12.11 46.06 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 21.6 t -99.83 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -1.133 . . . . 0.0 109.77 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.92 ' OE2' ' HB2' ' A' ' 59' ' ' ALA . 2.8 pp20? -53.39 -37.42 62.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 110.198 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.92 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . . . -86.04 -11.15 53.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.045 -1.035 . . . . 0.0 110.411 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 56' ' ' GLY . 11.1 mt -96.99 -20.26 18.19 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.767 HD12 ' CB ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -81.64 -37.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG3' HD13 ' A' ' 63' ' ' ILE . 13.7 ptm180 -81.07 -41.56 22.4 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.316 0.579 . . . . 0.0 110.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.58 HD13 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -54.51 -35.47 31.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.605 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.757 ' CB ' HD12 ' B' ' 61' ' ' ILE . 24.0 mt -81.59 -39.87 23.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.073 -1.017 . . . . 0.0 108.914 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.981 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -66.95 -37.92 85.16 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 5.6 tt0 -59.23 -54.4 47.3 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -42.72 75.28 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.139 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.981 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -62.25 -37.92 87.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 0.0 108.94 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -58.91 -21.33 57.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 108.97 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.9 mm -95.81 -10.42 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.552 -0.718 . . . . 0.0 109.414 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.687 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -74.05 -47.41 36.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.808 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 8.3 p90 -77.9 -6.37 54.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' O ' ' NE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 109.895 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.911 ' HH2' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.157 0.503 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' B' ' 58' ' ' GLU . 18.3 m -50.85 -21.66 1.8 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.692 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -63.77 -12.06 45.95 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CE3' ' B' ' 54' ' ' TRP . 21.7 t -99.89 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -1.103 . . . . 0.0 109.724 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.905 ' OE2' ' HB2' ' B' ' 59' ' ' ALA . 2.8 pp20? -53.37 -37.43 62.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 0.0 110.146 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.905 ' HB2' ' OE2' ' B' ' 58' ' ' GLU . . . -86.19 -10.99 53.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.139 -0.975 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.692 HD12 ' O ' ' B' ' 56' ' ' GLY . 11.2 mt -96.99 -20.25 18.2 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.759 HD13 ' N ' ' B' ' 61' ' ' ILE . 0.4 OUTLIER -81.66 -37.62 15.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.556 ' HG3' HD13 ' B' ' 63' ' ' ILE . 13.7 ptm180 -81.05 -41.49 22.54 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.341 0.591 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.556 HD13 ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -54.56 -35.44 31.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.603 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.767 ' CB ' HD12 ' A' ' 61' ' ' ILE . 24.2 mt -81.66 -39.81 23.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.044 -1.035 . . . . 0.0 108.902 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.95 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.1 OUTLIER -66.93 -37.93 85.23 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -59.24 -54.43 46.93 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -55.52 -42.79 75.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.131 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.95 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -62.19 -37.96 87.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 108.96 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -58.99 -21.27 58.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 108.933 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' B' ' 70' ' ' ILE . 16.9 mm -95.83 -10.37 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.495 0.664 . . . . 0.0 109.422 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.689 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -74.17 -47.29 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 109.814 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 8.1 p90 -77.96 -6.36 54.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.468 ' O ' ' NE ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.696 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 36.7 m95 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.556 0.693 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -51.9 -19.01 1.53 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.696 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.602 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -91.18 -21.14 36.35 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.809 -2.116 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 54' ' ' TRP . 21.9 t -91.78 -54.46 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.783 -0.834 . . . . 0.0 108.775 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -43.74 -57.55 3.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.429 -0.794 . . . . 0.0 109.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.703 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -61.5 -16.52 48.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 56' ' ' GLY . 21.4 mt -95.19 -21.26 18.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.917 HG12 HD22 ' B' ' 64' ' ' LEU . 6.7 mt -81.36 -33.29 12.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 8.8 ptm180 -82.81 -43.67 16.4 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.168 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -47.29 -32.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.076 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 HG12 ' B' ' 61' ' ' ILE . 6.8 mt -70.92 -55.48 8.31 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.649 0.738 . . . . 0.0 109.306 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.39 74.73 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.52 -0.872 . . . . 0.0 108.872 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 4.6 tt0 -68.2 -43.75 77.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.541 -0.724 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.8 -29.42 62.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.146 -0.971 . . . . 0.0 110.639 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -76.67 -32.19 57.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -71.81 -24.12 61.67 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 1.3 tp -84.48 -36.02 11.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -40.73 -56.25 2.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.168 0.509 . . . . 0.0 110.29 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 3.7 p90 -75.48 -2.36 28.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.535 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.686 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 36.6 m95 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.511 0.672 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -51.86 -19.03 1.52 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.276 -0.969 . . . . 0.0 108.762 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.613 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -91.2 -21.13 36.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 54' ' ' TRP . 21.7 t -91.76 -54.54 7.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.749 -0.854 . . . . 0.0 108.727 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' B' ' 57' ' ' VAL . 0.2 OUTLIER -43.8 -57.46 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.709 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -61.47 -16.56 48.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.318 -0.864 . . . . 0.0 109.667 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.613 HD12 ' O ' ' B' ' 56' ' ' GLY . 21.1 mt -95.15 -21.24 18.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 64' ' ' LEU . 6.7 mt -81.4 -33.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.548 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 8.7 ptm180 -82.72 -43.7 16.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.582 -0.699 . . . . 0.0 109.178 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.709 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.0 OUTLIER -47.23 -32.46 2.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.103 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 61' ' ' ILE . 6.7 mt -70.92 -55.53 8.2 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.659 0.742 . . . . 0.0 109.282 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.42 74.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.522 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 4.6 tt0 -68.19 -43.81 77.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 110.118 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.485 ' O ' HG22 ' B' ' 70' ' ' ILE . 0.1 OUTLIER -73.66 -29.53 62.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -0.985 . . . . 0.0 110.699 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.679 ' O ' HD12 ' B' ' 68' ' ' LEU . 0.1 OUTLIER -76.61 -32.26 57.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.086 -1.009 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.587 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -71.75 -24.16 61.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' B' ' 73' ' ' ARG . 1.3 tp -84.44 -36.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' HIS . . . . . 0.696 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -40.66 -56.33 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.139 0.495 . . . . 0.0 110.339 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 3.6 p90 -75.41 -2.37 28.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 110.6 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.608 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.234 0.54 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -47.5 -74.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.652 ' CZ3' HD22 ' B' ' 68' ' ' LEU . 20.2 m95 -82.21 -43.9 17.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' CD ' ' A' ' 58' ' ' GLU . 3.2 m -49.65 -22.4 1.32 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.319 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -89.95 -15.77 57.26 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 HD21 ' B' ' 68' ' ' LEU . 21.9 t -99.3 -54.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.451 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 59' ' ' ALA . 12.5 pt-20 -50.59 -45.89 57.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.616 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -71.62 -19.5 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.997 . . . . 0.0 109.05 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.6 mt -88.06 -22.38 24.21 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.638 HD11 ' HG ' ' B' ' 68' ' ' LEU . 25.3 mt -71.92 -37.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 11.3 ptp180 -87.96 -42.73 12.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 6.6 mm -53.83 -36.78 31.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.516 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 60' ' ' LEU . 21.3 mt -76.61 -41.09 47.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.239 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD13 ' B' ' 61' ' ' ILE . 1.8 pt20 -68.93 -40.22 79.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' HD13 ' A' ' 70' ' ' ILE . 8.0 tt0 -57.98 -53.67 55.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.438 -0.789 . . . . 0.0 109.301 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 14.5 mt -52.16 -61.87 2.0 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.814 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD21 HG11 ' B' ' 57' ' ' VAL . 1.8 mm? -44.86 -48.68 11.11 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.079 -1.013 . . . . 0.0 109.874 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.563 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -47.29 -32.27 4.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.41 -0.806 . . . . 0.0 109.752 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 1.2 mp -82.95 -51.85 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.605 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 10.5 t60 -46.67 -45.79 19.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -74.27 -38.25 63.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.556 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.81 -0.93 55.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.508 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG12 ' CD ' ' A' ' 73' ' ' ARG . 10.5 mm -135.07 -2.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.0 110.378 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -122.96 -33.17 0.86 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.1 t -104.27 -3.87 23.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 109.952 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 72' ' ' PHE . 3.8 ptm180 -167.62 35.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' ILE . 6.2 p80 -51.57 156.34 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.508 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -99.28 154.0 18.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 110.274 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -90.91 46.06 1.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' A' ' 79' ' ' SER . 1.0 OUTLIER -56.26 110.37 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.23 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.18 -58.61 0.68 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.63 -62.4 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -1.103 . . . . 0.0 110.226 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.3 mm 46.85 71.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.186 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 59.15 69.82 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.62 75.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.17 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -48.01 142.12 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.659 ' O ' HG22 ' A' ' 89' ' ' THR . 8.6 mtm180 -72.62 63.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.278 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 88' ' ' ARG . 13.7 t 38.26 38.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 57.73 -176.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -44.28 97.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.79 83.85 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 39.77 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -1.141 . . . . 0.0 110.223 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.64 -160.85 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.255 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -133.97 124.45 26.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 110.226 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 t0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.262 0.553 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.618 ' O ' HG23 ' B' ' 57' ' ' VAL . 0.7 OUTLIER -47.56 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.67 ' CZ3' HD22 ' A' ' 68' ' ' LEU . 20.4 m95 -82.09 -43.96 17.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.425 ' HA ' ' CD ' ' B' ' 58' ' ' GLU . 3.2 m -49.73 -22.31 1.35 Allowed 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.317 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.646 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -89.99 -15.7 57.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 68' ' ' LEU . 21.8 t -99.34 -54.93 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -1.077 . . . . 0.0 109.448 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' B' ' 61' ' ' ILE . 12.5 pt-20 -50.7 -45.8 58.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.93 . . . . 0.0 109.611 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.515 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -71.67 -19.55 62.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.036 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.895 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.6 mt -88.09 -22.25 24.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 65' ' ' GLN . 25.6 mt -71.95 -37.38 60.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 11.3 ptp180 -88.0 -42.69 12.27 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.391 0.615 . . . . 0.0 110.364 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.526 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 6.6 mm -53.82 -36.82 31.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.895 HD12 ' O ' ' B' ' 60' ' ' LEU . 21.3 mt -76.57 -40.98 48.07 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 109.234 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 61' ' ' ILE . 1.8 pt20 -69.16 -40.17 78.34 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.487 ' O ' HD13 ' B' ' 70' ' ' ILE . 7.9 tt0 -57.98 -53.67 55.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 14.5 mt -52.18 -61.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.747 HD21 HG11 ' A' ' 57' ' ' VAL . 1.8 mm? -44.81 -48.74 10.99 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.234 -0.916 . . . . 0.0 109.839 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.579 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -47.22 -32.23 4.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.814 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' B' ' 70' ' ' ILE . 1.2 mp -83.04 -51.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 10.6 t60 -46.65 -45.79 19.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -0.864 . . . . 0.0 110.744 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.4 OUTLIER -74.33 -38.18 63.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.064 -1.022 . . . . 0.0 110.614 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.558 ' CD ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -84.94 -0.89 55.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.107 -0.996 . . . . 0.0 110.495 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.558 HG12 ' CD ' ' B' ' 73' ' ' ARG . 10.5 mm -135.03 -1.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.38 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -122.9 -33.29 0.86 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 t -104.19 -3.84 23.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -1.088 . . . . 0.0 109.983 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' B' ' 73' ' ' ARG . 3.8 ptm180 -167.65 35.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.833 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' B' ' 74' ' ' ILE . 6.2 p80 -51.55 156.4 1.32 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.503 ' HB3' HG23 ' B' ' 81' ' ' ILE . 0.3 OUTLIER -99.37 154.0 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.239 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -90.87 45.92 1.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.19 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' B' ' 79' ' ' SER . 1.0 OUTLIER -56.24 110.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.235 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.13 -58.58 0.69 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.79 -62.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -1.108 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 32.4 mm 46.82 71.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 59.25 69.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.61 75.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -48.01 142.21 5.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.665 ' O ' HG22 ' B' ' 89' ' ' THR . 8.6 mtm180 -72.73 63.74 0.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.665 HG22 ' O ' ' B' ' 88' ' ' ARG . 13.7 t 38.29 38.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.549 -0.72 . . . . 0.0 110.616 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 57.63 -176.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -44.23 97.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.221 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.68 83.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.43 39.81 1.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -1.138 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.68 -160.84 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -133.97 124.41 26.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.179 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.268 0.556 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 p -72.6 -58.09 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.2 -0.938 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.677 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 26.3 m95 -107.66 -44.05 4.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.411 -0.806 . . . . 0.0 109.941 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.2 m -51.11 -22.3 2.41 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.441 -0.903 . . . . 0.0 108.749 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -86.19 -20.06 55.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.526 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 79.1 t -94.49 -51.57 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.522 -0.987 . . . . 0.0 108.996 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 61' ' ' ILE . 2.7 mm-40 -46.61 -56.8 5.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.262 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.856 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -62.89 -16.52 59.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.359 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 56' ' ' GLY . 13.2 mt -91.26 -21.66 20.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.919 ' CD1' HD12 ' B' ' 68' ' ' LEU . 83.5 mt -76.58 -34.42 24.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' CG ' ' N ' ' A' ' 63' ' ' ILE . 16.8 ptp180 -88.44 -41.8 12.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.804 -0.56 . . . . 0.0 110.468 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.23 -41.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.426 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' B' ' 64' ' ' LEU . 37.9 mt -69.66 -49.79 50.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -63.38 -33.84 76.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.13 . . . . 0.0 108.093 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.657 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.04 -53.92 51.26 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -53.46 -50.77 64.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 108.971 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.905 HD12 ' CD1' ' B' ' 61' ' ' ILE . 3.1 mt -48.94 -53.46 19.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.84 . . . . 0.0 109.314 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.3 m-85 -43.78 -39.98 4.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.748 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.063 ' CG2' HD12 ' A' ' 74' ' ' ILE . 1.9 mp -71.65 -38.88 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CG ' ' CZ2' ' B' ' 54' ' ' TRP . 1.5 t60 -53.71 -47.03 70.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.594 -0.692 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -76.32 -15.6 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 0.0 111.051 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.83 1.82 19.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.998 -1.063 . . . . 0.0 110.597 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.063 HD12 ' CG2' ' A' ' 70' ' ' ILE . 6.1 mt -130.42 -29.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 110.304 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.45 -50.32 2.03 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.4 m -68.75 -7.93 38.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -1.109 . . . . 0.0 109.783 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.464 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -140.39 12.41 2.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.917 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 79' ' ' SER . 0.0 OUTLIER 67.72 145.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.493 -0.754 . . . . 0.0 109.914 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.573 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -70.24 -145.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.818 . . . . 0.0 110.417 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 84' ' ' ILE . 15.2 ttp180 -113.49 26.73 10.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 81' ' ' ILE . 1.2 pp -69.62 66.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 80' ' ' ARG . . . -145.16 -120.65 1.37 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.678 HG23 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -72.08 -100.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -1.107 . . . . 0.0 110.287 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.678 ' H ' HG23 ' A' ' 83' ' ' ILE . 18.1 mt -134.16 -94.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.561 -1.337 . . . . 0.0 110.158 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.559 ' N ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -109.08 15.36 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 46.67 52.67 10.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -130.37 -1.51 4.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.233 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' NH1' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -142.9 74.67 1.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 0.2 OUTLIER 65.35 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -85.69 49.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.67 85.32 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.4 104.97 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.93 102.1 5.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -1.159 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 95' ' ' LYS . 82.0 p -76.1 117.26 17.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER 43.02 55.75 4.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 95' ' ' LYS . 84.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.212 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 16.2 p -72.57 -58.1 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.672 ' CZ2' ' CG ' ' A' ' 71' ' ' HIS . 25.6 m95 -107.69 -44.01 4.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 109.953 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -51.1 -22.29 2.38 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.783 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.621 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -86.2 -20.07 55.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 60' ' ' LEU . 79.1 t -94.53 -51.56 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.52 -0.988 . . . . 0.0 108.937 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' B' ' 61' ' ' ILE . 2.7 mm-40 -46.71 -56.71 5.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.843 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -62.89 -16.48 59.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.621 HD12 ' O ' ' B' ' 56' ' ' GLY . 13.2 mt -91.28 -21.69 20.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.905 ' CD1' HD12 ' A' ' 68' ' ' LEU . 82.7 mt -76.67 -34.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.506 ' CD ' ' HA ' ' B' ' 59' ' ' ALA . 16.8 ptp180 -88.51 -41.69 12.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.806 -0.559 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.843 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -44.29 -42.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.322 -179.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.662 HD12 HD12 ' A' ' 64' ' ' LEU . 38.4 mt -69.58 -49.83 50.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.61 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' B' ' 62' ' ' ARG . 0.9 OUTLIER -63.36 -33.84 76.4 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.998 -1.064 . . . . 0.0 108.163 178.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.662 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -61.02 -53.98 50.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -53.44 -50.74 64.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 108.987 178.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.919 HD12 ' CD1' ' A' ' 61' ' ' ILE . 3.0 mt -48.97 -53.4 20.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.323 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.3 m-85 -43.9 -39.93 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 1.062 ' CG2' HD12 ' B' ' 74' ' ' ILE . 1.8 mp -71.7 -38.82 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.677 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.5 t60 -53.75 -46.96 71.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.546 -0.721 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.8 OUTLIER -76.44 -15.45 59.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.996 -1.065 . . . . 0.0 111.078 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.561 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -109.83 1.77 19.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.084 . . . . 0.0 110.56 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 1.062 HD12 ' CG2' ' B' ' 70' ' ' ILE . 6.0 mt -130.39 -29.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 0.0 110.228 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.48 -50.35 2.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 76.5 m -68.67 -8.0 38.37 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -1.111 . . . . 0.0 109.809 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -140.44 12.45 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.873 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' B' ' 79' ' ' SER . 0.0 OUTLIER 67.79 145.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.914 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 0.7 OUTLIER -70.14 -145.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 110.412 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' B' ' 84' ' ' ILE . 15.3 ttp180 -113.5 26.65 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.593 ' O ' HD12 ' B' ' 81' ' ' ILE . 1.2 pp -69.55 66.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.309 -0.869 . . . . 0.0 110.378 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.21 -120.68 1.37 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.663 HG23 ' H ' ' B' ' 84' ' ' ILE . 0.2 OUTLIER -72.08 -100.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 110.354 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.663 ' H ' HG23 ' B' ' 83' ' ' ILE . 18.1 mt -134.25 -94.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.519 -1.363 . . . . 0.0 110.114 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.56 ' N ' HG22 ' B' ' 84' ' ' ILE . 0.0 OUTLIER -109.08 15.4 23.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 110.184 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 46.65 52.69 10.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.201 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -130.31 -1.54 4.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.498 ' NH1' HD13 ' B' ' 84' ' ' ILE . 0.0 OUTLIER -142.94 74.79 1.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.94 . . . . 0.0 110.21 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.446 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 0.2 OUTLIER 65.26 132.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -85.64 49.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.74 85.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.51 105.02 3.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.98 102.07 5.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -1.195 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . 0.411 ' O ' ' C ' ' B' ' 95' ' ' LYS . 81.6 p -76.22 117.37 17.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.201 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' B' ' 96' ' ' SER . 0.0 OUTLIER 42.9 55.8 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' B' ' 95' ' ' LYS . 84.9 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.193 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.309 0.576 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 p -56.75 -63.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.668 ' CZ2' ' CG ' ' B' ' 71' ' ' HIS . 20.2 m95 -104.28 -44.96 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -52.19 -21.06 3.0 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.001 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -95.04 -17.51 37.31 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' ILE . 25.0 t -97.52 -53.18 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.995 . . . . 0.0 109.426 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 62' ' ' ARG . 4.8 tp10 -49.97 -54.15 21.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.307 -0.87 . . . . 0.0 109.409 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -65.02 -19.41 65.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.439 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 64' ' ' LEU . 11.4 mt -89.06 -23.39 22.56 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 68' ' ' LEU . 31.7 mt -71.59 -34.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.5 ptp180 -90.96 -41.7 10.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.563 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 9.1 mm -58.4 -33.24 47.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.027 -1.046 . . . . 0.0 110.042 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 60' ' ' LEU . 26.3 mt -77.71 -37.1 50.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' ARG . 1.1 pt20 -78.67 -41.12 32.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -57.97 -47.94 81.44 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.434 -0.791 . . . . 0.0 108.996 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 9.4 tp -61.7 -46.19 90.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.982 HD12 ' CD1' ' B' ' 61' ' ' ILE . 1.1 mt -50.43 -54.99 17.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.474 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.8 m-85 -43.08 -40.35 3.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.416 -0.803 . . . . 0.0 110.067 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.769 HG23 HD12 ' A' ' 74' ' ' ILE . 1.3 mp -72.94 -47.44 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.583 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.659 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 2.5 t60 -46.05 -46.11 16.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -78.39 -14.64 59.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.856 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.574 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -114.65 14.08 17.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.981 -1.075 . . . . 0.0 110.557 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.769 HD12 HG23 ' A' ' 70' ' ' ILE . 10.2 mt -157.63 -34.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 0.0 110.357 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.32 -36.08 5.53 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 77' ' ' ARG . 5.8 t -48.28 -39.34 21.29 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.241 -1.152 . . . . 0.0 108.139 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER 150.96 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.596 ' CG ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.38 1.95 42.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.925 -1.109 . . . . 0.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -168.67 2.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.327 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 0.8 OUTLIER -72.45 0.24 10.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.368 -0.833 . . . . 0.0 110.395 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' HA ' ' NH2' ' A' ' 77' ' ' ARG . 3.8 mt 62.0 10.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.574 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 81' ' ' ILE . . . 35.51 47.36 0.85 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.733 HG23 ' H ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -48.07 -86.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.256 . . . . 0.0 109.868 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.733 ' H ' HG23 ' A' ' 83' ' ' ILE . 35.5 pt 33.51 33.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.226 -0.921 . . . . 0.0 111.365 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' ILE . 12.1 pt20 -160.43 -170.24 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.377 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' GLN . 5.9 mt-30 44.15 -168.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -130.35 46.97 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.29 54.69 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.122 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 90' ' ' ARG . 5.7 t -133.94 -143.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.211 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' N ' ' OG1' ' A' ' 89' ' ' THR . 7.9 mtp180 -73.66 80.78 1.53 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.88 -31.15 38.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.272 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.69 -23.49 2.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.24 81.32 2.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -155.35 39.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 94' ' ' SER . 1.1 mttt -43.96 -40.74 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 110.178 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.245 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.293 0.568 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 40.5 p -56.78 -63.74 1.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.184 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.659 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 19.9 m95 -104.27 -45.04 4.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.7 m -52.14 -21.01 2.89 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.008 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.64 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -95.11 -17.49 37.21 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 61' ' ' ILE . 25.1 t -97.44 -53.21 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.38 -1.07 . . . . 0.0 109.417 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.523 ' OE2' ' CZ ' ' B' ' 62' ' ' ARG . 4.8 tp10 -49.99 -54.23 21.41 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' B' ' 63' ' ' ILE . . . -64.98 -19.38 65.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.509 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.885 ' O ' HD12 ' B' ' 64' ' ' LEU . 11.4 mt -88.99 -23.46 22.62 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.982 ' CD1' HD12 ' A' ' 68' ' ' LEU . 32.1 mt -71.58 -34.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.5 ptp180 -90.98 -41.63 11.0 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.597 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 9.1 mm -58.45 -33.18 47.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.074 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.885 HD12 ' O ' ' B' ' 60' ' ' LEU . 26.9 mt -77.7 -37.1 50.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.561 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' B' ' 62' ' ' ARG . 1.1 pt20 -78.59 -41.23 32.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.512 ' O ' HD13 ' B' ' 70' ' ' ILE . 0.1 OUTLIER -57.86 -48.0 81.07 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.437 -0.79 . . . . 0.0 108.988 178.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' B' ' 63' ' ' ILE . 9.4 tp -61.64 -46.23 90.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -50.5 -54.92 18.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 2.8 m-85 -43.11 -40.33 3.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.785 HG23 HD12 ' B' ' 74' ' ' ILE . 1.3 mp -72.92 -47.43 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.668 ' CG ' ' CZ2' ' A' ' 54' ' ' TRP . 2.5 t60 -46.03 -46.16 16.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.529 -0.732 . . . . 0.0 110.767 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' B' ' 69' ' ' PHE . 0.3 OUTLIER -78.36 -14.71 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 110.925 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.576 ' O ' ' CG ' ' B' ' 78' ' ' HIS . 0.1 OUTLIER -114.54 13.95 17.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.09 . . . . 0.0 110.529 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.785 HD12 HG23 ' B' ' 70' ' ' ILE . 10.3 mt -157.62 -34.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 0.0 110.47 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' CYS . . . -95.4 -36.14 5.49 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.591 ' O ' ' CB ' ' B' ' 77' ' ' ARG . 5.7 t -48.23 -39.31 20.87 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.163 -1.198 . . . . 0.0 108.149 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.591 ' CB ' ' O ' ' B' ' 76' ' ' CYS . 0.0 OUTLIER 151.03 37.79 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.56 178.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.587 ' CG ' ' HA ' ' B' ' 74' ' ' ILE . 0.0 OUTLIER -84.36 2.05 42.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.928 -1.107 . . . . 0.0 110.062 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -168.74 2.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.272 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 0.8 OUTLIER -72.36 0.19 10.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 110.365 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.512 ' HA ' ' NH2' ' B' ' 77' ' ' ARG . 3.8 mt 61.84 11.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.392 -0.818 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.485 ' O ' HG12 ' B' ' 84' ' ' ILE . . . 35.45 47.43 0.84 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.73 HG23 ' H ' ' B' ' 84' ' ' ILE . 0.4 OUTLIER -48.07 -86.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -1.22 . . . . 0.0 109.8 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.73 ' H ' HG23 ' B' ' 83' ' ' ILE . 35.6 pt 33.55 33.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.0 111.339 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' B' ' 83' ' ' ILE . 12.1 pt20 -160.41 -170.27 2.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' B' ' 85' ' ' GLN . 5.9 mt-30 44.07 -168.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -130.33 47.08 2.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 110.15 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 54.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' B' ' 90' ' ' ARG . 5.7 t -133.86 -143.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' B' ' 89' ' ' THR . 7.8 mtp180 -73.74 80.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.9 -31.21 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.194 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.72 -23.48 2.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.27 81.25 2.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -1.145 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . 0.404 ' O ' ' C ' ' B' ' 95' ' ' LYS . 0.1 OUTLIER -155.31 39.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' B' ' 94' ' ' SER . 1.2 mttt -43.93 -40.78 4.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.172 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' TRP . 7.1 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 52' ' ' ASP . 2.0 m 65.93 -65.75 0.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.686 ' CG ' ' CE1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -123.08 -26.95 4.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.8 m -51.91 -22.1 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.065 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -58.26 -17.0 29.63 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.898 HG12 HD11 ' A' ' 61' ' ' ILE . 17.4 t -94.73 -55.79 5.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.421 -1.046 . . . . 0.0 109.026 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -45.52 -54.67 7.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.362 -0.836 . . . . 0.0 109.741 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -66.44 -13.07 60.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 56' ' ' GLY . 12.4 mt -96.26 -20.52 18.48 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.898 HD11 HG12 ' A' ' 57' ' ' VAL . 45.9 mt -81.56 -32.64 11.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 16.7 ptp180 -85.63 -43.98 12.99 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.47 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.532 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -51.07 -39.13 19.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.824 -1.151 . . . . 0.0 108.103 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' B' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.67 29.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 1.039 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -60.28 -40.23 89.69 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.743 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.81 -45.62 82.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.227 -0.92 . . . . 0.0 108.763 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.69 -42.01 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 109.756 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.039 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -55.08 -33.16 62.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 108.717 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -60.36 -60.59 3.57 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.743 HD12 ' O ' ' A' ' 66' ' ' GLN . 2.1 mp -52.39 -32.68 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.998 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.682 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 7.9 t60 -58.84 -32.79 69.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.375 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -91.07 -42.54 10.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.856 -1.153 . . . . 0.0 111.303 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.633 ' CG ' ' HA ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -66.94 -6.97 18.8 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.475 -1.391 . . . . 0.0 110.39 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.588 HD12 ' CG2' ' A' ' 70' ' ' ILE . 18.6 mt -122.01 -14.16 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.923 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.49 -57.42 0.75 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.2 m -82.89 -4.66 58.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -1.123 . . . . 0.0 109.809 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 78' ' ' HIS . 3.9 mtt180 -130.98 15.35 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.917 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 81' ' ' ILE . 28.7 t-80 -48.01 177.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.46 -0.775 . . . . 0.0 110.298 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -60.67 -147.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.64 9.39 29.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.184 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 78' ' ' HIS . 2.8 pt -73.34 55.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.0 110.251 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 83' ' ' ILE . . . -94.91 -100.39 1.74 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 82' ' ' GLY . 3.8 tp -178.16 -27.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.745 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.634 HG23 ' H ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -36.75 -85.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.634 ' H ' HG23 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -62.84 97.58 0.11 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.641 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 70.43 147.06 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.987 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' HA ' HG13 ' A' ' 83' ' ' ILE . 63.7 mtp180 -73.51 0.16 13.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.242 -0.911 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' NH2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 42.95 70.86 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.22 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.7 p -75.74 -29.34 58.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -89.16 146.52 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.233 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -152.44 49.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.218 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -140.14 179.99 18.46 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.13 -177.81 3.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -1.119 . . . . 0.0 110.14 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -115.44 -81.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.5 156.15 2.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.197 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' B' ' 54' ' ' TRP . 7.1 p-10 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.235 0.541 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.458 ' CB ' ' O ' ' B' ' 52' ' ' ASP . 2.0 m 65.97 -65.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.682 ' CG ' ' CE1' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -123.09 -26.86 4.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.684 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 86.0 m -52.03 -22.01 3.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.647 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -58.24 -17.03 29.62 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.893 HG12 HD11 ' B' ' 61' ' ' ILE . 17.3 t -94.75 -55.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.489 -1.006 . . . . 0.0 109.004 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.837 ' HA ' HD12 ' B' ' 61' ' ' ILE . 0.4 OUTLIER -45.6 -54.61 7.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' B' ' 62' ' ' ARG . . . -66.43 -13.12 60.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.647 HD12 ' O ' ' B' ' 56' ' ' GLY . 12.4 mt -96.35 -20.49 18.44 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.893 HD11 HG12 ' B' ' 57' ' ' VAL . 46.0 mt -81.64 -32.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 16.6 ptp180 -85.49 -44.01 13.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.526 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -51.14 -39.07 19.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.121 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.45 -54.72 28.23 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.976 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -60.27 -40.25 89.71 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.756 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.76 -45.7 81.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.188 -0.945 . . . . 0.0 108.756 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tt -70.59 -42.06 71.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.415 -0.803 . . . . 0.0 109.79 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.976 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -55.09 -33.2 62.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.054 -1.029 . . . . 0.0 108.655 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.603 ' O ' ' CD2' ' B' ' 72' ' ' PHE . 0.3 OUTLIER -60.29 -60.61 3.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 108.413 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.756 HD12 ' O ' ' B' ' 66' ' ' GLN . 2.1 mp -52.35 -32.82 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.686 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 7.9 t60 -58.73 -32.87 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.361 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -91.0 -42.64 10.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 111.248 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -66.91 -6.95 18.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.486 -1.384 . . . . 0.0 110.361 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.601 HD12 ' CG2' ' B' ' 70' ' ' ILE . 18.6 mt -122.03 -14.12 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.222 -0.924 . . . . 0.0 109.994 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.58 -57.39 0.75 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -82.92 -4.69 58.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -1.095 . . . . 0.0 109.8 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' B' ' 78' ' ' HIS . 3.9 mtt180 -130.93 15.34 5.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.02 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.528 ' CE1' HD11 ' B' ' 81' ' ' ILE . 28.6 t-80 -48.03 177.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.335 -0.853 . . . . 0.0 110.288 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.426 ' O ' ' O ' ' B' ' 78' ' ' HIS . 0.1 OUTLIER -60.67 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -107.55 9.35 29.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.917 . . . . 0.0 110.274 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.528 HD11 ' CE1' ' B' ' 78' ' ' HIS . 2.8 pt -73.41 55.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.298 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' B' ' 83' ' ' ILE . . . -94.89 -100.31 1.73 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.472 ' O ' ' C ' ' B' ' 84' ' ' ILE . 3.8 tp -178.08 -27.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -1.102 . . . . 0.0 110.776 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.629 HG23 ' H ' ' B' ' 85' ' ' GLN . 0.2 OUTLIER -36.67 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.788 . . . . 0.0 110.427 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.629 ' H ' HG23 ' B' ' 84' ' ' ILE . 0.7 OUTLIER -62.73 97.65 0.11 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.06 -1.025 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 85' ' ' GLN . 0.0 OUTLIER 70.28 147.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 109.976 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.431 ' HA ' HG13 ' B' ' 83' ' ' ILE . 63.7 mtp180 -73.47 0.16 13.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.943 . . . . 0.0 110.469 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' B' ' 85' ' ' GLN . 0.0 OUTLIER 42.8 70.93 0.25 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.253 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 43.7 p -75.74 -29.38 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -89.15 146.52 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -152.47 49.01 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.168 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -140.14 179.93 18.52 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.02 -177.88 3.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.242 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -115.39 -81.46 0.61 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.903 . . . . 0.0 110.243 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 156.14 2.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.251 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.266 0.555 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.632 HG22 ' CE1' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -54.46 -77.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.096 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.551 ' O ' ' N ' ' A' ' 57' ' ' VAL . 14.4 m95 -92.53 -52.51 4.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -42.73 -25.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.783 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.812 ' O ' HD23 ' A' ' 60' ' ' LEU . . . -102.02 37.47 3.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 61' ' ' ILE . 93.4 t -157.98 -53.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.946 -0.737 . . . . 0.0 109.557 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -62.44 -46.51 88.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.0 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.651 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -89.43 -5.14 57.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.922 HD21 HD22 ' B' ' 64' ' ' LEU . 0.2 OUTLIER -100.53 -21.29 15.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.639 HD11 ' CG1' ' A' ' 57' ' ' VAL . 44.0 mt -83.83 -37.33 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 12.4 ptm180 -78.97 -42.36 26.98 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -44.67 -42.29 2.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.184 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.898 HD22 HD21 ' B' ' 60' ' ' LEU . 25.4 mt -71.38 -44.65 64.57 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.348 -0.845 . . . . 0.0 108.985 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.805 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.66 -44.74 81.67 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.456 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -61.44 -47.39 85.97 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -60.83 -42.89 98.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.477 -0.765 . . . . 0.0 109.154 178.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -57.0 -43.62 81.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 108.78 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 1.8 m-85 -62.75 -17.27 60.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.807 . . . . 0.0 109.012 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.767 HG22 HD12 ' A' ' 74' ' ' ILE . 4.1 mt -95.88 -51.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.496 -0.752 . . . . 0.0 109.545 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.635 ' CE1' HG22 ' B' ' 53' ' ' THR . 1.5 t60 -46.98 -45.17 20.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -60.74 -35.51 76.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.542 ' NE ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -91.0 -5.78 54.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.767 HD12 HG22 ' A' ' 70' ' ' ILE . 5.8 mt -113.37 -17.96 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.315 -0.866 . . . . 0.0 109.441 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -99.8 -58.93 0.87 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 77' ' ' ARG . 57.9 m -87.31 -1.8 58.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.123 . . . . 0.0 109.942 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 73' ' ' ARG . 12.5 mmt180 -136.94 18.19 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 53.4 t-80 -45.87 152.68 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.2 m -108.49 -170.16 1.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' ILE . 5.9 mtp180 -119.01 49.6 1.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' ARG . 4.2 mt -43.4 111.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.46 -63.06 0.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.539 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 2.4 mp -120.02 -41.11 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 42.1 pt 36.64 58.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 110.718 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 1.6 mt-30 63.15 -70.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.285 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' ILE . 12.5 mt-30 -61.59 99.64 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -62.86 139.78 58.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.78 64.2 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 110.209 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.4 m -113.23 -55.1 2.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -124.24 -169.24 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 54.6 93.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.183 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.28 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.13 114.56 6.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -1.164 . . . . 0.0 110.149 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.1 p -168.49 169.39 10.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -75.4 -47.9 25.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.7 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.219 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.307 0.575 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.635 HG22 ' CE1' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -54.36 -76.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' B' ' 57' ' ' VAL . 14.6 m95 -92.46 -52.6 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' TRP . 0.2 OUTLIER -42.71 -25.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.78 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.816 ' O ' HD23 ' B' ' 60' ' ' LEU . . . -101.99 37.44 3.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' B' ' 61' ' ' ILE . 92.9 t -158.0 -53.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.845 -0.797 . . . . 0.0 109.539 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.952 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.666 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -89.49 -5.1 57.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.85 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.898 HD21 HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.6 -21.26 15.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' B' ' 57' ' ' VAL . 44.0 mt -83.75 -37.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.879 0.847 . . . . 0.0 108.799 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 12.4 ptm180 -79.09 -42.39 26.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.85 -0.531 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.666 HD13 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -44.48 -42.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.091 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.922 HD22 HD21 ' A' ' 60' ' ' LEU . 24.8 mt -71.2 -44.71 64.88 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.07 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.812 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -56.6 -44.86 81.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' B' ' 65' ' ' GLN . 0.2 OUTLIER -61.49 -47.23 86.59 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -61.0 -42.77 99.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.474 -0.766 . . . . 0.0 109.166 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -56.99 -43.58 81.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 108.788 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 1.8 m-85 -62.83 -17.32 61.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.885 . . . . 0.0 109.008 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.784 HG22 HD12 ' B' ' 74' ' ' ILE . 4.0 mt -95.85 -51.84 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.632 ' CE1' HG22 ' A' ' 53' ' ' THR . 1.5 t60 -46.93 -45.24 20.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.85 . . . . 0.0 110.133 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -60.72 -35.41 76.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 110.067 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.547 ' CZ ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -91.08 -5.73 54.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.95 . . . . 0.0 110.08 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.784 HD12 HG22 ' B' ' 70' ' ' ILE . 5.9 mt -113.36 -18.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -99.85 -58.95 0.87 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.425 ' O ' ' HD3' ' B' ' 77' ' ' ARG . 58.0 m -87.3 -1.73 58.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.955 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' B' ' 73' ' ' ARG . 12.5 mmt180 -137.01 18.22 3.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 53.3 t-80 -45.87 152.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.296 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 65.5 m -108.56 -170.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 110.137 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' B' ' 81' ' ' ILE . 5.9 mtp180 -118.97 49.63 1.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' B' ' 80' ' ' ARG . 4.2 mt -43.33 111.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.228 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.56 -63.09 0.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.535 ' O ' ' CG1' ' B' ' 84' ' ' ILE . 2.4 mp -120.06 -41.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -1.177 . . . . 0.0 110.223 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' B' ' 83' ' ' ILE . 42.2 pt 36.66 58.17 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.749 -0.594 . . . . 0.0 110.739 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' B' ' 84' ' ' ILE . 1.6 mt-30 63.1 -70.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 84' ' ' ILE . 12.7 mt-30 -61.64 99.62 0.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 0.0 110.16 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -62.85 139.73 58.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.76 64.17 1.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.201 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -113.2 -55.07 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -124.24 -169.28 1.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 54.53 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.177 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.27 -92.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.13 114.61 6.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -1.163 . . . . 0.0 110.121 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -168.55 169.34 10.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -75.35 -47.94 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.163 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 86.8 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.223 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.197 0.522 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -50.63 -60.99 2.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.104 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.809 ' CH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -124.57 -32.69 3.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.767 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -44.59 -26.58 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -53.92 -23.39 22.92 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.593 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 34.9 t -97.57 -33.63 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.583 -0.951 . . . . 0.0 109.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 3.3 tp10 -61.75 -51.34 68.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.291 -0.88 . . . . 0.0 109.458 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.528 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -63.51 -23.44 67.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.461 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.505 ' O ' ' CD1' ' B' ' 64' ' ' LEU . 37.8 mt -86.52 -21.41 26.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 68' ' ' LEU . 1.3 mm -76.09 -38.41 34.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.787 0.803 . . . . 0.0 108.991 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 15.2 ptm180 -84.04 -42.52 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -46.5 -42.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.828 -1.149 . . . . 0.0 108.743 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.645 ' HB3' HG12 ' B' ' 61' ' ' ILE . 49.4 mt -74.22 -41.87 60.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.08 -43.29 82.01 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.532 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 10.8 tt0 -62.43 -50.8 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 67' ' ' LEU . 4.9 tt -59.09 -45.69 90.2 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.207 -0.933 . . . . 0.0 108.714 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 HD12 ' B' ' 61' ' ' ILE . 0.9 OUTLIER -47.82 -56.9 6.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.484 -0.76 . . . . 0.0 109.643 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 4.9 m-85 -45.28 -33.53 2.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 67' ' ' LEU . 30.9 mm -79.9 -22.71 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.949 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.675 ' CE1' ' CD1' ' B' ' 54' ' ' TRP . 27.7 t60 -67.37 -34.78 78.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -0.852 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 1.6 p90 -88.89 -30.38 18.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.222 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -63.76 -19.88 65.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.572 ' CG1' ' HG3' ' A' ' 73' ' ' ARG . 4.5 mt -122.62 -17.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.139 -0.976 . . . . 0.0 109.344 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 -35.69 2.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.515 ' HB2' ' CA ' ' A' ' 72' ' ' PHE . 57.9 m -91.18 -12.18 36.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -1.184 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -136.9 15.04 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.324 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 43.4 t-80 -159.16 49.24 0.33 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.211 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.84 120.84 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 110.028 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -79.37 6.66 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.204 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 81' ' ' ILE . 28.8 mm -134.28 65.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 83' ' ' ILE . . . -137.47 8.81 3.73 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -43.61 -74.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.714 ' H ' HG23 ' A' ' 83' ' ' ILE . 31.0 mm 40.86 31.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.105 -0.997 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.728 ' HB2' HD12 ' A' ' 83' ' ' ILE . 18.2 mt-30 -122.23 -21.9 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 110.214 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 53.89 50.28 17.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.279 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -115.9 -6.04 12.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 59.72 86.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.192 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.3 t -145.0 20.52 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.18 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -107.89 134.9 50.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 110.202 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.86 30.52 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . 70.29 15.04 72.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 92' ' ' GLY . . . 58.43 18.54 5.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -1.17 . . . . 0.0 110.139 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -114.75 159.01 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.6 mttt 52.07 -172.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.233 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.283 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.312 0.577 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 91.1 m -50.58 -60.93 2.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 110.164 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.804 ' CH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -124.68 -32.66 3.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.766 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 58' ' ' GLU . 0.2 OUTLIER -44.58 -26.67 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -53.92 -23.37 22.82 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.596 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 35.1 t -97.5 -33.64 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.578 -0.954 . . . . 0.0 109.676 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.483 ' HB2' ' CZ2' ' B' ' 54' ' ' TRP . 3.4 tp10 -61.78 -51.35 68.64 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.52 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -63.43 -23.47 67.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.441 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 64' ' ' LEU . 38.3 mt -86.55 -21.4 26.91 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.861 HD12 HD12 ' A' ' 68' ' ' LEU . 1.3 mm -76.11 -38.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.771 0.796 . . . . 0.0 108.944 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 15.2 ptm180 -84.15 -42.51 15.94 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.533 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 0.7 OUTLIER -46.48 -42.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.844 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.636 ' HB3' HG12 ' A' ' 61' ' ' ILE . 49.1 mt -74.27 -41.8 60.65 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.296 -0.878 . . . . 0.0 108.735 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.01 -43.27 81.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 10.7 tt0 -62.57 -50.69 70.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 67' ' ' LEU . 4.9 tt -59.12 -45.68 90.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.753 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -47.87 -56.88 6.5 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.368 -0.832 . . . . 0.0 109.631 179.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 4.9 m-85 -45.13 -33.64 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.325 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' B' ' 67' ' ' LEU . 31.5 mm -79.88 -22.74 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -0.764 . . . . 0.0 109.932 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.68 ' CE1' ' CD1' ' A' ' 54' ' ' TRP . 27.7 t60 -67.29 -34.82 78.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.258 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 1.6 p90 -88.81 -30.39 19.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.11 -0.994 . . . . 0.0 110.252 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.574 ' HA ' ' HG2' ' B' ' 77' ' ' ARG . 0.0 OUTLIER -63.87 -19.84 65.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.068 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.572 ' CG1' ' HG3' ' B' ' 73' ' ' ARG . 4.5 mt -122.54 -17.16 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.01 -35.71 2.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.526 ' HB2' ' CA ' ' B' ' 72' ' ' PHE . 58.0 m -91.16 -12.19 36.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -136.91 15.04 3.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.212 -0.93 . . . . 0.0 110.309 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' B' ' 74' ' ' ILE . 43.5 t-80 -159.17 49.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.188 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.91 120.85 40.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 110.012 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -79.33 6.64 9.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.195 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.424 HG22 ' O ' ' B' ' 81' ' ' ILE . 29.0 mm -134.36 65.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' B' ' 83' ' ' ILE . . . -137.47 8.9 3.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.716 HD12 ' HB2' ' B' ' 85' ' ' GLN . 0.2 OUTLIER -43.57 -74.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -1.176 . . . . 0.0 110.255 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.702 ' H ' HG23 ' B' ' 83' ' ' ILE . 30.8 mm 40.85 31.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.716 ' HB2' HD12 ' B' ' 83' ' ' ILE . 18.6 mt-30 -122.07 -22.03 5.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.993 . . . . 0.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.01 50.25 17.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.215 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -115.95 -6.04 12.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.206 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 59.74 86.66 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 10.3 t -145.0 20.48 1.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 110.231 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' B' ' 90' ' ' ARG . 0.0 OUTLIER -107.86 134.84 50.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.96 30.42 7.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.259 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' B' ' 93' ' ' ALA . . . 70.24 15.13 72.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 92' ' ' GLY . . . 58.38 18.56 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -1.17 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -114.76 159.06 21.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.181 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 17.6 mttt 51.93 -172.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.238 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 53' ' ' THR . 23.8 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.206 0.527 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 14.9 m 60.35 -118.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 109.971 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 18.1 m95 -75.63 -51.05 13.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.0 109.998 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.24 -23.69 1.46 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -82.99 -30.64 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 16.7 t -82.47 -38.72 15.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.658 -0.907 . . . . 0.0 108.568 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -59.12 -54.36 47.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -64.47 -17.43 63.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 108.746 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' HD12 ' A' ' 64' ' ' LEU . 12.1 mt -88.29 -22.92 23.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.849 ' CD1' HD12 ' B' ' 68' ' ' LEU . 1.0 OUTLIER -72.09 -38.93 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.7 ptm180 -86.08 -41.75 14.51 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.802 -0.561 . . . . 0.0 110.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.1 mp -43.91 -42.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.321 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 64' ' ' LEU . 11.1 mt -70.68 -44.65 66.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -68.04 -30.51 69.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.134 -0.979 . . . . 0.0 108.805 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.53 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 32.5 tt0 -68.64 -53.97 19.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.436 -0.79 . . . . 0.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.7 -32.44 73.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.662 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' B' ' 61' ' ' ILE . 4.4 mt -63.61 -45.2 91.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CZ ' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -68.22 -25.28 65.12 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.278 -0.889 . . . . 0.0 109.195 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 13.8 mm -85.32 -18.84 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.158 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -68.91 -51.57 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.563 -0.711 . . . . 0.0 110.154 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 2.1 p90 -71.02 -14.85 62.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -77.81 -37.06 49.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 4.7 mt -125.3 -34.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -64.1 -25.3 69.44 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' C ' ' CG ' ' A' ' 77' ' ' ARG . 48.5 t -116.28 -1.73 12.28 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.659 -0.906 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 72' ' ' PHE . 7.9 mtt180 -146.72 7.01 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.219 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.53 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 22.4 t60 -41.4 104.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.281 -0.887 . . . . 0.0 110.148 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -109.57 122.67 47.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.22 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 56.92 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.636 HG23 ' HB2' ' A' ' 79' ' ' SER . 1.1 pt -92.41 65.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.13 39.45 0.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 84' ' ' ILE . 7.3 tp -79.16 -38.0 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -1.114 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 84' ' ' ILE . 6.1 mt 56.02 52.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 84' ' ' ILE . 16.8 mp0 41.58 67.43 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.345 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 87' ' ' ARG . 46.4 tt0 -106.04 6.94 31.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 86' ' ' GLN . 6.5 mmt85 44.02 57.96 3.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.29 35.38 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m 55.84 55.08 7.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.197 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 48.31 -166.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.176 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.61 153.62 16.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.265 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.33 14.07 66.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.98 -69.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.207 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t 46.39 35.19 2.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -114.76 85.93 2.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.152 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' B' ' 53' ' ' THR . 24.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.181 0.515 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 52' ' ' ASP . 14.9 m 60.4 -118.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.576 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 17.9 m95 -75.84 -51.07 13.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.941 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -49.19 -23.71 1.42 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.657 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.546 ' O ' ' HG ' ' B' ' 60' ' ' LEU . . . -82.93 -30.72 31.01 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 54' ' ' TRP . 16.9 t -82.39 -38.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.579 -0.954 . . . . 0.0 108.619 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' B' ' 61' ' ' ILE . 0.2 OUTLIER -59.19 -54.29 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.959 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -64.51 -17.4 63.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 108.762 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.553 ' O ' HD12 ' B' ' 64' ' ' LEU . 12.2 mt -88.23 -22.8 23.78 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.834 ' CD1' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -72.28 -38.92 63.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.5 ' CG ' ' N ' ' B' ' 63' ' ' ILE . 9.7 ptm180 -86.2 -41.61 14.52 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.368 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.959 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.1 mp -43.84 -42.18 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.355 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 11.4 mt -70.52 -44.78 66.85 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -68.06 -30.58 69.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 108.76 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.534 ' N ' ' HG3' ' B' ' 65' ' ' GLN . 32.3 tt0 -68.61 -54.01 19.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.332 -0.855 . . . . 0.0 109.264 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.66 -32.46 73.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.647 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 61' ' ' ILE . 4.4 mt -63.67 -45.24 91.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.981 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 70' ' ' ILE . 0.0 OUTLIER -68.08 -25.45 65.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.22 -0.925 . . . . 0.0 109.212 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 69' ' ' PHE . 13.9 mm -85.21 -18.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.804 . . . . 0.0 109.217 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.608 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 1.0 OUTLIER -68.82 -51.66 38.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.539 -0.725 . . . . 0.0 110.168 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.549 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 2.1 p90 -71.03 -14.75 62.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' B' ' 77' ' ' ARG . 0.0 OUTLIER -77.82 -37.03 49.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' HIS . 4.7 mt -125.36 -34.58 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.871 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -64.16 -25.25 69.49 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.463 ' C ' ' CG ' ' B' ' 77' ' ' ARG . 48.5 t -116.32 -1.72 12.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.653 -0.91 . . . . 0.0 109.782 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' B' ' 72' ' ' PHE . 7.9 mtt180 -146.69 6.91 0.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 111.271 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 74' ' ' ILE . 22.5 t60 -41.24 104.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.256 -0.902 . . . . 0.0 110.133 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.627 ' HB2' HG23 ' B' ' 81' ' ' ILE . 0.1 OUTLIER -109.62 122.6 47.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 56.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.308 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' B' ' 79' ' ' SER . 1.1 pt -92.39 65.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.25 39.42 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.507 HG23 ' N ' ' B' ' 84' ' ' ILE . 7.3 tp -79.08 -38.01 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -1.145 . . . . 0.0 110.219 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.752 ' O ' HG22 ' B' ' 84' ' ' ILE . 6.1 mt 56.04 52.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.257 -0.902 . . . . 0.0 110.367 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' ' 84' ' ' ILE . 16.7 mp0 41.55 67.42 0.56 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 87' ' ' ARG . 46.5 tt0 -106.04 6.89 31.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 86' ' ' GLN . 6.5 mmt85 44.02 57.98 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.26 35.37 1.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 24.3 m 55.81 55.15 7.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 48.23 -166.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.24 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.66 153.66 16.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 110.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.38 14.18 65.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.0 -69.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -1.184 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t 46.42 35.08 2.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -114.54 85.86 2.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.915 . . . . 0.0 110.211 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.186 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.257 0.551 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.01 -67.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.162 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.788 ' HH2' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -113.3 -24.16 9.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.923 . . . . 0.0 109.826 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 22.0 m -53.94 -19.1 4.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 109.729 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.69 -7.51 54.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 16.1 t -111.87 3.85 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -1.129 . . . . 0.0 110.269 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' THR . 11.0 pt-20 -121.86 -37.56 2.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 109.276 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 63' ' ' ILE . . . -87.88 -20.34 26.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.982 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 56' ' ' GLY . 23.1 mt -85.67 -25.34 26.61 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.924 ' CD1' HD12 ' B' ' 68' ' ' LEU . 3.9 mt -67.0 -45.11 87.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 7.6 ptm180 -78.97 -42.98 25.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.395 0.617 . . . . 0.0 109.857 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.583 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 2.6 mm -47.36 -41.01 6.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.937 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' B' ' 64' ' ' LEU . 95.5 mt -72.14 -45.49 60.33 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -57.41 -41.54 80.55 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -56.34 -54.56 44.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -54.98 -51.09 67.29 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.123 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' B' ' 61' ' ' ILE . 0.6 OUTLIER -43.24 -53.12 5.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.36 -0.838 . . . . 0.0 110.426 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -56.35 -25.55 49.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 109.043 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 66' ' ' GLN . 1.5 mt -91.47 -19.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.203 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.622 ' CE1' ' CD2' ' B' ' 54' ' ' TRP . 65.9 t60 -67.99 -30.93 70.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.649 -0.657 . . . . 0.0 110.52 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -86.62 -31.44 21.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.441 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.543 ' NE ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -82.68 -4.54 57.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.108 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.543 HG12 ' NE ' ' A' ' 73' ' ' ARG . 5.8 mm -116.29 -20.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 109.026 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.49 -46.28 1.24 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -72.27 -17.47 61.88 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.451 -1.029 . . . . 0.0 109.297 179.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.53 0.53 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.528 0.68 . . . . 0.0 109.661 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 1.8 t-160 -64.34 107.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -145.78 42.13 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 83' ' ' ILE . 13.6 mmt85 44.78 29.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 81' ' ' ILE . 2.5 mp 52.91 29.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.254 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.49 62.97 3.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' GLN . 84.4 mt -127.83 -32.95 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 83' ' ' ILE . 12.3 mt 63.98 -69.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.808 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' ILE . 9.8 mt-30 -113.07 -53.34 2.72 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.572 -0.705 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.0 pt20 -174.64 164.4 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 86' ' ' GLN . 11.1 mtm180 56.7 -171.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.147 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' ARG . 7.5 mtt180 -134.67 102.61 5.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.219 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 t -64.57 69.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.237 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' ARG . 11.5 mtm180 -93.39 166.73 12.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.86 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -71.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.27 -96.24 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.27 77.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -1.141 . . . . 0.0 110.273 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -143.25 -171.29 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 14.03 16.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.209 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.219 0.533 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.88 -67.36 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.238 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.787 ' HH2' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -113.36 -24.11 9.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' B' ' 58' ' ' GLU . 22.1 m -53.85 -19.22 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 109.769 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.671 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -68.56 -7.49 53.77 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' B' ' 54' ' ' TRP . 16.2 t -111.91 3.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 110.217 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' B' ' 55' ' ' THR . 11.0 pt-20 -121.84 -37.58 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.331 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' B' ' 62' ' ' ARG . . . -87.9 -20.25 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.975 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.671 HD12 ' O ' ' B' ' 56' ' ' GLY . 23.2 mt -85.77 -25.26 26.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.914 ' CD1' HD12 ' A' ' 68' ' ' LEU . 3.9 mt -67.13 -45.06 87.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 7.6 ptm180 -78.86 -43.06 25.87 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.433 0.635 . . . . 0.0 109.835 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' B' ' 62' ' ' ARG . 2.5 mm -47.5 -40.95 7.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.896 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.777 HD12 HD12 ' A' ' 64' ' ' LEU . 95.2 mt -72.05 -45.59 60.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.4 -0.812 . . . . 0.0 109.067 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -57.35 -41.62 80.42 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.592 ' O ' HD12 ' B' ' 70' ' ' ILE . 0.8 OUTLIER -56.12 -54.74 41.46 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -54.87 -51.2 66.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.924 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -43.29 -53.05 5.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 0.0 110.452 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.601 ' CE2' ' CD1' ' B' ' 70' ' ' ILE . 0.0 OUTLIER -56.36 -25.48 49.61 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.187 -0.946 . . . . 0.0 109.101 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.601 ' CD1' ' CE2' ' B' ' 69' ' ' PHE . 1.5 mt -91.52 -19.86 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.865 . . . . 0.0 109.195 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.648 ' CE1' ' CD2' ' A' ' 54' ' ' TRP . 65.8 t60 -68.03 -30.92 70.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.618 -0.676 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -86.58 -31.41 21.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.456 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.536 ' NE ' HG12 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -82.76 -4.56 58.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.041 . . . . 0.0 110.057 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.536 HG12 ' NE ' ' B' ' 73' ' ' ARG . 5.8 mm -116.16 -20.86 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 0.0 109.074 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.53 -46.37 1.22 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -72.17 -17.55 61.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -1.076 . . . . 0.0 109.279 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 0.0 OUTLIER -110.47 0.63 17.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.695 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 1.8 t-160 -64.44 107.84 1.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.124 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -145.77 42.06 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.353 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.474 ' O ' HD12 ' B' ' 83' ' ' ILE . 13.6 mmt85 44.71 29.11 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.59 HG22 ' O ' ' B' ' 81' ' ' ILE . 2.5 mp 52.82 29.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.189 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.46 62.98 3.41 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' B' ' 85' ' ' GLN . 84.7 mt -127.86 -32.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -1.102 . . . . 0.0 110.235 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' B' ' 83' ' ' ILE . 12.3 mt 63.92 -69.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.82 . . . . 0.0 110.424 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 83' ' ' ILE . 9.8 mt-30 -113.05 -53.4 2.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.474 -0.766 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 87' ' ' ARG . 3.0 pt20 -174.61 164.35 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' B' ' 86' ' ' GLN . 11.1 mtm180 56.64 -171.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' B' ' 90' ' ' ARG . 7.5 mtt180 -134.58 102.66 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 2.7 t -64.56 69.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' B' ' 88' ' ' ARG . 11.5 mtm180 -93.45 166.68 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.88 -71.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.33 -96.17 0.16 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.33 77.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -1.153 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -143.2 -171.3 3.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.19 14.0 16.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.229 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.222 0.534 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.95 -69.73 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 110.162 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.899 ' HH2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -125.17 -28.56 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.835 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' A' ' 58' ' ' GLU . 18.3 m -50.78 -21.67 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 109.578 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.75 -12.11 46.06 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.591 ' HB ' ' CZ3' ' A' ' 54' ' ' TRP . 21.6 t -99.83 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -1.133 . . . . 0.0 109.77 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.92 ' OE2' ' HB2' ' A' ' 59' ' ' ALA . 2.8 pp20? -53.39 -37.42 62.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 110.198 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.92 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . . . -86.04 -11.15 53.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.045 -1.035 . . . . 0.0 110.411 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 56' ' ' GLY . 11.1 mt -96.99 -20.26 18.19 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.767 HD12 ' CB ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -81.64 -37.61 15.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG3' HD13 ' A' ' 63' ' ' ILE . 13.7 ptm180 -81.07 -41.56 22.4 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.316 0.579 . . . . 0.0 110.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.58 HD13 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -54.51 -35.47 31.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.605 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.757 ' CB ' HD12 ' B' ' 61' ' ' ILE . 24.0 mt -81.59 -39.87 23.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.073 -1.017 . . . . 0.0 108.914 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.981 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -66.95 -37.92 85.16 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' CG ' ' A' ' 65' ' ' GLN . 5.6 tt0 -59.23 -54.4 47.3 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -42.72 75.28 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.139 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.981 HD23 ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -62.25 -37.92 87.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.267 -0.896 . . . . 0.0 108.94 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -58.91 -21.33 57.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 108.97 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 16.9 mm -95.81 -10.42 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.552 -0.718 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.687 ' CE1' ' CG ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -74.05 -47.41 36.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.808 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 8.3 p90 -77.9 -6.37 54.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.556 ' NE ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -109.34 -28.32 9.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 0.0 109.895 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG13 ' NE ' ' A' ' 73' ' ' ARG . 3.0 mt -129.18 -2.64 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.172 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -116.52 -19.29 5.44 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.555 ' CB ' ' HA ' ' A' ' 72' ' ' PHE . 26.9 t -117.47 -8.98 10.93 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 109.707 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 73' ' ' ARG . 9.4 ptp180 -154.04 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.344 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 24.6 t60 -60.66 99.05 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.0 109.864 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.93 87.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -0.894 . . . . 0.0 110.081 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -1.72 18.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 83' ' ' ILE . 30.9 mt -79.74 125.35 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.16 60.38 0.24 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.3 tp -109.35 -21.36 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -1.082 . . . . 0.0 110.026 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.563 HD12 ' C ' ' A' ' 83' ' ' ILE . 1.9 mp 63.26 115.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.237 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.17 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.138 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -50.89 133.22 26.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -129.22 -64.49 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.212 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 87' ' ' ARG . 9.2 mtp180 42.52 30.53 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 87' ' ' ARG . 1.6 p -109.58 -70.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 110.198 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -70.77 -152.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.208 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.8 94.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.73 -154.9 16.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.62 150.97 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.205 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 p -62.78 -171.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -63.68 -53.63 48.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.129 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.234 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.25 0.548 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.911 ' HH2' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -125.12 -28.49 3.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.492 ' HA ' ' CG ' ' B' ' 58' ' ' GLU . 18.3 m -50.85 -21.66 1.8 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.692 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -63.77 -12.06 45.95 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CE3' ' B' ' 54' ' ' TRP . 21.7 t -99.89 -55.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -1.103 . . . . 0.0 109.724 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.905 ' OE2' ' HB2' ' B' ' 59' ' ' ALA . 2.8 pp20? -53.37 -37.43 62.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 0.0 110.146 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.905 ' HB2' ' OE2' ' B' ' 58' ' ' GLU . . . -86.19 -10.99 53.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.139 -0.975 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.692 HD12 ' O ' ' B' ' 56' ' ' GLY . 11.2 mt -96.99 -20.25 18.2 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.759 HD13 ' N ' ' B' ' 61' ' ' ILE . 0.4 OUTLIER -81.66 -37.62 15.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.556 ' HG3' HD13 ' B' ' 63' ' ' ILE . 13.7 ptm180 -81.05 -41.49 22.54 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.341 0.591 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.556 HD13 ' HG3' ' B' ' 62' ' ' ARG . 1.0 OUTLIER -54.56 -35.44 31.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.603 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.767 ' CB ' HD12 ' A' ' 61' ' ' ILE . 24.2 mt -81.66 -39.81 23.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.044 -1.035 . . . . 0.0 108.902 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.95 ' HA ' HD23 ' B' ' 68' ' ' LEU . 0.1 OUTLIER -66.93 -37.93 85.23 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -59.24 -54.43 46.93 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' B' ' 67' ' ' LEU . 0.2 OUTLIER -55.52 -42.79 75.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.131 178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.95 HD23 ' HA ' ' B' ' 65' ' ' GLN . 0.1 OUTLIER -62.19 -37.96 87.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.925 . . . . 0.0 108.96 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.571 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.5 OUTLIER -58.99 -21.27 58.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 108.933 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' B' ' 70' ' ' ILE . 16.9 mm -95.83 -10.37 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.495 0.664 . . . . 0.0 109.422 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.689 ' CE1' ' CG ' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -74.17 -47.29 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 109.814 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 8.1 p90 -77.96 -6.36 54.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.544 ' NE ' HG13 ' B' ' 74' ' ' ILE . 0.0 OUTLIER -109.21 -28.51 8.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.544 HG13 ' NE ' ' B' ' 73' ' ' ARG . 2.9 mt -129.13 -2.65 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.399 -0.813 . . . . 0.0 109.197 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -116.54 -19.23 5.45 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.555 ' CB ' ' HA ' ' B' ' 72' ' ' PHE . 27.4 t -117.52 -8.99 10.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.462 -1.022 . . . . 0.0 109.748 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' B' ' 73' ' ' ARG . 9.4 ptp180 -154.04 23.18 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 111.433 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' B' ' 74' ' ' ILE . 24.9 t60 -60.67 99.06 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 109.874 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.88 87.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.88 -1.78 18.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.922 . . . . 0.0 110.243 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' B' ' 83' ' ' ILE . 30.8 mt -79.67 125.37 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.236 -0.915 . . . . 0.0 110.021 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.22 60.43 0.25 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.559 ' C ' HD12 ' B' ' 84' ' ' ILE . 1.3 tp -109.39 -21.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.559 HD12 ' C ' ' B' ' 83' ' ' ILE . 1.9 mp 63.1 115.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.322 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 58.17 100.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -50.82 133.32 26.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.521 ' O ' HG23 ' B' ' 89' ' ' THR . 0.0 OUTLIER -129.27 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 110.174 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' B' ' 87' ' ' ARG . 9.1 mtp180 42.59 30.39 0.22 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.521 HG23 ' O ' ' B' ' 87' ' ' ARG . 1.6 p -109.53 -70.54 0.8 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -70.76 -152.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.114 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.86 94.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.274 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.65 -154.82 16.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 150.96 2.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 1.1 p -62.8 -171.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 110.156 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -63.62 -53.56 49.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.267 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.236 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.49 0.662 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 p -53.43 -34.58 58.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.696 ' CE2' ' CD2' ' B' ' 71' ' ' HIS . 36.7 m95 -112.56 -50.56 2.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.109 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -51.9 -19.01 1.53 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.696 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.602 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -91.18 -21.14 36.35 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.809 -2.116 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 54' ' ' TRP . 21.9 t -91.78 -54.46 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.783 -0.834 . . . . 0.0 108.775 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -43.74 -57.55 3.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.429 -0.794 . . . . 0.0 109.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.703 ' O ' HD13 ' A' ' 63' ' ' ILE . . . -61.5 -16.52 48.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 56' ' ' GLY . 21.4 mt -95.19 -21.26 18.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.917 HG12 HD22 ' B' ' 64' ' ' LEU . 6.7 mt -81.36 -33.29 12.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG3' ' N ' ' A' ' 63' ' ' ILE . 8.8 ptm180 -82.81 -43.67 16.4 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.168 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -47.29 -32.42 2.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.076 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 HG12 ' B' ' 61' ' ' ILE . 6.8 mt -70.92 -55.48 8.31 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.649 0.738 . . . . 0.0 109.306 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.39 74.73 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.52 -0.872 . . . . 0.0 108.872 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.529 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 4.6 tt0 -68.2 -43.75 77.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.541 -0.724 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.8 -29.42 62.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.146 -0.971 . . . . 0.0 110.639 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -76.67 -32.19 57.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -71.81 -24.12 61.67 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 1.3 tp -84.48 -36.02 11.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.686 ' CD2' ' CE2' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -40.73 -56.25 2.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.168 0.509 . . . . 0.0 110.29 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 69' ' ' PHE . 3.7 p90 -75.48 -2.36 28.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -96.11 -27.26 15.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.535 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 78' ' ' HIS . 6.5 mt -132.27 -6.87 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.848 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -106.26 -44.75 1.33 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.567 ' CB ' ' HA ' ' A' ' 72' ' ' PHE . 48.2 t -81.26 -17.46 49.38 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -1.113 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 73' ' ' ARG . 7.8 ptp180 -133.85 25.45 3.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.618 -0.676 . . . . 0.0 109.829 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 9.5 p80 -40.07 140.39 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 110.541 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.71 114.87 27.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.405 -0.809 . . . . 0.0 109.883 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.666 ' HB2' HD13 ' A' ' 83' ' ' ILE . 58.0 mtm180 -86.73 33.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.7 mm 47.66 89.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.946 ' C ' HD12 ' A' ' 83' ' ' ILE . . . 100.96 36.74 3.84 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.946 HD12 ' C ' ' A' ' 82' ' ' GLY . 2.6 mp -139.66 7.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -1.175 . . . . 0.0 110.211 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 1.1 pt -75.49 65.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.1 156.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.57 40.81 31.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -139.18 -61.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.23 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HB3' ' CB ' ' A' ' 91' ' ' ASN . 15.2 mtt180 57.13 92.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -67.76 -33.13 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -72.55 -11.97 60.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.439 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 24.9 t30 -87.35 -80.14 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.229 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.36 169.21 52.44 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.423 ' O ' ' OG ' ' A' ' 94' ' ' SER . . . -80.9 -85.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -1.189 . . . . 0.0 110.184 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 93' ' ' ALA . 45.3 p 46.31 58.24 4.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.234 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -44.31 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.156 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.149 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.384 0.611 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 82.5 p -53.37 -34.57 58.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.179 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.686 ' CE2' ' CD2' ' A' ' 71' ' ' HIS . 36.6 m95 -112.57 -50.63 2.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.091 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -51.86 -19.03 1.52 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.276 -0.969 . . . . 0.0 108.762 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.613 ' O ' HD12 ' B' ' 60' ' ' LEU . . . -91.2 -21.13 36.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 54' ' ' TRP . 21.7 t -91.76 -54.54 7.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.749 -0.854 . . . . 0.0 108.727 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' B' ' 57' ' ' VAL . 0.2 OUTLIER -43.8 -57.46 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.709 ' O ' HD13 ' B' ' 63' ' ' ILE . . . -61.47 -16.56 48.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.318 -0.864 . . . . 0.0 109.667 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.613 HD12 ' O ' ' B' ' 56' ' ' GLY . 21.1 mt -95.15 -21.24 18.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 64' ' ' LEU . 6.7 mt -81.4 -33.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.548 ' HG3' ' N ' ' B' ' 63' ' ' ILE . 8.7 ptm180 -82.72 -43.7 16.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.582 -0.699 . . . . 0.0 109.178 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.709 HD13 ' O ' ' B' ' 59' ' ' ALA . 1.0 OUTLIER -47.23 -32.46 2.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.103 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 61' ' ' ILE . 6.7 mt -70.92 -55.53 8.2 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.659 0.742 . . . . 0.0 109.282 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' B' ' 66' ' ' GLN . 0.3 OUTLIER -62.45 -33.42 74.78 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.522 ' N ' ' HG2' ' B' ' 65' ' ' GLN . 4.6 tt0 -68.19 -43.81 77.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 110.118 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.485 ' O ' HG22 ' B' ' 70' ' ' ILE . 0.1 OUTLIER -73.66 -29.53 62.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.124 -0.985 . . . . 0.0 110.699 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.679 ' O ' HD12 ' B' ' 68' ' ' LEU . 0.1 OUTLIER -76.61 -32.26 57.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.086 -1.009 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.587 ' O ' ' CE2' ' B' ' 72' ' ' PHE . 0.0 OUTLIER -71.75 -24.16 61.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.539 ' HA ' ' HB3' ' B' ' 73' ' ' ARG . 1.3 tp -84.44 -36.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.696 ' CD2' ' CE2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -40.66 -56.33 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.139 0.495 . . . . 0.0 110.339 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' B' ' 69' ' ' PHE . 3.6 p90 -75.41 -2.37 28.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 110.6 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -96.1 -27.16 15.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.608 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' B' ' 78' ' ' HIS . 6.5 mt -132.35 -6.78 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.84 . . . . 0.0 109.899 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 71' ' ' HIS . . . -106.32 -44.72 1.32 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.56 ' CB ' ' HA ' ' B' ' 72' ' ' PHE . 49.1 t -81.21 -17.5 49.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.29 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' B' ' 73' ' ' ARG . 7.8 ptp180 -133.85 25.47 3.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 109.847 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' B' ' 78' ' ' HIS . 9.5 p80 -40.1 140.41 0.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.489 -0.757 . . . . 0.0 110.551 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.76 114.85 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.927 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.658 ' CB ' HD13 ' B' ' 83' ' ' ILE . 58.1 mtm180 -86.73 33.53 0.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 110.133 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm 47.58 90.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.304 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.955 ' C ' HD12 ' B' ' 83' ' ' ILE . . . 101.01 36.67 3.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.955 HD12 ' C ' ' B' ' 82' ' ' GLY . 2.6 mp -139.61 7.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.234 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.428 ' O ' ' CG1' ' B' ' 84' ' ' ILE . 1.1 pt -75.48 65.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.124 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' B' ' 84' ' ' ILE . 0.1 OUTLIER 63.18 156.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.912 . . . . 0.0 110.047 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.51 40.88 31.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -139.18 -61.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.244 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.435 ' HB3' ' CB ' ' B' ' 91' ' ' ASN . 15.3 mtt180 57.03 92.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -67.66 -33.22 74.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.207 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -72.66 -11.82 60.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.269 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' B' ' 88' ' ' ARG . 25.0 t30 -87.33 -80.17 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.3 169.19 52.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' B' ' 94' ' ' SER . . . -80.88 -85.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 93' ' ' ALA . 45.8 p 46.38 58.18 4.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' B' ' 95' ' ' LYS . 0.0 OUTLIER -44.2 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.176 -179.997 . . . . . . . . 0 0 . 1 stop_ save_